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 The restoration and repair of orofacial and large bone defects resulting from 
extreme trauma, disease, or genetic inheritance is a clinical challenge in need of new 
solutions, as current grafting techniques can result in donor site morbidity, graft rejection, 
and/or inadequate bone formation and quality.  Because bone is a complex organ, its 
hierarchical structure may only be restored in such defects if a temporary material guides 
tissue formation.  Bone tissue engineering explores combinations of materials, biological 
signals, and cell sources to achieve guided tissue formation with structure-function 
properties matching those of native tissue.    
By using nature’s building blocks, or amino acids, as a design platform to 
synthesize multi-dimensional biomolecules in the form of peptides, biological function 
can be influenced.  The idea is to provide specificity to induce a desired biological 
activity.  In addition, coating a material with biomimetic bone-like mineral can provide a 
surface morphology and composition similar to the native hydroxyapatite in bone.  While 
bone-like mineral can increase bone growth in vivo, the tissue formed is not uniform or 
spatially controlled, suggesting the need for better-designed scaffolding to 
spatiotemporally influence bone tissue development.  
No studies have investigated the potential impact biomolecule-laden bone-like 
mineral has on influencing cell behavior.  The work presented in this thesis is first to 
design dual-functioning peptides to increase in vitro cell attachment on bone-like mineral.  
Using a combinatorial phage library, computational modeling, and biological assays, 
specific peptide sequences that preferentially adsorb to bone-like mineral and attach to 
clonally derived human bone marrow stromal cells (hBMSCs) were identified.  When 
combined, these sequences formed a dual-functioning peptide that exhibited an increased 
ability to attach hBMSCs compared to previous peptide designs.  Additionally, a 
 xvi 
bioreactor was designed to coat three-dimensional porous scaffolds with uniform, 
continuous bone-like mineral, addressing a need for improved biomimetic coating 
fabrication techniques.  The presented strategies can influence guided bone growth and 
advance the current methodologies in bone engineering.  This work provides a new 
paradigm for peptide development linking organics to inorganics, not only for bone tissue 










Science is often inspired by nature, and the fields of biomimetics and 
biomineralization are no exception.  Examples found in nature that have inspired man-
made materials include calcium phosphate derived bones and teeth and calcium carbonate 
containing mollusk shells.  Hard tissues produced by organisms are created in shapes and 
structures at multiple levels of dimensional scale that are non-trivial to synthetically 
reproduce.  To understand the depth of complexity, one must first understand the 
concepts of biomimetics and biomineralization.  
Biomimetics and Biomineralization 
The field of biomimetics aims to replicate the formation, structure, and function 
of biological entities.  In other words, biomimetics uses the process of mimicry to achieve 
a desired functional effect in a man-made material.   Biomineralization is the process by 
which minerals, or ordered inorganic-organic structures, are fabricated by living 
organisms.  Biominerals are typically composite structures comprised of a precipitated 
inorganic structure intertwined with an organic molecular phase.  A structural hierarchy 
exists within biominerals from the macroscopic level down to the nanoscopic level.  The 
inorganic phase of natural biominerals can range from single crystals to semi-crystalline 
and amorphous phases.  Another striking feature of the development of biominerals in 
nature is that they are formed at ambient or physiological temperatures and pressures.  
The structural control that produces the unique morphologies of biominerals has been 
unmatched by any synthetic material.   The organic components found within biominerals 
have an amazing ability to direct nucleation and growth of the inorganic mineral.  
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Specific organic molecules produced by the organism can inhibit or promote crystal face 
growth to achieve a complex structure with extraordinary mechanical properties.    
We can apply knowledge from biomimetics towards the field of bone tissue 
engineering, which seeks to replace damaged bone tissue by restoring and/or improving 
the complex inorganic-organic bone structure (Langer and Vacanti, 1993).  The work 
presented in this thesis aims to improve the materials and methods used in guided bone 
repair; however, before attempting to do so, pertinent knowledge on bone composition 
and structure is reviewed.   
Basic Bone Biology 
Bones serve a variety of functions including both a structural role (supporting 
body weight, enabling movement, and protecting organs) and a biological role (storing 
calcium, maintaining calcium homeostasis, and producing red blood cells) (Gunn, 1996).  
Bone extracellular matrix is composed of 50-70% inorganic mineral, 20-40% organic 
components (collagen, non-collagenous proteins, lipids, and vascular elements), and 5-
10% water (Robey and Boskey, 2003).  The inorganic mineral phase is a form of 
hydroxyapatite (Ca10(PO4)6(OH)2) that is typically carbonated at 2-7 wt% (Posner et al., 
1984).  The mechanical strength and density of bone are derived from the ability of the 
organism to assemble hydroxyapatite imbedded within an organic matrix (Figure 1.1).  
The mineralization of bone consists of ordering the c-axis of hydroxyapatite crystals 
parallel with Type I collagen molecules.  Precipitation of the apatite onto collagen occurs 
when the ion activity product (IAP) of the surrounding fluid or solution exceeds the 
solubility product of the precipitating phase (Boskey, 1999).  Experimentally reproducing 
the hydroxyapatite structure often results in incorrect stoichiometric chemistries; thus, the 
term bone-like mineral (BLM) will be used to represent the biomimetic apatite phase 
formed synthetically from a supersaturated ionic solution at 37°C.  
Bone-like Mineral and Hydroxyapatite Structure 
The composition of hydroxyapatite is typically written as Ca10(PO4)6(OH)2, 
denoting that two formula units are represented within the unit cell.  The unit cell 
 3 
parameters for hydroxyapatite can vary (a=b=9.32-9.64 Å and c=6.78-6.90 Å) (Nesse, 
2000).  Pure hydroxyapatite has a monoclinic structure, even though fluorapatite 
(Ca5(PO4)3F) is defined as hexagonal, because the non-spherical hydroxyl groups within 
the channel position prevent a required mirror plane in the hexagonal structure definition 
(Figure 1.2).  The hydroxyapatite lattice can accommodate many chemical substitutions, 
most commonly Sr, Ba, Cd, Pb in the Ca position, V, As, S, Si, Ge, CO3 in the P position, 
and F, Cl, O, Br, CO3 in the OH position (Aoki, 1991).  Certain types of substitution can 
elicit an increase or decrease in the unit cell dimensions of apatite.  Slight changes to the 
chemical composition of hydroxyapatite can influence solubility, hardness, and thermal 
stability, among other structural and optical properties (Wopenka and Pasteris, 2005).  As 
an example, fluoride substitutes readily for hydroxyl ions in tooth enamel, increasing the 
apatite’s resistance to dissolution in acidic environments (e.g. soft drinks).  If a perfect 
hydroxyapatite crystal is not formed during crystallization, other phases with varied 
stoichiometries could form (Table 1.1) (Ben-Nissan et al., 1995; Wopenka and Pasteris, 
2005).  
Often, supersaturated solutions can precipitate hydroxyapatite that is deficient in 
calcium, resulting in a less stable form of hydroxyapatite more susceptible to the 
inclusion of impurities (e.g. carbonated apatite).  In synthetic apatites, Type A 
substitution (e.g. CO32- substitutes at the OH- site) occurs at high processing 
temperatures, whereas environments with low temperatures facilitate Type B 
substitutions (e.g. CO32- substitutes at the PO43- site) (Astala and Stott, 2005; Barralet et 
al., 1998).  Carbonated apatite samples are investigated for their ability to adsorb 
biological molecules in the form of peptides in Aim 2.  The apatite-based samples 
sintered at 1350°C are expected to possess Type A CO32- substitutions when carbonate is 
detected, whereas the apatite-based mineral precipitated on polymer films at 37°C 
possess Type B CO32- substitutions.  
Biomimetically precipitating bone-like mineral onto a substrate begins with the 
nucleation of bone-like apatite precursors from a supersaturated ionic solution, often 
called simulated body fluid.  Simulated body fluid (SBF) is comprised of similar ion 
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concentrations as those found in human serum (Table 1.2) (Kokubo, 1996).  By 
controlling the pH, temperature, and ionic concentration within the solution, the 
nucleation of precursors can be controlled.  Homogenous precipitation can also occur if 
these factors are changed, leaving a precipitated phase within the solution.  However, the 
objective of biomineralizing substrates with bone-like mineral is to coat the material via 
heterogeneous precipitation.  In order to maintain film formation, the thermodynamics of 
the system must be held between homogeneous precipitation and the solute saturation 
limit (Figure 1.3) (Bunker et al., 1994). To drive heterogeneous precipitation, the net 
energy between a nucleated precursor and the substrate must be less than the net energy 
of the nucleated precursor within the ionic solution (Bunker et al., 1994).  A biomimetic 
layer of BLM precipitated on organic, biodegradable polymer films and scaffolds serve 
as the apatite-based substrate investigated throughout this thesis.  
Bone Tissue Engineering 
The restoration and repair of orofacial defects resulting from disease, trauma, or 
genetic inheritance is still a major clinical challenge (Feinberg et al., 2005; Muschler and 
Midura, 2002; Parikh, 2002; Wiesmann et al., 2004).  Autogenous bone grafting is the 
current method used in repairing skeletal defects; however, limitations of donor site 
morbidity, graft rejection, inadequate bone formation and quality often result (Ducheyne 
and Qiu, 1999; Parikh, 2002; Yaszemski et al., 1996).  Current concepts in bone tissue 
engineering strive to induce bone formation using a combination of scaffolding, cells, and 
biological signals (Garcia and Reyes, 2005; Hubbell, 1999; Maskarinec and Tirrell, 2005; 
Shin et al., 2003).  Three approaches have been identified in the tissue engineering field: 
conduction, induction, and cell transplantation (Alsberg et al., 2001; Hirano and Mooney, 
2004).  Initial research has focused on the conduction approach to recruit host cells 
towards an implanted material and initiate bone regeneration.  Inductive approaches of 
incorporating cell-recruiting factors/molecules in or on the implant are used to improve 
the quality and amount of bone formation (Chen and Mooney, 2003).  In parallel, 
explanted cells, such as bone marrow stromal cells (BMSCs), seeded on substrates and 
then implanted to direct bone formation has been explored (Rose and Oreffo, 2002). An 
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advantage to using BMSCs is that they are readily available in most patients in need of 
bone defect repair, allowing for autologous expansion ex vivo.  The expansion capability 
of BMSC is also advantageous, as these cells secrete paracrine factors that promote 
osteogenic growth and differentiation.  Other cells seeded on these constructs have 
consisted of established bone cell lines, cells capable of genetic manipulation or viral 
infection, and stem cells.  In Aim 1 of this thesis, phage panning experiments are used to 
identify peptide sequences that preferentially bind to a population of clonally derived 
human bone marrow stromal cells (hBMSCs).  These peptide sequences are then linked 
to an apatite-seeking sequence and jointly investigated for their potential to increase 
hBMSC attachment to BLM in Aim 3.   
The organic, biodegradable class of polymers named the poly(α-hydroxyesters) 
that include poly-L-lactic acid (PLLA), polyglycolic acid (PGA), and polylactic-co-
glycolic acid (PLGA), have been fabricated into inter-connected, porous structures (Chen 
et al., 2000; Ma and Langer, 1999; Mikos et al., 1994) and studied for osteogenic 
potential as bone graft materials (Ishaug et al., 1994). PLGA as a substrate material is 
well established because it is easily fabricated into two- and three-dimensional structures 
that degrade in the body within 6-24 months, depending on the ratio of PLLA to PGA.  
To control the function of explanted cells and direct new tissue growth, a consensus of 
desired scaffold properties has emerged.  The implanted scaffold needs to be 
biocompatible, non-toxic, biodegradable, and structurally sound (Liu and Ma, 2004; 
Wiesmann et al., 2004; Yaszemski et al., 1996).  Additional features identified include 
ideal pore size for osseoinduction and vascularization, ability to control material 
degradation rate to match tissue formation rate, and incorporation and controlled release 
of biomolecules. While poly(α-hydroxyesters) possess the biodegradability necessary for 
an implant material to guide bone growth, the surface composition and mechanical 
integrity of PLGA are not the same as that of native bone or the ceramic and metallic 
materials used for bone implants.  
The technique of biomimetically precipitating apatite onto the surface of a 
biomaterial was introduced on titanium implants to induce implant-bone osseointegration 
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(Abe et al., 1990).  Using the biomimetic technique in bone scaffolding has evolved into 
mineralizing biodegradable polymeric scaffolds with the intent of tailoring calcium-
phosphate ratios to evoke particular cell responses. The design goals of using a 
biomimetic technique to precipitate a mineral layer on bone scaffolding aim to reduce the 
time of apatite formation, to tailor calcium-phosphate ratios, and to mineralize the interior 
of three-dimensional scaffolding (Oliveira et al., 2003).  Altering compositional or 
surface characteristics of the material can alter biological responses, such as increased 
tissue growth or cell death (apoptosis).  Biomimetically precipitated apatite is 
hypothesized to recruit host cells as well as have the ability to control the differentiation 
of explanted cells towards a bone phenotype (Luong et al., 2006).  Still, the technique of 
biomimetically precipitating apatite is an alternative to high temperature ceramic 
processing methods (Habibovic et al., 2002) that also increases the mechanical integrity 
of PLGA scaffolding (Murphy et al., 2000). While continuous growth of apatite on three-
dimensional (3D) PLGA scaffolds is attainable, the apatite precipitated is not uniform, 
does not completely cover the surface of the scaffold, and takes at least 16 days to 
precipitate (Murphy and Mooney, 2002; Murphy et al., 2000; Zhang and Ma, 2004).  To 
increase the amount of bone growth in three dimensions, a PLGA scaffold uniformly 
coated with biomimetically-precipitated apatite is necessary, particularly for thick porous 
constructs (> 2 mm in thickness).  In Aim 4, flow induction via a bioreactor capable of 
three-dimensional mineralization of PLGA scaffolds addresses this current limitation in 
the field of bone tissue engineering.  Increased mineral coverage in three-dimensions 
would prove useful not only for PLGA porous scaffolds, but also metallic or other 
polymeric materials used in bone scaffolding design.  
Protein Engineering 
The complex role of proteins in bone formation continues to stimulate new 
research regarding which specific proteins are agonists or antagonists to bone growth 
and/or resorption.  As proteins are identified and their functions are elucidated, they can 
be implemented in bone scaffold designs via protein engineering to control a specific cell 
function.  Protein engineering employs rational design of protein polymers using 
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enzymes, cells, or synthetic methods.  An ultimate goal of protein engineering is to use 
nature’s building blocks, or amino acids, as a design platform to synthesize multi-
dimensional biomolecules that contain multiple levels of organization that influence 
biological function.  In Aim 1, phage panning, computational modeling, and biological 
assays are used to identify amino acid sequences that bind to apatite-based materials and 
hBMSCs, independently.  The apatite-binding and hBMSC-binding sequences are then 
linked, and the peptide design is tested for its ability to increase cell attachment with and 
without the designed peptides on BLM in Aim 3.   
Surface Modification via Peptides to Increase Biological Function 
A strategy in controlling cell function includes presenting biomolecules on the 
bone-like apatite surface.  Growth factors and peptides have been ionically or covalently 
attached to surfaces to increase cell adhesion, and ultimately, the amount of bone growth. 
While several proteins enhance cell adhesion, proteins are subject to isolation and prone 
to degradation (Hersel et al., 2003).  Proteins can also change conformation or orientation 
because they possess sections with varying hydrophobicities that control cellular 
functions other than adhesion.  On the other hand, peptides can mimic the same response 
as a protein while being smaller, cheaper, and less susceptible to degradation.   Peptides 
have a greater potential for controlling initial biological activity, because they can contain 
specific target amino acid sequences and can permit control of hydrophilic properties 
through sequence design (Ladner et al., 2004).  Identifying peptide sequences on apatite 
could prove beneficial in designing molecules for guided bone repair.    
Understanding the steps involved in cell adhesion is imperative when trying to 
link the influence of a peptide. Cell adhesion progresses in four steps: cell attachment, 
cell spreading, production of organized actin filaments, and focal adhesion formation 
(Figure 1.4) (LeBaron and Athanasiou, 2000).  The importance of cell adhesion has been 
demonstrated in a variety of tissues including the differentiation of myoblasts (Menko 
and Boettiger, 1987), terminal keratinocytes (Adams and Watt, 1990), mammary 
epithelium (Streuli et al., 1991), and osteoblasts (Damsky, 1999).  Since cell attachment 
is the first step of adhesion, Aim 3 of this work strives to show hBMSC cell attachment 
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can be increased with the design of peptides that both adhere to apatite and to hBMSCs.  
Establishing cell attachment is essential in guided bone repair, as the subsequent 
phenotypic differentiation cannot occur if cells do not attach. 
Identification of short recognition sequences has motivated the development of 
bioactive materials that can recruit a certain cell population to adhere to a material 
surface via specific integrin mediated bonding.  One peptide that interacts with a variety 
of cell adhesion receptors, including those on osteoblasts, is the RGD (Arg-Gly-Asp) 
sequence (Hersel et al., 2003). The RGD binding sequence, first found in fibronectin, is 
an adhesion sequence that interacts with multiple adhesion receptors including the αVβ3 
integrin that binds not only to vitronectin and fibronectin, but to the bone proteins 
osteopontin and bone sialoprotein (Hersel et al., 2003).  RGD sequences can act as 
inhibitors of cell adhesion if present in solution, even though they promote cellular 
adhesion when adsorbed on a material surface (Ruoslahti, 1996).  Utilizing the RGD 
sequence is one way to create a more attractive surface for cells to regenerate bone.  
Other peptide sequences mimic sections of extracellular matrix proteins that include bone 
sialoprotein (Fujisawa et al., 1997), osteopontin (Gilbert et al., 2000; Shin et al., 2004a; 
Shin et al., 2004b), fibronectin (Huebsch et al., 1996), statherin (Gilbert et al., 2000; 
Shaw et al., 2000a), elastin (Simionescu et al., 2005), and osteonectin (Fujisawa et al., 
1996) and have been examined for increased cell attachment, proliferation, and 
differentiation.  Peptide sequences have also been designed to increase cellular adhesion 
to titanium (Ferris et al., 1999; Verrier et al., 2002), to provide conformational stability 
via cyclic RGD sequences (Pallu et al., 2003), or to model non-RGD adhesion 
mechanisms of the heparin binding domain (Dalton et al., 1995; Dee et al., 1998). A 
limited list of adhesion peptide sequences, other than RGD, involved in cell integrin-
ligand binding includes PSHRN (Benoit and Anseth, 2005), FHRRIKA (Rezania and 
Healy, 1999) and YIGSR (Massia and Hubbell, 1990).  
Peptides have been designed to bind to PLGA, sintered hydroxyapatite, and glass, 
but have not yet been designed to adhere to biomimetic BLM.  BLM as an apatite-based 
coating has potential to impact current bone biomaterials as it has been shown to increase 
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bone growth in vivo, increase murine bone marrow stromal cells spreading in vitro, and 
controls surface dissolution behavior via tailored SBF solutions, making it an attractive 
candidate to investigate (Kohn et al., 2005; Leonova et al., 2006; Shin et al., 2007).  
Hydroxyapatite binding sites have been divided into two classes: those involved in post-
translational modifications (phosphorylated amino acid and gammacarboxyglutamic acid 
sequences) and consecutive basic amino acid sequences (poly-Glu, poly-Asp) (Fujisawa 
et al., 1996).  While these peptide design guidelines are a starting point for BLM peptide 
design, the approach of identifying peptide sequences that preferentially bind to apatite-
based materials via combinatorial libraries is a novel one that is tested in Aim 1.  The 
peptide sequences identified using the combinatorial libraries are tested against a peptide 
designed using conventional methods of joining RGD with a polyglutamic acid chain 
(EEEEEEEPRGDT or E7PRGDT).  It is possible that the non-specific RGD sequence 
may not be appropriate for all cell sources, particularly those used for bone regeneration, 
and alternative methods of peptide design and discovery are necessary to apply protein 
engineering principles towards a BLM coated scaffold.     
Regardless of material, engineered peptides need to be presented on the substrate 
surface in a manner that will stimulate bone tissue formation.  Peptides are typically 
presented on the surface of apatite-based substrates using surface adsorption, as ceramics 
are not as conducive to surface modifications as polymer or metals.  Since BLM and 
other apatite-based materials are used throughout the aims tested, surface adsorption is 
the main method of peptide adhesion throughout this thesis. 
Surface Adsorption and Quantification of Peptides 
Surface adsorption is a simple way to introduce peptides onto a substrate.  The 
preparation of peptide solutions prior to adsorption onto a substrate includes 
reconstituting the peptide in water or a buffer solution.  The concentration the peptide 
depends on the aim of the experiment, but a typical range of concentrations used is 
between 1-250 µg/mL.  Therefore, the amount of peptide that physically adsorbs to the 
surface should be accurately quantified to better elucidate the role of peptide 
concentration on the observed biological response.  Properties of the substrate that can 
 10 
influence peptide adsorption include chemistry, morphology, and surface charge.  
Consistent peptide adsorption can only occur when substrate properties, peptide 
concentrations, and solution contents do not vary.  Too much or too little peptide can 
have no effect or can cause adverse cell behavior.  Amino acid analysis, a method that 
determines the quantity of each amino acid in solution, is one of the most accurate 
quantification techniques.  However, since amino acid analysis is expensive to perform 
on large sample sets, peptide concentrations are approximated by fluorescence or 
absorbance characterization (Barber et al., 2005). When a direct peptide quantification 
method is not published, researchers often report initial peptide concentrations of the 
solutions used in the experiment.  Peptide adsorption assays are utilized in Aims 1, 2, and 
3 of the work presented, and as such, care was taken to develop reliable methods of 
detecting peptide adsorption.  UV Spectrophotometry was used to quantify peptide 
present for standard curves (Appendix B) and peptides adsorbed on multiple apatite-
based materials.  The initial peptide concentration introduced to the substrates was also 
analyzed via amino acid analysis.   
Another aspect of investigating the interaction between cells and a substrate 
includes determining the strength of cell adhesion to the surface.  Decreased cell adhesion 
can result from changing a single amino acid in a peptide sequence, particularly when the 
change is within a region of the peptide known to contribute to cell adhesion mechanisms 
(e.g. replacing the aspartic acid in RGD with a glutamic acid, making it RGE) (Rezania et 
al., 1997).  These initial results indicate that cell adhesion strength is increased when an 
RGD peptide is present on the surface, mainly because of increased cell spreading.  In the 
presented work, peptides designed with RGD and RGE sequences were used as controls 
and are investigated in Aim 3 for their ability to influence hBMSC attachment compared 
with dual-functioning peptides designed in Aim 1.   
Phage Display 
A complete set of sequences known to adhere to the variety of materials used in 
bone tissue engineering would provide better design guidelines when designing a 
biomaterial. Aim 1 of this thesis describes the use combinatorial phage display 
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technology to elucidate specific sequences or sequence patterns that adhere to apatite-
based materials and a population of clonally derived hBMSC.  Phage display 
technologies introduce a combinatorial library (on the order of 109 sequences) of 7-mer 
or 12-mer linear peptide sequences to a molecule, ligand, or material.  The concept 
behind phage display is to create an oligonucleotide insertion mutation on the gene of a 
virus (typically M13 bacteriophage) allowing a library of sequences to be expressed on 
the exterior protein coat of the phage (Rodi and Makowski, 1999).  After several rounds 
of panning, or expanding and reintroducing the sequences that adhere, consensus 
sequences emerge and are identified by DNA sequencing (Figure 1.5).  Although this 
technology has been mostly used in identifying enzyme substrates and inhibitors, DNA 
and protein binding peptides, tissue specific peptides, and receptors (Ladner et al., 2004; 
Marks and Marks, 1996; Uchiyama et al., 2005), the principle of the technique can be 
applied to identifying peptides that have high specificity to biomaterials.  The phage 
display technique has proven effective for a variety of inorganic substrates such as silver, 
palladium, platinum, titanium, and carbon nanotubes, in addition to organic plastics 
(Adey et al., 1995; Kriplani and Kay, 2005).  Moreover, the usefulness of phage display 
in cell adhesion research has been shown through the isolation of integrin receptor 
sequences that bind to RGD (Pasqualini et al., 1995).  Peptide sequences identified from 
panning experiments introducing a combinatorial 12-mer phage library on apatite-based 
substrates and hBMSCs are analyzed in Aim 1 using a bioinformatics tool, RELIC 
(REceptor LIgand Contacts) (Mandava et al., 2004), specifically designed to analyze data 
generated using phage display libraries (Makowski and Soares, 2003; Rodi et al., 2004).  
Modeling Apatite 
The experimental techniques utilized to investigate peptide secondary structure 
and structure-function relationships that are responsible for adhesion receptor specificity 
(Reyes and Garcia, 2003b; Stayton et al., 2003) are often expensive and time consuming; 
therefore, molecular modeling is being used to investigate organic-inorganic interactions. 
Modeling is useful in investigating protein-substrate and peptide-substrate interactions in 
calcite, calcium oxalate, and apatite systems (Dahlin et al., 1998; Fujisawa and Kuboki, 
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1998; Qiu et al., 2004).  Molecular modeling is also used to model carbonate substitution 
within the hydroxyapatite lattice.  Because synthetic apatite, including BLM formed from 
SBF, is often carbonated, models determining favored carbonate substitution locations 
within the lattice are useful.  Using extracted model information, the composition and 
type of carbonate substitutions can be tailored when fabricating synthetic apatite. 
Simulated inorganic lattice structures and organic-inorganic interfaces can be observed at 
varied temperatures, pressures, and levels of hydration.  Utilizing a model provides 
insight to unobservable interactions and can compliment bench-top experimental 
analysis.  In the presented work, molecular modeling was used to investigate the behavior 
of a group of peptides isolated from phage panning in Aim 1 on apatite-based materials 
on a hydroxyapatite lattice.  Modeling data of peptide adsorption behavior on the (001) 
hydroxyapatite face and a [010] step on the (001) hydroxyapatite face, aimed to isolate 
peptide sequences having the highest adsorption energies to the hydroxyapatite lattice.  
Modeling Approaches 
In order to represent accurate lattice structures, the positions and bond angles of 
all of the atoms in the lattice and the locations of substitutions are important parameters 
needed in both ab initio and empirical modeling.  Empirical modeling performs 
simulations on crystal structures with experimentally defined lattice parameters (via 
molecular mechanics), whereas ab inito modeling performs simulations on atoms to 
determine their positions with respect to one another (via quantum mechanics).  Prior to 
modeling with organic-inorganic interactions, an inorganic lattice structure must first be 
defined and well understood.   
Molecular modeling can be performed on a cluster or periodic structure.  A 
molecular mechanics, or empirical, approach requires a force field, developed either ab 
initio or experimentally, and a structure.  A force field defines the molecular mechanics 
of the system in question using parameterized analytical expressions (Cygan RT, 2001).   
Molecular modeling using empirical methods utilizes molecular mechanics to perform 
calculations during the simulations.  Molecular mechanics simulations use Newtonian 
physics in a time dependent manner to calculate the forces on a system.  Energy 
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minimizations, conformational analyses, lattice dynamics, molecular dynamics, and 
Monte Carlo simulations are examples of molecular mechanics modeling (Cygan RT, 
2001).  Molecular dynamics is an atomistic simulation technique that uses Newton’s Law 
of Motion with updated atom positions and velocities during numerical calculation.  
While running molecular dynamics increases computing times, it has the advantage that it 
can also be applied to fluids (Parker et al., 2001).  Because the various approaches to 
modeling a system evaluate the energy of a system, they have similar outputs including: 
structure information, physical properties, thermodynamic data, kinetic information, and 
spectroscopy predictions (Gale and Rohl, 2003).   
The development of the General Utility Lattice Program (GULP) has enabled 
simulations on solid-state structures and structural defects (Gale and Rohl, 2003).  GULP 
can be utilized to develop force fields.  An example of the types of potential energy terms 
that can be included within a force field are bonded energy terms (bond stretching, angle 
bending, and dihedral torsion) and non-bonded energy terms (van der Waals, and/or 
Coulombic interactions) (Equation 1). 
ETotal = Enon-bonded energy terms + Ebonded energy terms    [1]  
The Universal Force Field (UFF) is a force field applicable to a range of 
molecular systems used in both inorganic and organic simulations (Rappe et al., 1992). 
However, the UFF cannot be solely utilized in these applications, because it does not 
define molecular interactions between the inorganic lattice and the organic molecules.  
As a result, an accurate force field describing interactions between the inorganic apatite 
lattice and organic molecules is also essential.  Much effort has been put into modeling 
the different stoichiometric and structural variations of apatite in order to reveal 
unrecognized alternatives that were not defined when the definition of apatite was 
recorded over 70 years ago (Hughes et al., 1989; Hughes et al., 1990).  Rigid and flexible 
models of fluorapatite and hydroxyapatite have also been produced (Hauptmann et al., 
2003).  
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Modeling Inorganic-Organic Interactions 
Evidence of acidic proteins participating in bone precipitation has led 
investigators to consider the involvement of acidic peptides or acidic portions of proteins 
on nascent bone crystal formation and existing bone apatite crystals (Dahlin et al., 1998; 
Fujisawa and Kuboki, 1998; Gilbert et al., 2000; Moradianoldak et al., 1992; Sarig, 
2004).  Evidence that bone proteins contain large portions of aspartic and glutamic acid 
residues has also supported the hypothesis that acidic regions are participating during 
bone formation.  Presence of glutamic and aspartic acids is thought to be the mechanism 
of association of negatively charged peptides with the apatite mineral (Glimcher, 1984; 
Moradianoldak et al., 1992; Sahai, 2005).  Because the apatite lattice is complex and 
conformations of all of the bone proteins thought to be involved are unknown, it has been 
difficult to pinpoint the exact interactions between the organic and inorganic components 
of the system.  To complicate things, some bone proteins have been identified as both 
promoters and inhibitors of bone formation (Robey and Boskey, 2003).  Modeling the 
interaction of an entire protein requires intense computer calculations, which is time 
consuming.  Thus, modeling peptides or small proteins (≤ 30 kDa) is a feasible 
alternative.   
In Aim 1, computational modeling strives to elucidate peptide sequences with 
high adsorption energies on a hydroxyapatite lattice.  The peptide-hydroxyapatite 
computational model used aimed to provide a high-throughput validation technique 
where multiple interactions can be investigated prior to in vitro or in vivo testing.    
Hypothesis and Aims 
The clinical need for improved strategies for guided bone growth exists.  In 
addition, the incorporation of biological molecules is important in synthetic materials in 
directing cellular behavior.  The aims of this thesis were structured to improve 
biomolecular design and biomimetic coating techniques used to regenerate bone.  Multi-




Global Hypothesis: Dual-functioning peptide sequences designed to both 
specifically adhere to apatite-based materials and human bone marrow stromal 
cells (hBMSC) will increase cell attachment on bone-like mineral.   
 
To test this global hypothesis, phage display, a modified ELISA, and computational 
modeling were combined to derive peptide sequences specific to apatite-based materials.  
Peptide sequences from a combinatorial library population that preferentially bind to 
hBMSCs were also found using phage display and immunohistochemistry techniques.  
Combining the apatite-binding sequence with the hBMSC preferential binding sequence 
yielded dual-functioning peptides that were tested for their cell attachment properties 
using a centrifugation assay.  Furthermore, a bioreactor system was designed to nucleate 
and precipitate a uniform, continuous bone-like mineral layer on three-dimensional 
PLGA porous scaffolds. Four aims were addressed in the presented work. 
 
Hypothesis 1a:  Amino acid sequences that strongly adhere to biomimetically-
precipitated apatite, or bone-like mineral, and hBMSCs are identifiable using preferential 
adherence experiments, such as a combinatorial phage library. 
Hypothesis 1b:  Computational modeling peptide sequences from the apatite-adherent 
phage in Aim 1 can elucidate peptides with favorable binding energies on a 
hydroxyapatite lattice. 
Aim 1:   Design dual-functioning adhesion peptides that adsorb to biomimetic apatite and 
promote hBMSC attachment.  Phage display technology determined 12-mer peptide 
sequences that have the specificity to adsorb to biomimetic apatite through multiple 
rounds of panning.  Peptide sequences obtained through DNA analysis were analyzed 
using the bioinformatics tool (RELIC) specifically designed to analyze data generated 
using phage display libraries.  A modified ELISA verified that the isolated phage 
sequences were preferentially being adsorbed to the apatite-based materials. The 
adsorption potential of designed peptides on apatite via computational modeling were 
determined using molecular simulations (Cerius2 and Materials Studio v3.1) on a 
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hydroxyapatite step defect in the [010] direction on the (001) face, in addition to a 
hydroxyapatite slab structure on (001) face. The computational modeling was used to 
identify sequences with favorable binding energies.   A subset of 2-4 peptides based on 
validation via RELIC analysis, ELISA, and computational modeling, was further 
evaluated in Aim 3.  Immunohistochemistry was used to verify identified phage binding 
on hBMSCs.  Generated sequences were compared to protein sequences available on the 
Protein Database (PDB) to identify specific regions of proteins that may be involved in 
cell adhesion.   
 
Hypothesis 2:  Because the incorporation of carbonate into the hydroxyapatite lattice can 
alter surface charge periodicity, carbonate incorporated in hydroxyapatite will decrease 
adsorption of apatite-adherent peptides derived in Aim 1.   
Aim 2:  Investigate the adsorption of synthetic, apatite-adherent peptides on apatite-based 
materials.  Four apatite-based materials with a range of CO32- from 0-5wt% and differing 
carbonate substitutions were fabricated.  Absorbance readings via UV Spectrophotometry 
quantified the amount of peptide adsorbed to each material.  Material characterization 
methods (scanning electron microscopy, Fourier-transform infrared spectroscopy, x-ray 
diffraction, ‘Brunauer-Emmett-Teller’ method) were performed on all apatite-based 
substrates to verify compositions and surface areas.  Peptide adsorption was normalized 
to each material using surface area data to elucidate the effect of CO32- incorporation on 
peptide adsorption.  
 
Hypothesis 3:  Adsorbing peptide sequences designed in Aim 1 onto bone-like mineral 
will improve initial hBMSC attachment compared to bone-like mineral devoid of peptide.   
Aim 3:  Determine if functionalizing biomimetic apatite with the designed dual-
functioning adhesion peptide sequences increases hBMSC attachment.  Bone like-mineral 
coated PLGA films were used to investigate the potential advantage of adsorbed peptides 
to improve initial cell adhesion.  Absorbance readings on a UV Spectrophotometer were 
used to quantify the amount of peptide adsorbed to each material.  The number of 
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attached hBMSCs to control and peptide-laden samples was determined using 
centrifugation and WST-1 assays, where the WST-1 assay only detected living cells.  
 
Hypothesis 4:  Induction of fluid flow through the pores of a polymer scaffold will 
provide a favorable thermodynamic environment for a uniform, continuous layer of bone-
like mineral to nucleate and precipitate. 
Aim 4:  Develop a method of uniformly coating a continuous layer of bone-like mineral 
on the surface of porous structures.  A bioreactor capable of holding multiple porous 
scaffolds was constructed capable of inducing fluid flow through the pores of the 
scaffolds.  A model protein, bovine serum albumin, was coprecipitated to demonstrate 
feasibility of biomolecular incorporation.  Uniform, continuous mineral formation and 
protein incorporation throughout the thickness of the scaffolds were characterized using 
confocal microscopy, micro-computed tomography, Fourier transform infrared 
spectroscopy, x-ray diffraction, and the bicinchoninic (BCA) protein quantification assay.   
 
Chapter Two discusses the identification and validation of peptide sequences that 
adhere to apatite-based materials as presented in Aim 1.  Through a rigorous, tri-fold 
validation combining bioinformatics, an established biological assay, and computational 
modeling, three 12-mer peptide sequences, were identified as preferential apatite-binding 
peptides.  The hypothesis in Aim 2, discussing how the incorporation of carbonate into 
the hydroxyapatite lattice can alter surface charge periodicity and therefore peptide 
adsorption is also discussed in Chapter Two.  Chapter Three presents data testing Aims 1 
and 3, identifying hBMSC preferential binding-sequences, in addition to the adsorption 
and cell adhesion trends of the dual-functioning peptides, respectively.  The dual-
functioning peptides influence on cell attachment to bone-like mineral compared to the 
peptide E7PRGDT is also presented.  This method of identifying preferential binding 
sequences to cell populations is a new approach to selecting or recruiting specific cell 
populations in vitro or in vivo.  Finally, data corresponding to the bioreactor design and 
validation hypothesized in Aim 4 are presented in Chapter Four.  Inducing fluid flow 
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through the pores of hydrophobic polymeric scaffolds to improve mineral nucleation and 
precipitation throughout the thickness is tested.  
   The collected work presented provides alternative design methods that can 
implement peptide sequences capable of improving initial hBMSC adhesion.  This work 
is first to present detailed methods on how peptides can be rationally designed using 
phage display, established biological assays, and computational modeling.  Furthermore, 
while advancing the current biomolecular design paradigm, this work also improves upon 
traditional methods used in fabricating BLM coatings on current bone regenerative 
materials.  Ultimately, the peptide design scheme presented can be used in disciplines 
unrelated to bone to improve tissue development in other areas of the body, be used in 
multi-tissue platforms that involve bone (e.g. bone-tendon research), or be used even in 




Figure 1.1:  Hierarchical Bone Structure.  The schematic shows some of the many levels 
of hierarchy found in bone, from the macroscopic whole bone down to the atomic level 
arrangement of calcium and phosphate ions to form hydroxyapatite, the main inorganic 
phase.  Organic collagen molecules serve as templates during bone formation and 
remodeling for appropriate thermodynamic conditions to occur, allowing hydroxyapatite 




Figure 1.2:  Hydroxyapatite Lattice Structure. Hydroxyapatite, Ca10(PO4)6(OH)2, is the 
main inorganic phase present in bones and teeth.  The hexagonal symmetry is evident 
when looking at the (001), and the unit cell parameters fall between a=b=9.32-9.64 Å and 
c=6.78-6.90 Å, with α = γ = 90°, β = 150° (Nesse, 2000).  The OH- ions are situated in 
the middle of the hexagonal channels of Ca2+ ions, as indicated in the figure by the X.  
Synthetic formation of hydroxyapatite often produces impurities in the form of carbonate 
substitutions.  Type A substitution, where CO32- substitutes at the OH- channel site, 
occurs at high processing temperatures, whereas environments with low temperatures 
facilitate Type B substitutions, where CO32- substitutes at the PO43- site (Astala and Stott, 
2005; Barralet et al., 1998). 
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Figure 1.3:  Thermodynamic Conditions for Film Formation.  General solubility diagram 
for the formation of films in water (adapted from Bunker et al., 1994).  Solutes are 
dissolved in water (A) in concentrations that create a supersaturated solution (B).  During 
film formation, heterogeneous precipitation is occurring on the substrate, depleting the 
solution from some solute (C).  This process is regulated by the concentration of solute 
present in solution, pH, and temperature.   Therefore, this schematic provides a two-
dimensional design domain at 37°C for heterogeneous bone-like mineral deposition.  For 
a bone-like mineral to precipitate heterogeneously on a substrate the product of the 
concentrations of Ca2+, PO43-, and OH- must be greater than 10-114M, or 
[Ca]5[PO4]3[OH]2 ≥ 10-114M. 
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Figure 1.4:  Steps Involved in Cell Adhesion. (a) Cell adhesion to a material begins when 
cell receptors recognize adsorbed or attached biomolecules.  (b) The cell begins to spread 
out after recognizing the biomolecules. (c) Actin filaments, or organized protein 
structures, begin to form after the cell flattens. (d) The organization of actin filaments 
allows focal adhesions to form.  (e) The bone-like apatite can contain and present 
multiple biomolecules that can initiate the beginning stages of cell adhesion. (f) 
Development of second generation biomolecules will allow specified cell receptors to 
attach to the biomolecules present on the material.         
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Figure 1.5:  Phage Display Schematic.  A combinatorial library housing ~109 different 
12-mer peptides on the protein coat of bacteriophage, or phage, is introduced to a 
substrate of interest.  The substrate is rigorously washed, and the high affinity phage are 
eluted and amplified, constituting one round of panning.  The amplified high affinity 
phage are reintroduced to the substrate for successive rounds of panning to eliminate non-
specific binding phage.  After multiple rounds of panning, the DNA of the phage are 
sequenced and the 12-mer peptides with high affinity to the substrate are identified.  
 24 
 
Table 1.1:  Formulas and Names for Common Non-Stoichiometric Apatite Phases (Ben-











IDENTIFICATION OF PREFERENTIAL BINDING PEPTIDES ON APATITE-
BASED MATERIALS AND AN INVESTIGATION OF THEIR SURFACE 
ADSORPTION  
Introduction 
 Understanding biomimetic principles of replicating the formation and structure of 
tissues can aid in restoring organ function.  Repair and restoration of orofacial and long-
bone defects caused by trauma or disease could benefit from advances, as current grafting 
methods have limitations of donor site morbidity, graft rejection, and/or inadequate bone 
formation and quality (Ducheyne and Qiu, 1999; Feinberg et al., 2005; Muschler and 
Midura, 2002; Parikh, 2002; Wiesmann et al., 2004; Yaszemski et al., 1996).  
 Concepts in bone tissue engineering strive to induce bone formation using a 
combination of scaffolding, biological signals, and cells (Alsberg et al., 2001; Garcia and 
Reyes, 2005; Hubbell, 1999; Maskarinec and Tirrell, 2005; Shin et al., 2003).  A number 
of scaffold materials, such as biodegradable polymers (Chen et al., 2000; Ishaug et al., 
1994; Ma and Langer, 1999; Mikos et al., 1994), titanium (Ferris et al., 1999; Verrier et 
al., 2002), calcium phosphate-based ceramics (Barrere et al., 2003; Ignatius et al., 2001; 
LeGeros, 1991; de Groot et al., 1998) and glass (Garcia et al., 1998; Lobel and Hench, 
1998) have been investigated for their ability to elicit the formation of bone tissue with or 
without donor cells.  The variety of material choice stems from the requirements that 
bone implant materials should demonstrate biocompatibility, mechanical integrity, and 
biodegradability (Liu and Ma, 2004; Wiesmann et al., 2004; Yaszemski et al., 1996).  
Both the composition and the surface morphology of an implanted material influence 
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protein adsorption and the subsequent cell adhesion (Anselme et al., 2000; Garcia et al., 
1998; Healy et al., 1996; Kilpadi et al., 2001; Prime and Whitesides, 1991; Redey et al., 
1999).   Cell adhesion is important for survival, proliferation, and differentiation of 
multiple cell types, including osteoblasts (Adams and Watt, 1990; Damsky, 1999; Menko 
and Boettiger, 1987; Streuli et al., 1991).   
 While both proteins and peptides can promote cell adhesion on biomaterials, 
peptides have advantages over proteins in that they are smaller, cheaper, less susceptible 
to degradation, and can be fabricated quickly which increases availability, all while 
containing specific target amino acid sequences (Hersel et al., 2003; Ladner et al., 2004).  
Furthermore, peptide fabrication does not involve purification from an animal source, 
eliminating the chance of an immune response in the recipient.  These advantages led to 
the development of peptide sequences that mimic sections of extracellular matrix 
proteins, including bone sialoprotein (Fujisawa et al., 1997), osteopontin (Gilbert et al., 
2000; Shin et al., 2004b), fibronectin (Huebsch et al., 1996), statherin (Gilbert et al., 
2000; Shaw et al., 2000a; Shaw et al., 2000b), elastin (Simionescu et al., 2005), and 
osteonectin (Fujisawa et al., 1996) for improved cell adhesion, proliferation and 
osteoblastic differentiation.  Peptide sequences, other than the common cell adhesion 
sequence RGD (Hersel et al., 2003), involved in integrin-ligand binding that have been 
identified from extracellular matrix proteins are limited, but include PSHRN (Benoit and 
Anseth, 2005), FHRRIKA (Rezania and Healy, 1999), and YIGSR (Massia and Hubbell, 
1990).  Research investigating the effect of peptide composition and density on cell 
adhesion to poly-lactic-co-glycolic-acidic (PLGA) polymers, glass, and sintered 
hydroxyapatite has shown that optimal peptide quantities and conformations are required 
to elicit a cellular response.   
 Hydroxyapatite (HA) can fill bone defects and accelerate osseointegration 
(Geesink, 2002).  HA can also be made osteoinductive by incorporation, attachment, or 
adsorption of biological factors such as growth factors, DNA, proteins, and peptides 
(Alsberg et al., 2001).  However, the efficacy of incorporated biological factors is limited 
by processing conditions (e.g. >1000°C sintering temperatures); hence, biomimetic 
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formation of bone-like mineral (BLM) via incubation in supersaturated solutions 
maintaining ion concentrations appropriate for heterogeneous precipitation (Kokubo, 
1995) is an attractive alternative because the benign processing temperature of 37°C 
permits the retention of biomolecular function.  The biomimetic method of forming BLM 
on a biodegradable polymeric substrate provides a conductive apatite layer with 
controlled stoichiometries (Shin et al., 2007), that induces increased osteogenesis in vivo 
(Kohn et al., 2005) and that provides a template for coprecipitation and adsorption of 
biological molecules (Luong et al., 2006; Segvich et al., 2008b).   
While the BLM can increase osteogenesis in vivo, the additional bone growth is 
not uniform or spatially controlled, suggesting the need for exogenous factors to 
spatiotemporally influence tissue development.  Since the surface of hydroxyapatite-
based materials are not easily modified with surface treatments that form functional 
hydroxyl-, amino-, or carboxyl- groups, such as on polymers and metals, peptides 
designed to adsorb to these materials are a logical alternative.  The long strings of acidic 
amino acids found in extracellular bone matrix protein sequences in a previous peptide 
design proved effective in increasing cell attachment to apatite (Itoh et al., 2002).  
Peptides have been derived from bone extracellular matrix proteins (Dee et al., 1998; 
Dettin et al., 2005; Fujisawa et al., 1997), but have not been designed to preferentially 
attach to a biomaterial of specific composition.  Furthermore, none of these peptides have 
been investigated on BLM.  
The technique of phage display panning is effective in isolating specific peptide 
sequences attracted to inorganic substrates such as silver, palladium, platinum, titanium, 
and carbon nanotubes, in addition to organic plastic (Adey et al., 1995; Kriplani and Kay, 
2005).  Phage display technology has been mostly used in identifying enzyme substrates 
and inhibitors, DNA and protein binding peptides, and tissue specific peptides (Ladner et 
al., 2004; Marks and Marks, 1996; Uchiyama et al., 2005).  An objective of this work was 
to identify high affinity peptide sequences to apatite to provide insight into the design of 
functional peptides that preferentially adsorb to apatite-based materials.  A combinatorial 
phage display library was used to elucidate specific 12-mer linear peptide sequences that 
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have preferential adsorption properties on BLM and sintered hydroxyapatite (HA).  The 
preferential affinity of the identified peptides towards apatite-based materials was 
confirmed with a modified ELISA and synthetic peptide adsorption assays.  Another 
objective of this work was to test the hypothesis that a change in surface morphology 
and/or the presence of carbonate within apatite will alter the adsorption of peptides 
identified as having high affinity towards apatite-based materials.  Surface morphology 
changes and carbonate incorporation can alter charge distribution on the apatite surface, 
both of which could alter peptide adsorption.  To achieve this second objective, 
morphologies (scanning electron microscopy) and surface areas (“Brunauer-Emmett-
Teller” Method, or BET) obtained for four apatite-based materials (BLM, sintered 
hydroxyapatite disks, and two sintered carbonated apatite disks) were used to normalize 
peptide adsorption data to account for changes from substrate composition and/or 
morphology.  Composition and morphology of the apatite-based materials were further 
characterized using x-ray diffraction (XRD), and Fourier Transform Infrared 
Spectroscopy (FTIR).   
Materials and Methods 
Reagents and solutions were obtained for all experiments from Sigma-Aldrich 
unless otherwise noted. 
Preparation of Biomimetic Films and Apatite Disks 
A 5 w/v% 85:15 polylactic-co-glycolic acid (PLGA, Alkermes)-chloroform 
solution was cast on 15mm diameter glass slides and dried overnight.  The PLGA films 
were etched in 0.5M NaOH for 7 minutes and rinsed in Millipore water (ddH2O).  Etched 
films were soaked in modified simulated body fluid (mSBF) for 5 days at 37°C (Kokubo, 
1995). The mSBF was made by dissolving the following reagents in Millipore water at 
25°C and titrating to pH 6.8 using NaOH:  141 mM NaCl, 4.0 mM KCl, 0.5 mM MgSO4, 
1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0 mM CaCl2•2H2O, and 2.0 mM KH2PO4.  The 
mSBF, a supersaturated solution that enables self-assembly of a carbonated apatite layer 
onto the polymer substrate, was changed daily to maintain supersaturation.  Mineralized 
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films were rinsed with ddH2O, dried under a hood, and desiccated until use.   
Hydroxyapatite disks (10 mm diameter x 4 mm thick) were pressed from powder (Plasma 
Biotal Ltd. P220) at 1 metric ton for 1 minute and sintered at 1350°C for 1 hour (heating 
rate of 10°C/minute). The sintered disks were sonicated in 10mM HCl, then in ddH2O.  
The BLM films and HA disks were placed in 24-well plates and soaked in ddH2O 
overnight prior to phage panning. 
Carbonated apatite disks were made from 5.6% (CA5) and 10.5% (CA10) 
carbonated apatite powders (generous gift from Dr. Mary Tecklenburg).  Carbonated 
apatite disks (8-10mm diameter x 2-4mm thick) were pressed from powders at 0.5 metric 
ton for 1 minute and sintered at 1350°C for 1 hour (heating rate of 10°C/minute).  
Carbonated disks were also sonicated in 10mM HCl, then in ddH2O.  All sintered disks 
(CA5, CA10, and HA) were autoclaved prior to use.  Macroscopic dimensions of all 
disks were measured with calipers.  
Identification and Sequencing of BLM and HA Binding Peptides 
Peptide sequences with preferential binding to apatite-based materials were 
identified by screening the Ph.D.12TM Phage Display Library (New England Biolabs, 
#E8110S), consisting of 109 different phage with 12-mer amino acid linear peptide 
inserts, against BLM films and HA sintered disks.  A streptavidin control was run in 
parallel with the two apatite-based materials.  The ddH2O was removed and replaced with 
blocking buffer (Tris-HCl Buffer Solution with 0.1% or 0.5% Tween (TBST) and bovine 
serum albumin (BSA)) and incubated at 4°C for 1 hour.  The blocking buffer was 
discarded and the substrates were washed 6X with TBST (0.1%).  An aliquot of the 
original Ph.D.12TM library containing 1011 pfu (plaque-forming units) diluted in 1mL of 
TBST (0.1%) was introduced to each substrate and gently rocked (LabLine 4625) for 40 
minutes at room temperature.  Non-binding phage were discarded and the substrates were 
washed 10X with TBST (0.1%).  The phage bound to the substrates were eluted with 
1mL of Glycine/HCl, pH 2.2, with 1 mg/mL BSA for 10 minutes at room temperature 
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while being gently rocked.  The eluted phage were collected and neutralized with 1M 
Tris-HCl, pH 9.1.   
A small amount of the phage eluate was titered to determine the number of phage 
bound to each substrate.  The rest of the eluate was amplified with E. coli (ER2738) by 
culturing the bacteria and phage in 20mL Lurie broth with vigorous shaking for 4.5 hours 
at 37°C.  The culture was centrifuged for 10 minutes at 10,000 rpm (Sorvall SS-34) at 
4°C.  The supernatant was transferred to a fresh tube, respun, and the upper 80% of the 
final supernatant was placed into a fresh tube and allowed to precipitate with 1/6 the 
volume of PEG/NaCl (20 w/v% polyethylene glycol-8000 in 2.5M NaCl) solution.  The 
phage were allowed to precipitate at 4°C overnight.  The PEG precipitation was spun for 
15 minutes at 10,000 rpm at 4°C, decanted and briefly respun.  The pellet was suspended 
in Tris-HCl Buffered Solution (TBS) and transferred to a microcentrifuge tube, respun in 
a microcentrifuge for 5 minutes at 10,000 rpm at 4°C.  The supernatant was precipitated 
with 1/6 the volume of PEG/NaCl solution for 60 minutes on ice, recentrifuged for 10 
minutes at 10,000 rpm at 4°C, and the pellet was resuspended in TBS with 0.02% NaN3.  
A small amount of the purified phage eluate was titered to determine the number of 
amplified phage.  This amplified and purified phage elute was used in the next round of 
panning.  Subsequent rounds of panning introduced at least 109 pfu as the input phage 
concentration.  Three to four rounds of panning were performed for each substrate.  The 
entire experiment was repeated 3 times, and a streptavidin control yielding the HPQ 
consensus sequence was run in parallel each time.     
Titering was performed with appropriate serial dilutions for both the eluted phage 
and amplified phage after each round of panning. Agar plates treated with IPTG 
(isopropyl-b-D-thiogalactoside) and Xgal (5-bromo-4-chloro-3-indoyl-b-D-
thiogalactoside) were able to visually identify correct plaques using blue/white screening.  
Individual plaques picked from plates having no more that ~100 plaques were amplified 
by infecting a log phase E. Coli culture.  Amplified phage from selected phage plaques 
were purified by PEG/NaCl precipitation.  Single stranded DNA was isolated using an 
iodide buffer extraction, cleaned in ethanol, and resuspended in DNase/RNase free water.  
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The DNA was sequenced via dideoxy chain termination method using a DNA sequencer 
(Applied Biosystems, 3730XL DNA Analyzer, UM DNA Core) with the NEB -96 gIII 
sequencing primer provided in the kit.   
Peptide Selection 
A tri-fold analysis, involving a bioinformatic tool, biological ELISA, and 
computational model, was devised to determine the peptides with greatest potential to 
adhere to apatite-based materials.  The computational model was previously published 
and not discussed in the present work (Segvich et al., 2008a).  The bioinformatics tool 
REceptor LIgand Contacts (RELIC) (http://relic.bio.anl.gov/index.aspx) (Makowski and 
Soares, 2003; Mandava et al., 2004; Rodi et al., 2004) was used to analyze the data from 
the phage display runs.  The programs DNA2PRO, AAFREQ, and INFO determined 
peptide translation sequences from DNA code, amino acid frequency as a function of 
position, and information numbers for each peptide reflecting the probability of selecting 
individual phage by chance, respectively.  The AAFREQ analysis did not show amino 
acid specificity by position (data not included).  The most informative data was obtained 
using the INFO program.  The INFO program calculates an information measure for each 
peptide identified that expresses the probability that each peptide occurs by chance 
(Information measure = -ln[probability]).  For example, a high information measure can 
be indicative of an uncommon sequence with a low growth rate during amplification; 
whereas, a low information measure could represent a phage sequence likely to appear 
based on composition and/or high growth rates.  The program INFO was run with 
subtraction of a random selection of phage from the parent library (12R, 441 random 
sequences from NEB 12-mer Ph.D. kit).  
Phage Binding ELISA 
To determine the binding efficiency of the identified phage to the bone-like 
substrate materials, an ELISA was performed on BLM films, HA disks, PLGA films, and 
tissue culture polystyrene (TCPS) wells.  The substrates were soaked in ddH2O overnight 
in 24-well plates. The ddH2O was removed and replaced with blocking buffer (TBST 
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(0.1%) w/BSA) and incubated at 4°C for 1 hour.  For each plate with samples, a second 
24-well plate was blocked and used to prepare serial dilutions for each individual phage.  
The blocking buffer was discarded and the substrates were washed 6X with TBST 
(0.1%).  In the blocked plate, dilutions of individual phage were prepared in TBST 
(0.1%) in the concentrations of 106, 107, 108, and 1010 pfu (n=1 per dilution).  Each phage 
concentration was introduced to the four substrates and incubated at room temperature for 
1.5 hours with gentle rocking (LabLine 4625).  The non-binding phage were discarded 
and the substrates were washed 6X with TBST (0.1%).  HRP-conjugated anti-M13 
antibody (GE Healthcare, #27-9421-01) was prepared in 1:5000 ratio in blocking buffer 
and added to each well.  The substrates were washed again 6X with TBST (0.1%).  
Immediately prior to detection, a 30% H2O2 (Corco, Fairless Hills, PA #1403)-ABTS 
(2’,2’-azino-bis(3-ethybenz-thiazoline-6-sulphonic acid) diammonium salt) solution in a 
0.05M citric acid solution at pH 4.0, was added to each well and allowed to incubate at 
room temperature for 50 minutes.  For each sample, an aliquot of each well was read on a 
UV Spectrophotometer (Biorad SmartSpec 3000) at 410nm.   
Synthetic Peptide Adsorption Assay 
Three high affinity peptides identified (APWHLSSQYSRT [A], 
VTKHLNQISQSY [V], and STLPIPHEFSRE [S]) and a positive control peptide  
(E7PRGDT [E]) (Fujisawa et al., 1997), were fabricated on a Rainin Symphony 
synthesizer and determined as >86% pure via HPLC (Synthetic peptides were provided 
by The University of Michigan Protein Structure Facility, Dr. Henriette Remmer, 
director).  Amino acid analysis was performed to verify peptide concentration for 
standard curves created with UV absorbance at 205nm and 220 or 225nm wavelengths 
(BioRad Smartspec 3000).  Standard curves for APWHLSSQYSRT, VTKHLNQISQSY, 
and STLPIPHEFSRE were also generated using UV Spectrophotometry at 280nm, 
274nm, and 257 nm, respectively.  Each peptide was reconstituted in ddH2O and diluted 
to ~500µg/mL in 50mM Trizma buffer (T7818, pH=7.5).  In 24-well tissue culture 
dishes, BLM films, HA disks, CA5 disks, CA10 disks, and blank TCPS wells were 
soaked in ddH2O overnight at 4°C (n=5).  Prior to introducing 1mL of the peptide or 
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buffer solutions for negative controls, plates were allowed to warm to room temperature 
and then the overnight solution was removed.  The plates were agitated on a Titer Plate 
Shaker at ~80rpm for 3 hours at room temperature.  The films and disks were rinsed with 
ddH2O and then soaked in a 10mM HCl solution for 18 hours at room temperature on the 
same shaker.  Aliquots of the HCl solution were read on a UV spectrophotometer.  
Statistics   
All data are presented as mean values ± one standard deviation.  Non-parametric 
one-way ANOVAs run with the Dunnetts T3 post-hoc test determined the effect of 
substrate on peptide adsorption.  The effect of peptide on substrate was also calculated 
with this statistical test.  Statistical significance was defined as p<0.05.   
Material Characterization 
Scanning Electron Microscopy (SEM):  Morphologies of all apatite-based 
materials were examined using scanning electron microscopy (Philips XL30 FEG 
Scanning Electron Microscope, UM EMAL). Samples from each group (n=2) were 
coated gold coated and examined at 10-15 kV.   
Surface Area Determination (BET):  Single Point BET surface area at P/P0 = 0.1 
was determined for all apatite-based materials on a surface area and porosity analyzer 
(Micrometrics ASAP 2020).  At least 1g of material was used and data acquisition was 
performed in duplicate. Peptide adsorption data for all apatite-based substrates were 
normalized to their respective surface areas using sample dimensions (MacroSA) and 
BET analysis data (MicroSA).  The well area of TCPS was used for both MacroSA and 
MicroSA normalizations. 
Fourier Transform Infrared Spectroscopy (FTIR):  Characteristic peaks for apatite 
were detected using a Fourier Transform Infrared Spectroscopy (Spectrum BX FT-IR, 
Perkin Elmer).  A 300:1 ratio of KBr to apatite sample was used prepare a pellet and 
analyze all of the apatite-based materials (n=3).   Spectra were recorded from 400 to 4000 
cm-1 and baseline corrected.  The wt% CO32- incorporation range was determined using 
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FTIR spectra for each substrate using two established methods (Featherstone et al., 1984; 
LeGeros, 1991) taking the peak height ratio of 1450cm-1/569cm-1 or 1410cm-1/600cm-1. 
X-ray Diffraction Analysis (XRD):  XRD spectra were obtained from a 
representative sample of each composition using a Rigaku Miniflex X-ray Diffractometer 
with a fixed incidence of 4.2°.  A range of 10-90° was scanned using a step size of 0.1° 
and a scan rate of 1°/minute. All spectra were normalized to their respective maximum 
peaks.  Hydroxyapatite from Sigma-Aldrich (#289396) was scanned as a calcium 
phosphate standard.  
Results 
Identification of High Affinity Phage Towards Apatite-based Materials 
Of the ~109 phage present in the original library, 243 were identified as binders to 
apatite (Figure 2.1). The streptavidin control yielded the HPQ consensus sequence 
signifying successful panning in all experiments.  Within the 243 apatite-binding phage 
identified, 19 sequences appeared in repeated experiments after DNA sequencing.   Of 
these 19 sequences, 17 were found in more than one experiment on the same substrate, 
either BLM or HA.  Of these 17 phage clones, 7 phage had high affinity towards both 
BLM and HA (bold – Table 2.1).  While the frequency data showing 7 sequences bound 
to both BLM and HA in multiple experiments provided evidence that these sequences 
were specific to apatite, further validation was required to verify this.  Bioinformatic 
analysis, computational modeling, and an ELISA were therefore used to analyze the 
entire set or subsets of the original 243 clones identified.   
 All 243 phage sequences identified as binders to BLM and/or HA were analyzed 
with the INFO program provided by RELIC.  When the phage set identified as adsorbing 
to the BLM and/or HA was compared to a RELIC provided NEB Background phage set, 
the BLM/HA data showed a shift towards higher information content (Figure 2.2).  To 
isolate this subset of phage valued with high information content, regions of greater 
occurrence were partitioned from information content ranges 0-28.3, 33.0-35.8, and 36.5-
40.0.  These ranges were chosen as regions that exhibited higher occurrence levels within 
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the apatite-based material phage set when compared to the NEB background.  Sixty-eight 
sequences were partitioned and deemed “high information clones”.    
 A representative set of 10 clones from the original 243 clones was chosen for 
ELISA analysis (labeled with ◊ in Table 2.1).  Of the ten, 6 occurred as repeats, whereas 
4 occurred only once.  Both repeated and single-occurrence phage were tested to identify 
if the repeated phage occurred in higher frequencies than the single-occurrence phage, 
because of advantageous growth properties in the Lurie Broth.  Phage dilutions of 108 
and 1010 pfu resulted in positive ELISA readings, with stronger positive signals for the 
1010 dilution (Figure 2.3). Favorable phage binding was not observed for 
VSPLSFGSPRYP and WSPAPHVIMGTT, two of the four single-occurrence phage.  Of 
the 6 repeats tested, four showed positive ELISA results.  For the phage with positive 
ELISA results, TCPS and PLGA films showed consistently low background adsorption 
for all concentrations tested, illustrating the specificity of the phage identified as binders 
to BLM and HA. 
 From the original frequency data encompassing all 243 identified clones, the 19 
phage sequences that appeared in repeated experiments were also analyzed via 
computational modeling on a hydroxyapatite lattice (data reported (Segvich et al., 2008a), 
but A, S, and V data reported here in Table 2.2, so the integrated role of the model along 
with the bioinformatics and ELISA can be illustrated) (Table 2.2). Peptides identified as 
having high peptide adsorption energies, or more negative energies, as neutral or charged 
peptides were deemed as having greater binding potential.  A neutral peptide is given an 
overall charge of zero prior to any energy minimization, whereas a charged peptide is 
assigned a peptide-appropriate overall charge (e.g. VTKHLNQISQSY would be assigned 
an overall charge of +1).  At a pH 7.5, the net charges for A, S, and V were estimated as 
+1, -1, and +1, respectively.  The isoelectric points for A, S, and V were estimated from 
amino acid contributions of C, D, E, H, K, R, Y, and the amino- and carboxy- termini as 
9.9, 5.3, and 9.7, respectively.  In deciding which peptides to synthetically fabricate for 
the peptide adsorption experiments, the results from the RELIC analysis, modified 
ELISA, individual clone frequency over the three phage experiments, and computational 
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modeling were evaluated (Figure 2.1).  Of the six peptides that exhibited positive ELISA 
signals, sequences were only considered if present in the top 5 ranking of any of the 
computational models run, eliminating NMNTHIHKDRPP and SMRLPLLSSHAL.   
From the remaining sequences, only those deemed as high information clones from the 
INFO analysis were chosen, eliminating ALTLHPQPLDHP.   Three phage sequences, 
APWHLSSQYSRT [A], STLPIPHEFSRE [S], and VTKHLNQISQSY [V], emerged as 
having superior behavior compared to the other sequences.   
S and V Adsorb Consistently With the Highest Affinity on the Apatite-based Materials 
Peptides S and V adsorb in statistically greater amounts on the apatite-based 
materials in comparison to peptide A, (For S vs. A, BLM p=0.001, CA5 p<0.001, CA10 
p<0.001, HA p=0.038; For V vs. A, BLM p=0.006, CA5 p=0.033, CA10 p=0.029) 
(Figure 2.4).  Peptides S and V also have significantly higher adsorption to CA5 and 
CA10 disks in comparison to peptide E (For S vs. E, CA5 p=0.005, CA10 p=0.004; For 
V vs. E, CA5 p=0.026, CA10 p=0.010).  Peptide adsorption to HA disks was less 
specific, as the only significant difference was between peptides A and S, p=0.038.  The 
BLM was the only material which supported a greater adsorption of peptide V when 
compared to peptide S, p=0.006. Consistently low peptide adsorption to TCPS was found 
for all peptides, verifying specificity to calcium phosphate substrates.   These results 
suggest that peptide adsorption is not only dependent on substrate composition, but also 
on the peptide composition. 
Adsorption of Preferential Binding Peptides on Apatite-based Materials Depends on 
Substrate Composition and Morphology 
HA, CA5, and CA10 had similar surface feature sizes, whereas the bone-like 
mineral revealed a smaller plate-like structure with evident spherical areas of nucleation 
and growth (Figure 2.5).  Higher magnification images of the surfaces (Figure 2.5 insets) 
illustrate the characteristic plate-like features on the bone-like mineral and more granular 
surface features on the HA, CA5, and CA10 disks.  BET surface areas for BLM, HA, 
CA5, and CA10 were 121.55, 0.05, 0.11, and 0.19m2/g, respectively.  
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All of the apatite-based materials show phosphate adsorption bands correlating 
with hydroxyapatite at ca. 1087, 1032, 602, and 574 cm-1 (Figure 2.6).  Carbonate peaks 
at ca. 1455 and 875 cm-1 were detected for BLM, CA5, and CA10.  The carbonate peaks 
in BLM indicate that a Type B carbonate substitution is occurring during formation, 
whereas the small but distinct peak that both CA5 and CA10 exhibited, taken into 
account with the fabrication temperature of 1350°C, is indicative of Type A carbonate 
substitution (Liao et al., 1999).   
XRD characteristic peaks correlating with hydroxyapatite (PDF 9-432) existed in 
all of the materials at or around 2θ (crystal family plane) = 25.9° (200), 31.8° (211), 34.0 
(202), 39.8° (310), 46.7° (222), 49.4° (213), and 53.1° (401, 303) (Figure 2.7).  Narrow, 
distinct peaks were observed in the HA, CA5, and CA10 spectra as a result of the high 
sintering temperature during disk fabrication.  Additional HA peaks were evident for HA, 
CA5, and CA10 at or ± 0.2° for 2θ (crystal family plane) = 32.2° (122) and 32.9° (300).  
The BLM peaks were broadened in comparison to the sintered disks, revealing that either 
a less crystalline apatite or a nano-crystalline phase forms over the 5 day soak in the 
supersaturated ion solution at 37°C.  Small 2θ peaks at 29.7° and 37.3° were found for 
the sintered disks pressed from carbonated apatite powders, CA5 and CA10.  These small 
peaks are most likely a combination of calcium oxide (CaO) and/or α-TCP that did not 
completely revert back to hydroxyapatite during cooling (Liao et al., 1999).  These peaks 
are not present in the HA spectrum.  This inconsistency leads to the interpretation that 
these peaks result from the incorporation of carbonate into the powder prior to sintering 
the CA5 and CA10 disks.  Because the height of this peak is small in relation to the 
highest apatite peak, the amounts of calcium oxide and/or α-TCP present on the surface 
are thought to be minimal. 
 When normalized to MacroSA, Figure 2.8, adsorption of A and S were 
significantly greater on carbonated disks (CA5, CA10) versus the BLM (For A, CA5 
p=0.006, CA10 p=0.001; For S, CA5 p=0.001, CA10 p<0.001).  Differences between the 
carbonated disks and HA disks also existed for peptide S (CA5 p=0.004, CA10 p=0.001).  
Because the surface area of BLM is three orders of magnitude greater than the sintered 
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disks, the MicroSA normalized peptide adsorption values (Figure 2.9) are in the picogram 
range and are significantly lower than other apatite-based materials, p<0.050.   Despite 
CA5 and CA10 possessing similar carbonate content, the CA5 disks had a significantly 
higher ability to adsorb peptide S, p=0.007.  Moreover, a trend of decreased adsorption to 
CA10 versus CA5 or HA was seen for A, V, and E.  For MacroSA and MicroSA 
normalization, apatite groups HA, CA5, and CA10 were significantly different, p<0.050, 
in comparison to TCPS for A, S, and V, again indicating the peptides are specific to 
calcium phosphate substrates. 
Discussion 
This work is the first to present detailed methods, to our knowledge, that identify 
peptide sequences with preferential adsorption towards synthetic bone-like mineral or 
apatite substrates.  Phage display libraries expressing combinations of linear or cyclic 
peptide inserts have isolated sequences with high affinity towards inert materials (Adey et 
al., 1995; Whaley et al., 2000), cell lines cultured in vitro (Samoylova et al., 2002; Zhang 
et al., 2001), and cell/organ targets in vivo (Pasqualini et al., 1995). Three 7-mer peptide 
sequences have been reported as specific to hydroxyapatite, but the review presenting this 
data lacked methods on the preparation of the hydroxyapatite substrate (Tamerler and 
Sarikaya, 2007).  Through repetitive experimentation and a rigorous, tri-fold validation 
technique, three peptides APWHLSSQYSRT [A], STLPIPHEFSRE [S], and 
VTKHLNQISQSY [V] were identified to exhibit preferential adsorption towards apatite-
based materials.  
Many of the hydroxyapatite binding sequences identified have been from non-
collagenous bone-related proteins present in the extracellular matrix of bone and/or 
proteins present in saliva.  These proteins include, but are not limited to, bone 
sialoprotein, osteopontin and osteonectin (Shin et al., 2003), and a number of these 
proteins have a high proportion of acidic amino acids, such as glutamic and aspartic 
acids. In comparison to the bone sialoprotein derived peptide E with seven acidic amino 
acids, peptides A, S, and V that did not contain strings of acidic amino acids adsorbed in 
comparable, if not increased amounts on all the apatite-based materials and with lower 
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variability (Figure 2.4).   Therefore, phage display derived sequences may offer an 
alternative to peptide identification compared to protein sequence searching and 
ultimately, contribute to peptide design that can enhance the bioactivity of implanted 
materials.  
Adsorbed or covalently attached peptide sequences have been shown to mediate 
cell adhesion, as functionalizing biomaterials with the ubiquitous RGD (Gly-Arg-Asp) 
sequence increases cell adhesion (Hersel et al., 2003).  Other peptide sequences have 
been designed to increase cellular adhesion to titanium (Ferris et al., 1999; Verrier et al., 
2002), to contain cyclic RGD sequences (Pallu et al., 2003), or to be modeled from the 
heparin binding domain (Dalton et al., 1995; Dee et al., 1998).  However, these cell 
adhesive sequences were not designed based on preferential affinity towards a specific 
material.  Weakly attached surface molecules can be redistributed by cells attempting to 
attach to a surface (Choquet et al., 1997; Pelham and Wang, 1998), and softer substrates 
can cause the disorganization of actin filaments (Pelham and Wang, 1998).  In both cases, 
effective formation of focal adhesions will not occur, demonstrating the need to consider 
both the substrate material and cell source in the peptide design. Furthermore, a cell-
influencing sequence can be linked to the peptides to specify cell behavior, such as 
attachment. 
 Not only do the surface peptides need to withstand contractile forces from 
attached cells, the peptide concentration presented on the material surface should be 
optimized for a specific cellular behavior (Hubbell, 1999).  Adjusting the initial peptide 
concentration introduced to an apatite-based substrate can provide the specific surface 
density required for the promotion of cell adhesion.  To ensure appropriate surface 
densities are present for the cells, the amount of peptide adsorbed to the surface must be 
quantified, as the peptide adsorption can change depending on substrate charge and 
morphology. The presented work highlights the adsorption capacity through 
quantification of the high affinity peptides to various apatite-based materials.   
Normalization of peptide adsorbed to MacroSA (Figure 2.8) provided insight 
towards the amount of peptide that would be required to coat apatite-based implants.  
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Slight carbonate incorporation in the CA5 and CA10 groups increased adsorption of 
peptides S and A compared with HA.  The MacroSA normalization data also indicate that 
a sintered apatite coating on an implant may be more capable of adsorbing S and A 
peptides compared with a BLM coating.  However, the additional factor of peptide 
surface density must be considered, as extracellular matrix mineralization varies with 
adhesive peptide surface densities (Rezania and Healy, 1999). 
Normalization of peptide adsorbed to MicroSA (Figure 2.9) was performed to 
investigate the effects carbonate incorporation and morphology have on the amount of 
peptide adsorbed.  Slight changes in carbonate percentage did not influence peptide 
adsorption. This result does not rule out that a larger change in carbonate incorporation 
affect peptide adsorption.  The range of carbonate present in the studied materials did 
vary (CA5 and CA10 vs. HA); however, at the same morphological scale, the carbonate 
differences were minimal (~2wt%).  A trend of decreased adsorption to CA10 in 
comparison to CA5 and HA was shown across all peptides.  CA5 adsorbed significantly 
higher amounts of peptide S compared with CA10, indicating that a morphological 
difference, not a compositional difference, was evident for this case only.  The 
morphology difference between CA5 and CA10 could change the charge distribution on 
the apatite surface, promoting peptide adsorption. Better control of the surface 
morphology accompanied by larger differences in carbonate content would better 
investigate if carbonate incorporation has an effect on peptide adsorption.   
 Both material composition and surface morphology influence protein adsorption 
(Kilpadi et al., 2001; Rosengren et al., 2002; Zeng et al., 1999) and the resulting cell 
adhesion and proliferation (Healy et al., 1996; McFarland et al., 2000; Keselowsky et al., 
2003).  Calcium phosphates exhibit the ability to adsorb more protein than other 
materials, which has led to the suggestion that Ca2+ and PO43- present themselves as 
preferential binding sites for proteins (Zeng et al., 1999). Changes in surface morphology 
(e.g. pore size) also affect protein adsorption.  Microporosity has been shown to increase 
protein adsorption, but decrease cellular differentiation (Anselme et al., 2000; Rouahi et 
al., 2006).  Taken together, these studies suggest that with a certain composition and 
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morphology, calcium phosphates allow a preferred charge pattern that promotes protein 
binding.  Identifying peptides that preferentially adsorb to apatite-based materials without 
disrupting the charge distribution that may prove beneficial in vivo by allowing protein 
adsorption to transpire.  Despite BLM being classified as a calcium phosphate with a 
distinct nano-morphology, BLM has not been investigated in biomolecular adsorption 
studies.  The presented data parallels the literature discussing factors that affect protein 
adsorption and offers a new perspective on peptide adsorption to BLM. 
 Phage display combinatorial libraries offer potential in isolating binding peptide 
sequences from a vast library, making otherwise unfathomable experiments possible 
(Rodi and Makowski, 1999; Scott and Craig, 1994; Uchiyama et al., 2005). Phage 
libraries can express an unequal representation of each amino acid within the library, are 
not able to include every peptide combination possible, and oftentimes omit important 
post-translational modifications such as phosphorylation of serine residues in the parent 
library.  The results from the presented phage display experiments did not preferentially 
isolate peptide sequences with long strings of acidic amino acids, as the peptides isolated 
from the phage display had an average overall charge of ±1.  This unexpected result 
could have occurred because poly-acidic peptide sequences were not initially present in 
the parent library, or because the identified sequences bound with greater affinity than 
poly-acidic peptide sequences. Nonetheless, the array of peptides presented in these 
libraries provided the opportunity to identify sequences specific to the apatite-based 
materials. Furthermore, the A, S, and V peptides identified in this study contain amino 
acid residues that can be phosphorylated.  Phosphorylating the serine, threonine, and/or 
tyrosine residues on peptides A, S, and V would increase the negative charge on these 
peptide sequences, possibly enhancing their adsorption to apatite.  It is possible with 
phage display techniques to identify high adsorbing, non-modified sequences that could 
achieve even higher affinity after synthetic phosphorylation. 
While the lack of controlled peptide adsorption was taken into account when 
analyzing carbonate effect on adsorption by normalizing peptide adsorbed by its 
respective surface area (micro or macro), we do not report saturation curves, and cannot 
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conclusively say that peptide saturation was attained.  However, increased fluorescence 
intensities with increased concentrations of FITC-labeled E7RGD peptide on HA disks 
shows a strong intensity visible at 100µg/mL (Sawyer et al., 2005b).  Since the initial 
peptide concentrations used in these studies were ~500µg/mL, we can only speculate that 
saturation was achieved. 
The work described in this chapter provides a stimulus to explore alternative 
methods to better engineer current tissue repair constructs.  For example, apatite-binding 
peptides can be combined with soft tissue or ligament binding recognition sequences to 
help re-establish tissue interfaces in the tooth-gum and bone-ligament systems, 
respectively. The presented work also strives to emphasize that a multitude of factors 
influence not only protein or peptide adsorption, but other biomolecules such as growth 
factors and DNA as well.  Therefore, it is imperative to fully characterize the substrate 
material to better understand how the material will regulate biomolecular adsorption or 
incorporation prior to the addition of cells.   
Three peptides, APWHLSSQYSRT [A], STLPIPHEFSRE [S], and 
VTKHLNQISQSY [V], were identified as high affinity binders specific to apatite-based 
materials.  The morphology of the apatite-based materials influenced synthetic peptide 
adsorption more than slight changes (2%) in carbonate content.  Because the identified 
peptides have preferential adsorption to apatite, their use can now be investigated in a 
variety of bone-based research including bone and dentin tissue engineering, tendon and 
ligament repair, and enamel formation. 
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Figure 2.1:  Schematic displaying the tri-fold analysis approach used to identify peptides 
that preferentially adhere to BLM and HA. 
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Figure 2.2: INFO content values calculated in RELIC for NEB background and phage 
subset identified as high affinity binders to apatite-based materials.  High information 
content correlates to a lower incidence of being selected by chance. The phage subset 
shows a shift towards a higher information content signifying this subset was selected 




Figure 2.3: Modified ELISA results for 10 representative peptides on 4 substrates 
showing a higher absorbance value at OD 410 with a higher concentration of phage.  
PLGA and TCPS background adsorption of each phage was minimal in 6 of 10 phage 
sequences tested.  An example of a phage with high background is shown for peptide 
WSPAPHVIMGTT.  Positive readings on the modified ELISA supports that the phage 
identified are indeed specific to apatite-based materials. (*) Indicates peptide sequences 




Figure 2.4 Adsorption of peptides EEEEEEEPRGDT [E], APWHLSSQYSRT [A], 
STLPIPHEFSRE [S], and VTKHLNQISQSY [V] on (a) bone-like mineral (BLM), (b) 
sintered disks from 5.6% carbonated apatite powder (CA5), (c) sintered disks from 
hydroxyapatite powder (HA), (d) sintered disks from 10.5% carbonated apatite powder 
(CA10), and (e) tissue culture polystyrene (TCPS).  Peptides S and V showed better 
adherence to all apatite-based materials in comparison to A, (For S vs. A, BLM p=0.001, 
CA5 p<0.001, CA10 p<0.001, HA p=0.038; For V vs. A, BLM p=0.006, CA5 p=0.033, 
CA10 p=0.029), and to both carbonated disks CA5 and CA10 in comparison to E, (For S 
vs. E, CA5 p=0.005, CA10 p=0.004; For V vs. E, CA5 p=0.026, CA10 p=0.010).  
Differences between S and V were also only seen on bone-like mineral, p=0.006.   These 
results suggest that peptide adsorption is not only dependent on substrate composition, 




Figure 2.5 Representative SEM images showing low and high magnification 
morphologies of the four apatite-based materials: (a) bone-like mineral (BLM), (b) 
sintered disks from 5.6% carbonated apatite powder (CA5), (c) sintered disks from 
hydroxyapatite powder (HA), and (d) sintered disks from 10% carbonated apatite powder 
(CA10).  These higher magnification images show that the bone-like mineral has small 
surface features that relate to the bone-like mineral having a 100X higher surface area 




Figure 2.6: Representative FT-IR spectra for bone-like mineral (BLM), sintered disks 
from 5.6% carbonated apatite powder (CA5), sintered disks from 10.5% carbonated 
apatite powder (CA10), and sintered disks from hydroxyapatite powder (HA) substrates.  
Phosphate peaks are found for all samples at 1031, 600, and 561 cm-1 and a carbonate 
peaks are found at 875 or 1456 cm-1. 
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Figure 2.7: X-ray diffraction patterns for bone-like mineral (BLM), sintered disks from 
10.5% carbonated apatite powder (CA10), sintered disks from 5.6% carbonated apatite 
powder (CA5), sintered disks from hydroxyapatite powder (HA), and a calcium 
phosphate standard (CaP Std). The bone-like mineral was less crystalline than the 
sintered disks; however, all samples showed characteristic hydroxyapatite peaks 
(labeled).  The disks sintered from carbonate powder, CA10 and CA5, revealed small 
peaks at 2θ = 29.7 and 37.3° (*), which reflect traces of calcium oxide and/or α-TCP. 
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Figure 2.8: Peptide adsorption data normalized to sample dimensions (MacroSA) shows 
that peptides A and S have increased adsorption on CA5 and CA10 when compared with 
BLM (For A, CA5 p=0.006, CA10 p=0.001; For S, CA5 p=0.001, CA10 p<0.001).  
Differences for peptide S were also evident between HA and the carbonated disks (CA5 
p=0.004, CA10 p=0.001). Apatite groups HA, CA5, and CA10 were significantly 
different, p<0.050, in comparison to TCPS for A, S, and V. Horizontal lines represent 





Figure 2.9: Peptide adsorption data normalized to sample dimensions (MicroSA).  
Despite CA5 and CA10 possessing similar carbonate content, the CA5 disks had a higher 
affinity to adsorb peptide S, p=0.007.  Trends of decreased adsorption to CA10 versus 
CA5 or HA were seen for peptides A, V, and E.  Apatite groups HA, CA5, and CA10 
were significantly different, p<0.050, in comparison to TCPS for A, S, and V.  Horizontal 




Table 2.1: Peptide Sequences Identified via Phage Display with Preferential Adsorption 
Towards Apatite-Based Materials 
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Table 2.2: Summary of Computational Modeling Data for Peptides A, S, and V on 









 PEPTIDES DESIGNED TO ADHERE TO BOTH APATITE AND HUMAN 
BONE MARROW STROMAL CELLS IMPROVE CELL ATTACHMENT ON 
BONE-LIKE MINERAL  
Introduction 
The current concepts in bone tissue engineering aim to replace large defects with 
new bone tissue having properties that mimic native tissue through a combination of 
scaffolding, cells, and/or biological signals (Alsberg et al., 2001; Garcia and Reyes, 2005; 
Hubbell, 1999; Maskarinec and Tirrell, 2005; Shin et al., 2003).  Improvements in the 
materials and methods used in bone repair are needed to overcome clinical limitations of 
autogenous bone grafting, such as graft rejection, donor site morbidity, and inadequate 
bone formation (Ducheyne and Qiu, 1999; Parikh, 2002; Yaszemski et al., 1996).  In 
addition to osteoconductivity of implantable materials, exogenous signals or cell sources 
capable of osteogenic differentiation are required to attain directed bone formation both 
in vitro and in vivo (Abiraman et al., 2002; Liu et al., 2005; Shimaoka et al., 2004).  
Research identifying and incorporating biological molecules has been ongoing in parallel 
with research isolating and manipulating appropriate cell sources for use in bone 
engineered systems (Chen and Mooney, 2003; Rose and Oreffo, 2002).     
Cellular adhesion can dictate the success of an implanted construct.  Cells can be 
seeded on a construct ex vivo or a specific cell population can be recruited in vivo; 
however, either scenario requires cell attachment to ensure cell viability with subsequent 
proliferation and differentiation.  Understanding the steps involved in cell adhesion is 
imperative when trying to incorporate biological signals that can promote adhesion in 
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scaffold design.  Cell adhesion progresses in four steps:  cell attachment, cell spreading, 
production of organized actin filaments, and focal adhesion formation (LeBaron and 
Athanasiou, 2000).  The importance of cell adhesion has been demonstrated in a variety 
of cells and tissues including the differentiation of myoblasts (Menko and Boettiger, 
1987), terminal keratinocytes (Adams and Watt, 1990), mammary epithelium (Streuli et 
al., 1991), and osteoblasts (Damsky, 1999).  The establishment of an integrin mediated 
bond between a cell and a protein initiates a cascade of signals that provides structural 
support and phenotypic influence (Garcia and Boettiger, 1999).  When a material is 
implanted in the body, extracellular matrix proteins such as fibronectin and vitronectin 
adsorb onto the material and initiate integrin-ligand binding of cells to the material 
(Garcia and Boettiger, 1999).  However, proteins are subject to isolation and prone to 
degradation (Hersel et al., 2003).  Proteins can also change conformation or orientation, 
because they possess sections with varying hydrophobicities that address cellular 
functions other than adhesion.   
Identification of short cell recognition sequences has motivated the development 
of peptide-laden bioactive materials that can recruit a certain cell population to adhere to 
a material surface via specific integrin mediated bonding.  Peptides can effectively mimic 
the same response as a protein while being smaller, cheaper, and less susceptible to 
degradation.   Peptides have a greater potential for controlling initial biological activity, 
because they can contain specific target amino acid sequences and can permit control of 
hydrophilic properties through sequence design (Ladner et al., 2004).  One peptide that 
interacts with a variety of cell adhesion receptors, including those on osteoblasts, is the 
RGD (Arg-Gly-Asp) sequence (Hersel et al., 2003).  The RGD binding sequence is an 
adhesion sequence that interacts with multiple adhesion receptors including the αVβ3 
integrin that binds not only to vitronectin and fibronectin, but to the bone proteins 
osteopontin and bone sialoprotein (Hersel et al., 2003).  RGD sequences can act as 
inhibitors of cell adhesion if present in solution, even though they have been shown to 
promote cellular adhesion when adsorbed on some material surfaces (Ruoslahti, 1996).  
In addition, RGD adsorption, when combined with other adhesive extracellular bone 
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matrix proteins on a hydroxyapatite surface, proved detrimental to human mesenchymal 
stem cell adhesion and survival (Hennessy et al., 2008), suggesting RGD presence in vivo 
could hinder tissue growth.  Therefore, non-RGD adhesion sequences are an attractive 
alternative that could prove more effective in establishing initial cell attachment.  Such 
peptide alternatives could also offer increased specificity towards a specific cell source as 
compared to the ubiquitous RGD. 
Since the osteoconductivity of a bone implant is improved if made or coated with 
an apatite-based material (Abe et al., 1990; Kohn DH et al., 2005), it is of interest to 
design peptide sequences with preferential adsorption to apatite.  Inorgainic-organic 
hybrid systems that employ bone-like mineral coatings to biodegradable polymers are 
often used to improve the osteoconductivity of materials compositionally dissimilar to 
apatite.  A bone-like mineral (BLM) coating can be achieved by soaking the polymer in a 
supersaturated ionic solution capable of heterogeneously precipitating a film of apatite.  
However, compared with polymers, apatite-based materials are less tolerant to surface 
modifications that allow covalent molecular attachment.  Therefore, apatite-based 
materials must rely on their inherent material properties to allow consistent, ionic 
adhesion of peptides.  Post-translational modifications and poly-acidic peptide strings are 
two strategies used to encourage peptide adhesion to apatite-based materials (Fujisawa et 
al., 1996; Fujisawa et al., 1997).  While these design strategies have been used to 
fabricate sequences, such as E7PRGDT, that aim to increase cell adhesion, sequences 
discovered via peptide selection from a combinatorial library of sequences could provide 
alternative sequences that prove to be better at increasing cell adhesion. 
Combinatorial phage display libraries can be utilized to identify 12-mer peptide 
sequences with preferential binding to apatite-based materials (refer to Chapter Two), 
including bone-like mineral.  Phage display is a useful technique in identifying peptide 
sequences not only specific to tissues (kidney tubules (Odermatt et al., 2001), breast 
vasculature (Essler and Ruoslahti, 2002), muscle (Samoylova and Smith, 1999), bone 
marrow (Nowakowski et al., 2004)) and malignant cell types (Morita et al., 2006; 
Samoylova et al., 2003),  but also to inorganic materials such as platinum (Seker et al., 
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2007), silver (Naik et al., 2002a; Naik et al., 2002b), and semiconductors (Lee et al., 
2002; Mao et al., 2003; Whaley et al., 2000).  Specific to bone, phage display has been 
utilized in vitro to identify potential osteoblast binding sites during the resorption-
formation process in remodeling bone (Sheu et al., 2002).  It has also been suggested that 
7-mer peptide sequences have been identified on hydroxyapatite substrates, but limited 
information on the substrate preparation or properties is reported (Sarikaya et al., 2003; 
Tamerler et al., 2003).  The limited peptide research on bone-like mineral led the pursuit 
of sequences that preferentially bind to BLM.  Since bone-like mineral is a synthetic form 
of apatite synthetically fabricated at benign physiologic conditions (pH=6.8, 37°C), BLM 
is capable of biomolecular incorporation and positively influencing cell spreading 
(Leonova et al., 2006; Luong et al., 2006; Segvich et al., 2008b), making it an important 
apatite-based substrate to investigate.  Specifically, the sequence VTKHLNQISQSY, was 
identified as a preferential apatite-binder having increased ability to bind to 
hydroxyapatite and carbonated apatite materials compared with the previously reported 
ability of bone sialoprotein derived peptide E7PRGDT (refer to Chapter Two).  
  The goal of the work presented in this chapter was to identify peptide sequences 
that preferentially bind to clonally derived hBMSC cells that can then be implemented in 
a dual-functioning peptide design to promote hBMSC cell attachment on apatite-based 
substrates.  The hypothesis that dual-functioning peptides adsorbed to BLM will increase 
hBMSC attachment compared to BLM devoid of peptide was tested.  To identify peptides 
that preferentially bind to hBMSC, a combinatorial phage display library was used.   Data 
from the phage display experiments were analyzed using the bioinformatics tool RELIC 
and immunohistochemistry techniques, and as a result, two 12-mer peptide sequences, 
LLADTTHHRPWT [L] and DPIYALSWSGMA [D], were identified as preferential 
binding peptides to the hBMSC population used in this study.  Dual-functioning peptides 
were built using the hBMSC binding sequences combined with the previously identified 
VTKHLNQISQSY [VTK] apatite-binding peptide. The intent of this work is to 
demonstrate the feasibility of using such peptides to create a linkage between inorganic 
and organic constituents, in this case BLM and hBMSCs.   
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Materials and Methods 
Reagents and solutions were obtained for all experiments from Sigma-Aldrich 
unless otherwise noted. 
Preparation of Bone-like Mineral Films and Apatite Disks 
A 5 w/v% 85:15 polylactic-co-glycolic acid (PLGA, Alkermes)-chloroform 
solution was cast on 15mm diameter glass slides and dried overnight.  The PLGA films 
were etched in 0.5M NaOH for 7 minutes and rinsed in Millipore water (ddH2O).  Etched 
films were soaked in modified simulated body fluid (mSBF) for 5 days at 37°C.  The 
mSBF was made by dissolving the following reagents in Millipore water at 25°C and 
titrating to pH 6.8 using NaOH:  141 mM NaCl, 4.0 mM KCl, 0.5 mM MgSO4, 1.0 mM 
MgCl2, 4.2 mM NaHCO3, 5.0 mM CaCl2•2H2O, and 2.0 mM KH2PO4.  The mSBF, a 
supersaturated solution that enables self-assembly of a carbonated apatite layer onto the 
polymer substrate, was changed daily to maintain supersaturation.  Following a 5 day 
soak in mSBF, films with a precipitated bone-like mineral (BLM) layer were rinsed with 
ddH2O, dried under a hood, and desiccated until use.    
Hydroxyapatite disks (HA) (10 mm diameter x 4 mm thick) were pressed from 
powder (Plasma Biotal Ltd. P220) at 1 metric ton for 1 minute and sintered at 1350°C for 
5 hours (heating rate of 10°C/minute).  Carbonated apatite disks were made from 5.6% 
(CA5) carbonated apatite powders (generous gift from Dr. Mary Tecklenburg).  
Carbonated apatite disks (8-10mm diameter x 2-4mm thick) were pressed from powder at 
0.5 metric ton for 1 minute and sintered at 1350°C for 1 hour (heating rate of 
10°C/minute).  Both hydroxyapatite and carbonated apatite disks were sonicated clean in 
10mM HCl, then in ddH2O.  The HA and CA5 disks contained 0-1.1% and 1.5-2.1% 
CO32-, respectively (refer to Chapter Two).  All disks were autoclaved prior to use.  
Macroscopic dimensions of all disks were measured with calipers. 
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Cells 
Clonally derived human bone marrow stromal cells (hBMSC), a generous gift 
from NIH, were maintained in alpha minimum essential media (α-MEM) (Gibco, 
#12561) with glutamine containing 20% fetal bovine serum (FBS) and antibiotics (100 
U/mL penicillin, 0.1 mg/mL streptomycin (P/S)) (Gibco, #15140) at 37°C in a 5% CO2 
incubator.  Media consisting of α-MEM with supplements (both FBS and antibiotics) is 
referred to as ‘normal media’.  Media consisting of α-MEM without supplements (no 
FBS nor antibiotics) was used where appropriate in the following experiments and is 
denoted as ‘α-MEM without supplements’.  Cells were passaged or plated when they 
reached 80-90% confluence.  Media was replaced every 2-3 days.   
Phage Display on hBMSCs  
Peptide sequences were identified by screening the Ph.D.12TM Phage Display 
Library (New England Biolabs, #E8110S), consisting of 109 different phage with 12-mer 
amino acid linear peptide inserts, against clonally derived hBMSC (Passage 3-6).  2x104 
hBMSCs were plated in 2 wells of a 6-well dish and cultured for 6 days in normal media 
at 37°C and 5%CO2.  After 6 days of culture, the NEB 12-mer peptide library was 
prescreened against sintered HA disks prior to introduction to the cells, to preferentially 
screen for sequences attracted to the cells and not the apatite.  A streptavidin control was 
run in a separate dish per the manufacturers protocol. 
Prior to phage introduction to the cells, the sintered HA disks and streptavidin 
control were incubated in ddH2O and 1.5mg/mL streptavidin in 0.1 M NaHCO3, 
respectively, overnight at 4°C in a humidified container.  The following day, the ddH2O 
or 0.1M NaHCO3 was removed and replaced with blocking buffer and incubated at 4°C 
for 1 hour. Blocking buffer solution consisted of TBST (0.1%) (Tris-HCl buffered 
solution 50mM Tris-HCl pH 7.5, 150mM NaCl with 0.1% Tween-20) w/BSA for HA 
disks, TBST (0.1%) w/BSA + 0.1µg/mL streptavidin for control.  The blocking buffer 
was discarded, and the substrates were washed 6X with TBST (0.1%).  An aliquot of the 
original Ph.D.12TM library containing 1011 pfu (plaque-forming units) diluted in 1mL of 
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TBS for HA disks and TBST (0.1%) for streptavidin control was introduced to each 
substrate and gently rocked (LabLine 4625) for 40 minutes at room temperature.   
Non-binding phage on the HA disks were harvested and set aside.  Plated cells in 
6-well dishes were rinsed 2X with phosphate buffered solution (PBS, Gibco #10010) and 
pre-blocked with α-MEM without supplements containing 0.1% BSA at 37°C and 5% 
CO2 for 30 minutes.  The aliquot of phage harvested from the HA disks were then 
introduced to the cells (n=2) in 1mL of α-MEM without supplements containing 0.1% 
BSA for 1 hour at 37°C and 5% CO2.  Non-binding phage to the cells was then discarded, 
and the cells were washed 5X in cold PBS.  The phage bound to the cells were eluted 
with 1mL of Glycine/HCl, pH 2.2, with 1 mg/mL BSA for 10 minutes at room 
temperature while being gently rocked.  The eluted phage was collected and neutralized 
with 1M Tris-HCl, pH 9.1. 
Non-binding phage was discarded for the streptavidin control plate, which was 
then washed 10X with TBST (0.1%).  Bound phage were eluted from the control plate 
using 0.1mM biotin in TBS for 30 minutes at room temperature.   
A small amount of each phage eluate was titered to determine the number of 
phage bound to each substrate.  The rest of the eluate was amplified in E. coli (ER2738) 
by culturing the bacteria and phage in 20mL Lurie broth with vigorous shaking for 4.5 
hours.  The culture was centrifuged for 10 minutes at 10,000 rpm (Sorvall SS-34) at 4°C.  
The supernatant was transferred to a fresh tube, respun, and the upper 80% of the final 
supernatant was placed into a fresh tube and allowed to precipitate with 1/6 the volume of 
PEG/NaCl solution (20 w/v% polyethylene glycol-8000 in 2.5M NaCl).  The phage were 
allowed to precipitate at 4°C overnight.  The PEG precipitation was spun for 15 minutes 
at 10,000 rpm at 4°C, decanted and briefly respun.  The pellet was suspended in TBS and 
transferred to a microcentrifuge tube, respun in a microcentrifuge for 5 minutes at 10,000 
rpm at 4°C.  The supernatant was precipitated with 1/6 the volume of PEG/NaCl solution 
for 60 minutes on ice, recentrifuged for 10 minutes at 10,000 rpm at 4°C, and the pellet 
was resuspended in TBS with 0.02% NaN3.  A small amount of the purified phage eluate 
was titered to determine the number of amplified phage.  This amplified and purified 
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phage eluate was used in the next round of panning.  Subsequent rounds of panning 
introduced at least 109 pfu as the input phage.  Three rounds of panning were performed 
for each sample.  
Titering was performed with appropriate serial dilutions for both the eluted phage 
and amplified phage after each round of panning.  Agar plates treated with IPTG 
(isopropyl-b-D-thiogalactoside) and Xgal (5-bromo-4-chloro-3-indoyl-b-D-
thiogalactoside) were able to visually identify correct plaques using blue/white screening.  
For the cell samples, a total of 60 individual plaques picked from plates having no more 
that ~100 plaques were individually amplified by infecting 1mL of a log phase E.coli 
culture.  A fraction of the amplified phage stock from selected phage plaques were 
purified by PEG/NaCl precipitation.  Single stranded DNA was isolated using an iodide 
buffer extraction, cleaned in ethanol, and resuspended in DNase/RNase free water.  The 
DNA was sequenced via dideoxy chain termination method using a DNA sequencer 
(Applied Biosystems, 3730XL DNA Analyzer) with the NEB -96 gIII sequencing primer 
provided in the kit.  The remainder of the amplified phage stock for 20 selected phage 
plaques was amplified again by infecting 20mL of a log phase E. coli (ER2738 in Lurie 
broth) with vigorous shaking for 4.5 hours.  The culture was centrifuged for 10 minutes at 
10,000 rpm (Sorvall SS-34) at 4°C.  The supernatant was transferred to a fresh tube, 
respun, and the upper 80% of the final supernatant was placed into a fresh tube and 
allowed to precipitate with 1/6 the volume of PEG/NaCl solution.  The phage were 
allowed to precipitate at 4°C overnight.  The PEG precipitation was spun for 15 minutes 
at 10,000 rpm at 4°C, decanted and briefly respun.  The pellet was suspended in TBS and 
transferred to a microcentrifuge tube, respun in a microcentrifuge for 5 minutes at 10,000 
rpm at 4°C.  The supernatant was precipitated with 1/6 the volume of PEG/NaCl solution 
for 60 minutes on ice, recentrifuged for 10 minutes at 10,000 rpm at 4°C.  Each pellet 




The bioinformatics tool REceptor LIgand Contacts (RELIC) 
(http://relic.bio.anl.gov/index.aspx) (Makowski and Soares, 2003; Mandava et al., 2004; 
Rodi et al., 2004) was used to analyze the data from the phage display.  The programs 
DNA2PRO, MOTIF1, and INFO determined peptide translation sequences from DNA 
code, continuous conserved motifs within the peptide population allowing for 
conservative substitutions, and information numbers for each peptide reflecting the 
probability of selecting individual phage by chance, respectively.  For example, a high 
information measure can be indicative of an uncommon sequence with a low growth rate 
during amplification; whereas, a low information measure could represent a phage 
sequence likely to appear based on composition and/or high growth rates.  The phage 
display experiment on hBMSCs yielded 50 peptides, which were subsequently used in 
the MOTIF1 and INFO programs.  The program MOTIF1 searched for 3-mer and 4-mer 
continuous conserved motifs.  The program INFO was run with subtraction of a random 
selection of phage from the parent library (12R, 441 random sequences from NEB 12-
mer Ph.D. kit). 
  
Immunohistochemistry  
1x104 hBMSC cells (Passage 5-6) were plated in each well of 4-well chamber 
glass slides (Nunc Lab-Tek Chamber Slide Systems, Fisher #1256521) in normal α-
MEM.  Cells were allowed to attach and grow until confluent.  Prior to phage 
introduction, the media was removed and the cells were incubated with 500µL of normal 
α-MEM containing 0.1% BSA overnight at 37°C in 5% CO2.  Chosen individual phage 
plaques (Table 3.1) that had been amplified and isolated were introduced to this culture 
medium in a concentration of 0.5 x 1011 pfu/100µL and allowed to mix gently for 2 hours 
at 37°C in 5% CO2.  The media with phage was removed, and the cells were washed 6X 
with PBS.  The cells were then fixed in 4% paraformaldehyde (Electron Microscopy 
Sciences #15710) in PBS for 10 minutes and washed 2X with PBS.  Half of the fixed 
slides for each peptide were treated with 0.1% saponin in PBS with 0.1% BSA for 15 
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minutes.  All fixed slides were incubated with mouse anti-M13 monoclonal antibody (GE 
Healthcare, #27-9420-01) diluted to 1:250 in PBS for 1 hour.  The cells were washed 3X 
with PBS, and then incubated with FITC-conjugated sheep anti-mouse IgG (Jackson 
ImmunoResearch Labratories, Inc., #515-095-003) diluted 1:250 in PBS for 1 hour, 
covered from light.  The cells were again washed 3X in PBS and allowed to soak in PBS 
overnight.  The antibody solution, PBS wash solution, and PBS overnight soak solution 
for the saponin treated slides contained 0.1% saponin.   
Cells were covered with a glass coverslide after preparing in Vectashield (Vector 
Laboratories H-1200), and were subsequently viewed on a confocal laser-scanning 
microscope at an excitation wavelength of 488nm (Nikon TE 3000 Inverted Microscope). 
A BioRad Radiance 2000 LaserSharp program was used to image 20µm into the depth of 
the cells at 2µm intervals under 20x magnification.  An excitation wavelength of 568nm 
was used to obtain similar series of images to identify the cells in the background without 
exciting the FITC attached to the phage.  Each series of images was compiled in the 
LaserSharp program to obtain images showing adhesion of phage onto or into cells.  
Controls were run each day images were collected on the confocal microscope.  Controls 
included:  cells without phage receiving both antibody and FITC and cells only to detect 
any background fluorescence. Two samples for each phage and each condition were 
imaged.  Three individual scorers blinded to the phage number and saponin treatment 
scored each image on a scale of 0-3 (3 having the most stain present).  The scores were 
averaged, and phage having the highest stain present in both saponin treatments were 
further considered.  
Peptide Synthesis and Adsorption  
The two identified preferential hBMSC binding sequences (Figure 3.1) were 
combined with the previously identified apatite-based material binding sequence 
VTKHLNQISQSY [VTK] to build the dual-functioning peptides 
GGLLADTTHHRPWTGGGSVTKHLNQISQSY [L-VTK, MW = 3218.0 g/mol] and 
GGDPIYALSWSGMAGGGSVTKHLNQISQSY [D-VTK, MW = 3081.2 g/mol] (Table 
3.2) (refer to Chapter Two) (bold – cell adhesive sequence, underline – apatite-based 
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material adhesive sequence).  The idea of the dual-functioning peptide stems from the 
apatite-based binding sequence being able to anchor the peptide to BLM, while the cell 
binding sequence accessible to the hBMSCs to increase cell adhesion.  Two peptides with 
RGD sequences, one with a glutamic acid tail (EEEEEEEPRGDT [E, MW = 1447.6 
g/mol]) and the other with the V peptide (GGRGDGGGSVTKHLNQISQSY [RGDV, 
MW = 2117.6 g/mol]) were also fabricated to use as positive controls.  A peptide with 
RGE and V (GGRGEGGGSVTKHLNQISQSY [RGEV, MW = 2131.6 g/mol]) was built 
as a negative control against cell-attachment.  The peptide sequences were fabricated on a 
Rainin Symphony synthesizer and determined as >86% pure via high performance liquid 
chromatography (HPLC) (UM Protein Core).  Amino acid analysis was performed to 
verify initial peptide concentration read at A205nm with UV spectrophotometry (UM 
Protein Core).  Standard curves for all peptides were also generated using UV 
spectrophotometry (BioRad Smartspec 3000) at 205nm and 274nm (except 
EEEEEEEPRGDT for 274nm).  Each peptide was reconstituted in ddH2O and diluted to 
~500µg/mL in 50mM Trizma buffer (Sigma, pH=7.5).  In 24-well tissue culture dishes, 
blank tissue culture polystyrene (TCPS) wells, BLM films, HA disks and CA5 disks were 
soaked in Trizma buffer overnight at 4°C (n=5).  Prior to introducing 1mL of the peptide 
or buffer solutions for negative controls, plates were allowed to come to room 
temperature, and then the overnight solution was removed.  The plates were agitated on a 
Titer Plate Shaker at ~80rpm for 3 hours at room temperature.  The films and disks were 
rinsed with 1X with Trizma and then soaked in a 10mM HCl solution for 18 hours at 
room temperature on the same shaker.  Aliquots of the HCl solution were read on a UV 
spectrophotometer at 205nm and 274nm wavelengths.  
Cell Attachment Assay 
hBMSC cell attachment was tested with and without peptides on BLM and TCPS 
substrates.  Both BLM films (n=6) and TCPS wells (n=6) were soaked in Trizma buffer 
overnight at 4°C in a humidified container, prior to peptide adsorption.  The same method 
of peptide adsorption was followed as previously stated.  After the peptides were allowed 
to adsorb for 3 hours, the peptide solution was removed and the films and wells were 
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rinsed 1X with Trizma buffer solution (#T7818).  The control samples, devoid of peptide, 
received a 3 hour soak in Trizma buffer solution, and were then treated the same as the 
peptide groups.  All films and wells were blocked with denatured BSA (dBSA) (1% BSA 
in PBS heated to 80°C for 6 minutes) for 1 hour, followed by 1X rinse with PBS.  A 
concentration of 5x104 hBMSCs (Passages 5-8) suspended in α-MEM without 
supplements were seeded in all wells and allowed to attach for 1 hour at 37°C in 5% CO2.  
A cell standard curve prepared in 500µL of α-MEM without supplements was plated in a 
separate 24-well dish and incubated at 37°C in 5% CO2 at the same time cells were 
introduced to the films and wells.  After the 1 hour cell attachment, the α-MEM without 
supplements was removed and the plates were centrifuged upside-down at 300rpm for 5 
minutes (Eppendorf 5810R).  The films and wells were rinsed 1X with PBS, 500µL of α-
MEM without supplements was added to each well, and 50µL of WST-1 reagent 
(CloneTech #630118) was added to each well.  50µL of WST-1 was also added to each 
well in the cell standard curve.  All plates were incubated at 37°C in 5% CO2 for 3 hours.  
After 3 hours, the plates were shaken for 1 minute, and a 100µL aliquot was removed 
from each well, transferred to a 96-well plate, and read on a UV Microplate reader at 
420nm wavelength (Genios Tecan).  The WST-1 assay detects live cells only.  
Background values from films and wells without peptide were subtracted out for each run 
prior to normalization.  Percent cell adhesion was calculated by dividing the number of 
cells adhered by the number of initial cells seeded.  Initial cell seeding numbers were 
determined from an average of n=4 individually plated wells.  For BLM samples with 
peptide present, the percent cell adhesion was then normalized to the amount of peptide 
adsorbed to the mineral film.  All substrates were run with n=6, and each experiment was 
performed in duplicate.  
Statistics   
Statistical analysis was performed using SPSS (16.0).  Data are reported as mean 
± one standard deviation.  To determine differences in peptide adsorption to a given 
substrate, a one-way analysis of variance (ANOVA) was run with the Dunnetts T3 post-
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hoc multiple comparisons test.  Significance was determined by if the p-value < 0.05.  To 
detect differences in cell attachment normalized to nmol of peptide adsorbed on BLM for 
each peptide tested, an Independent Samples t-test was run with significance determined 
by a p-value < 0.05. 
Results 
Identification of Preferential Cell Adhesion Sequences to hBMSCs via Phage Display 
Three rounds of phage panning on duplicate samples of hBMSC populations 
yielded a total of 50 sequences that were DNA sequenced and analyzed using the RELIC 
software.  One sequence, LLADTTHHRPWT, was identified in both replicates of the 
phage experiment on the hBMSC populations.  From the 50 sequences identified, the 
MOTIF1 program identified continuous motif sequences 3 and 4 amino acids long as 
NHT, and (S/T)(I/V)LS, respectively (Figure 3.2).  Peptides DPIYALSWSGMA and 
LLADTTHHRPWT are included to show sequence homology with the 4- and 3-mer 
motifs identified.  The motif NHT or equivalent was present in 6% of the total peptides 
identified, whereas (S/T)(I/V)LS was present in 12%.  The streptavidin control run 
yielded the consensus HPQ sequence, signaling successful panning.   
 The INFO analysis revealed a shift towards higher information content in the 
phage identified as binders to hBMSCs compared to the NEB background (Figure 3.3).  
Higher information content describes a peptide sequence less likely to occur by chance.  
For the analyzed set of 50 peptides, a peptide sequence was deemed a higher information 
clone if the information measure was calculated as greater than 33.5, where 27 of 50 
peptides identified were labeled as high information clones.  The shift towards higher 
information content shows the successive rounds of panning isolated a unique pool of 
phage bound to the hBMSCs; however, the results from both the MOTIF1 and INFO 
show that one unique sequence was not identified.  Rather, multiple sequences with high 
information and shared motifs were identified.  A subset of 20 sequences, 10 higher 
information clones and 10 lower information clones, were analyzed using 
immunohistochemistry techniques.  
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 The peptide sequence, DPIYALSWSGMA, had the highest combined score, 
where the combined IHC score (Table 3.1) was taken as the addition of scores with 
saponin and without saponin.  Both the groups with and without saponin for each phage 
sequence tested was an average of three independent scores on n=2.  On average, the 
higher information clones showed evidence of more staining, and hence, more phage 
binding to the hBMSCs.  The higher information clones had an average combined score 
of 3.50 ± 1.01, whereas the lower information clones had an average combined score of 
2.23 ± 1.20.  Peptides 11 and 13 could not be scored for samples without saponin and 
were not taken into account when calculating the averages.  The sequence, 
LLADTTHHRPWT that occurred in both wells of hBMSCs also showed positive 
scoring.  When the frequency data, the RELIC INFO analysis, and IHC are taken 
collectively, the two sequences that showed the most promise as preferential binding 
sequences to the hBMSCs were DPIYALSWSGMA [D] and LLADTTHRPWT [L].  
Peptides D and L show positive binding to hBMSCs with and without saponin (Figure 
3.4).  Confocal image stacks acquired after excitation at wavelength 568nm to view cell 
location are also shown.  
Adsorption of Dual-Functioning Peptides on Apatite Materials 
On BLM, D-VTK showed superior binding compared to all other peptides with 
the VTK apatite-binding anchor (Figure 3.5) (For BLM D-VTK vs: L-VTK p=0.019, 
RGDV p=0.016, RGEV p=0.019; For HA D-VTK vs: L-VTK p=0.031, RGEV p=0.003; 
For CA5 D-VTK vs: L-VTK p=0.003, RGEV p<0.001).  The peptide E, also displayed 
high binding, although not significant, to BLM compared with L-VTK, RGDV, and 
RGEV, despite having a large standard deviation.  This adsorption and standard deviation 
is consistent with previously reported values for E (Refer to Chapter Two).  The 
adsorption of VTK peptide alone (previously reported average adsorption of VTK in 
nmol on BLM, HA, CA5, and TCPS were 2.72 ± 0.57, 2.60 ± 1.01, 2.61 ± 0.87, and 0.08 
± 0.13, respectively) was consistently higher than the dual-functioning peptides for each 
substrate tested.  Adsorption of the dual-functioning peptides was minimal, or at the 
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limits of the peptide detection method, for TCPS.  This data reinforces the substrate 
selectivity of the VTK portion of the dual-functioning peptides.  
Dual-Functioning Peptide Influences hBMSC Adhesion to Bone-Like Mineral 
Peptides L-VTK and D-VTK showed increased cell adhesion on BLM compared 
to RGDV, RGEV, and E (Figure 3.6).  The nature of the cell adhesion assay limits the 
number of peptides analyzed in one experiment; thus, a no peptide control was run in 
parallel for each experiment (white bars in Figures 3.6a,b).  On TCPS, L-VTK and 
RGEV had a positive influence on cell attachment compared to D-VTK, RGDV, and E.   
For both substrates, peptide E consistently showed low adhesion values, signaling that no 
more hBMSCs attached compared to the appropriate control when this peptide was 
adsorbed.  Because the initial amount of peptide adsorbed to the BLM is not easily 
controlled via chemical alteration of the ceramic substrate, adhesion data were 
normalized to the amount of peptide adsorbed on each material.  This normalization was 
only calculated for BLM (Figure 3.7), as some of the peptide adsorption values for TCPS 
were at the detection limits of the technique, which could produce erroneous values.  
Peptide L-VTK increased the ability of the hBMSCs to attach the most out of all the 
peptides tested.  Surprisingly, RGEV also showed the ability to positively influence 
hBMSC adhesion to BLM. (L-VTK vs. D-VTK p=0.046, For E vs: L-VTK p=0.006, D-
VTK p<0.001, RGDV p=0.029, RGEV p=0.026) 
Discussion 
Peptide sequences with an inherent preference to adsorb to the surface of apatite 
were identified within a peptide combinatorial library via phage display (refer to Chapter 
Two).  The identified peptide sequences are not useful biologically unless they promote 
desired cell functions, such as adhesion or proliferation.  In the present work, the phage 
display technique was also able to isolate peptides that preferentially bind to a clonally 
derived hBMSC population (Figure 3.4), which when combined with the apatite-binding 
peptide sequence, improved hBMSC attachment to bone-like mineral, particularly for L-
VTK (Figure 3.7).  The efficacy of the presented peptides is not limited to bone tissue 
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engineering applications, as this work illustrates that dual-functioning peptides can be 
designed, in general, to link inorganic substrates to organic sources. 
The efficacy of the ubiquitous cell adhesive sequence Arg-Lys-Asp (RGD), 
whether ionically or covalently bound to a plastic, metal, or ceramic, on cell adhesion has 
been studied extensively (Bearinger et al., 1998; Benoit and Anseth, 2005; Cavalcanti-
Adam et al., 2002; Ferris et al., 1999; Hennessy et al., 2008; Houseman and Mrksich, 
2001; Hu et al., 2003; Itoh et al., 2002; Koo et al., 2002; Maheshwari et al., 2000; 
Mardilovich and Kokkoli, 2004; Massia and Hubbell, 1990; Niu et al., 2005; Okamoto et 
al., 1998; Rapuano et al., 2004; Sawyer et al., 2005a; Sawyer et al., 2005b; Shin et al., 
2002; Shin et al., 2004a; Tosatti et al., 2004; VandeVondele et al., 2003).  While RGD 
can promote cell adhesion and proliferation when used in appropriate concentrations, 
recent experiments have reported that coating RGD on the surface of implanted 
hydroxyapatite may have negative implications, such as the lack of osseointegration, on 
bone-implant integration (Hennessy et al., 2008).  Additionally, passive adsorption of 
RGD on HA substrates decreased mesenchymal cell adhesion compared to HA substrates 
having the RGD sequence with a polyglutamate motif attached.  Linking the cell-binding 
peptides tested to the apatite-binding peptide VTK allows the VTK peptide to anchor the 
cell-binding peptide to the apatite surface, so passive adsorption of the cell-binding 
peptide is avoided. 
 The dual-functioning peptides designed in this study showed a positive effect on 
the ability to adhere hBMSCs on BLM compared to the E peptide having a glutamic-acid 
tail for apatite adhesion and RGD for cell adhesion (Figure 3.7).  In fact, the E peptide 
had the highest mean adsorption on BLM (Figure 3.5), but did not improve cell 
attachment.  The D-VTK peptide had adsorption values on the same order as the E 
peptide, but was able to positively influence cell attachment, suggesting that the 
composition of the D-VTK peptide promoted hBMSC attachment.  The E peptide data 
contradicts previous reports that state E7PRGDT has the ability to increase cell adhesion 
of murine KUSA/A1 osteoblast cells (Itoh et al., 2002) and human mesenchymal stem 
cells (Sawyer et al., 2005b) on HA, although both studies performed their experiments on 
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sintered hydroxyapatite samples.  Neither study quantified the amount of peptide on the 
surface of their HA samples, and both studies used serial washing as a method of cell 
detachment, making it difficult to compare the results to those reported in this study.  Cell 
adhesion methods using centrifugation eliminate any questions of reproducibility and 
sensitivity than washing methods (Garcia and Gallant, 2003; Reyes and Garcia, 2003a). 
Also, slight changes in substrate morphology can influence peptide adhesion at similar 
initial adsorption concentrations (refer to Chapter Two).  While adhesive proteins may 
contain acidic and RGD amino acid sequences, isolating these portions of proteins as 
peptides may not be beneficial on all substrates and/or cell sources.  Alternatively, acidic 
peptides may have lower ionic binding strength to the BLM than the other peptides 
tested, creating a weaker acidic peptide-BLM bond that could be broken more easily 
during the centrifugation step in the cell attachment assay.  This suggests that the D-VTK 
and L-VTK peptides favorably interact with the BLM surface compared with E, again 
indicating that the phage derived sequences identified prove advantageous in promoting 
cell attachment on BLM.   
  Surprisingly, no difference in cell adhesion to the BLM was seen between the 
positive control, RGDV, or the negative control, RGEV (Figure 3.7).  The attachment of 
the VTK peptide could have interfered with the binding or presentation of RGD and RGE 
to the cells.  If this were the case, the cell attachment that did occur could have resulted, 
because the VTK sequence contains a peptide sequence that influences cell attachment to 
the BLM.  VTK alone would have to be investigated to rule out the influence this apatite-
seeking sequence.  Likewise, the hBMSC population studied may not be influenced by 
the RGD or RGE sequences as much as other cell sources, decreasing the response of the 
hBMSCs to RGD or RGE.  The unresponsiveness of hBMSCs to RGD was shown in a 
previous study that showed immobilized linear and cyclic RGD containing peptides on 
hydroxyapatite displayed no effect of the peptide on initial adhesion of hBMSCs after 1 
hour incubation (Durrieu et al., 2004).   
 Increased cell adhesion to TCPS coated with L-VTK and RGEV was seen (Figure 
3.6b), despite negligible amounts of these peptides being adsorbed (Figure 3.5).  The 
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inability to accurately quantify peptide at the nanogram level is a limitation of using the 
UV absorbance technique for peptide adsorption.  Traces of these peptides could have 
been undetected on the TCPS, allowing small amounts to influence hBMSC attachment. 
Alternative explanations could be that the L-VTK and RGEV peptides alter the surface 
charge of the TCPS, yielding an altered surface for the hBMSCs to attach, or the VTK 
peptide is influencing cell attachment.    
While the lack of controlled peptide adsorption was taken into account by 
normalizing cell adhesion to the amount of peptide adsorbed, we do not report saturation 
curves, as this would be an expensive experiment for the concentrations and materials 
used, and cannot conclusively say that peptide saturation was attained.  However, 
increased fluorescence intensities with increased concentrations of FITC-labeled E7RGD 
peptide on HA disks shows a strong intensity visible at 100µg/mL (Sawyer et al., 2005b).  
Since the initial peptide concentrations used in these studies were ~500µg/mL, we can 
only speculate that saturation was achieved. 
Increased hBMSC attachment resulting from the presence of the dual-functioning 
peptide, L-VTK, on bone-like mineral demonstrates the feasibility of rational peptide 
design using phage display technology.  The surface modification limitations for ceramic 
materials have impeded the development of functionalization methods that can control 
peptide concentrations present on the surface of apatite-based materials.  This was 
addressed in the current study by normalizing the cell adhesion data with the adsorbed 
peptide amounts.  Only recently have methods of silanization been used to covalently link 
peptides to apatite surfaces (Durrieu et al., 2004); however, it is not known if chemical 
alteration of the apatite surface will affect cell behavior.  
Peptide design has focused on identifying portions of known bone extracellular 
matrix proteins (e.g. osteonectin (Fujisawa et al., 1996), bone sialoprotein (Fujisawa et 
al., 1997), statherin (Gilbert et al., 2000)) that are potential apatite binders via ionic 
binding, such as phosphorylated sites or long strings of acidic amino acids (Fujisawa et 
al., 1997; Itoh et al., 2002; Sarig, 2004; Sawyer et al., 2005b).  In both cases, these 
peptide regions on proteins are thought to adhere to the apatite in bone due to their 
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negative charge in a biological environment, which is typically at neutral pH.  It has been 
suggested both experimentally and computationally that this negative charge is attracted 
to the calcium ions on the surface of the apatite (Boanini et al., 2006; Fujisawa and 
Kuboki, 1991; Fujisawa and Kuboki, 1998; Fujisawa et al., 1997; Gilbert et al., 2000; 
Gilbert et al., 2003; Pan et al., 2007).  The design scheme of using negatively charged 
peptides works if the apatite surface maintains a periodic surface charge with calcium 
ions available.  Bone-like mineral precipitated from a 1X or 1Xmodified SBF solution 
possesses spherical rosette clusters with plate-like features at the nanometer scale (Luong 
et al., 2006; Murphy and Mooney, 2002; Murphy et al., 2000).  The unique morphology 
of BLM could alter the charge distribution on its surface, limiting the benefits of acidic 
peptides.  Peptide E displayed increased adsorption on BLM compared to the other 
peptides tested, but also had the largest standard deviation making the adsorption of this 
acidic peptide to BLM less predictable.  The HA plates in BLM coatings are positioned 
close to one another, so that even if the correct surface charge periodicity is present on 
one plate, the overall charge periodicity on a cluster of plates may provide an unattractive 
surface for long strings of negatively charged peptides.  Further, identifying non-acidic 
peptide sequences that preferentially bind to apatite materials may provide an advantage 
in that they may not bind to free calcium sites on the surface of the material, allowing 
serum proteins, when present, to concurrently adsorb and promote other cell functions.  It 
has been suggested that HA is more osteoconductive than other materials because of its 
ability to adsorb increased amounts of adhesive proteins when introduced to serum 
(Kilpadi et al., 2001).  
Two hBMSC binding peptides, DPIYALSWSGMA and LLADTTHHRPWT, 
were identified via phage display and linked to a previously identified apatite-binding 
peptide VTK.  The combined peptide D-VTK showed superior ability to adsorb onto the 
three apatite-based materials tested when compared to the other peptides possessing the 
VTK anchor.  Both D-VTK and L-VTK were able to increase the attachment of hBMSCs 
on BLM compared to E.  When cell attachment was normalized to peptide adsorbed, L-
VTK proved most influential on hBMSC attachment to BLM.    
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The phage display technique utilized in Chapters Two and Three to isolate 
preferential binding sequences to apatite-based materials and a clonally derived hBMSC 
population, respectively, illustrates the wide-range of advantageous information that can 
be harnessed using phage display.  A peptide combining the sequences identified, L-
VTK, increased hBMSC attachment to BLM, validating the new proposed design 
approach.  This technique can potentially be used to isolate populations of cells, a 
concept that would provide great control over bone engineered scaffolds.  Additionally, 
multiple permutations can be investigated to apply this design rationale not only to bone 
engineering, but also to cartilage, ligament, tendon, and soft tissue research.   
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Figure 3.1:  Schematic displaying data analysis progression used to identify peptides that 
preferentially adhere to clonally derived hBMSCs. 
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Figure 3.2: Consensus sequences from the MOTIF1 program showing (S/T)(I/V)LS and 
NHT as the 4- and 3-mer motifs having the most frequent hits.  The RELIC program 
MOTIF1 was run with 50 peptide sequences identified from three rounds of phage 
display panning on clonally derived hBMSCs.  Peptides DPIYALSWSGMA and 
LLADTTHHRPWT are included to show sequence homology with the 4- and 3-mer 
motifs identified via MOTIF1.   
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Figure 3.3: INFO content values calculated in RELIC for NEB background and phage 
subset identified as preferential binders to clonally derived hBMSCs.  High information 
content correlates to a lower incidence of being selected by chance. The phage subset 
shows a shift towards a higher information content signifying this subset was selected 
based on the binding affinity to hBMSCs.  The INFO values of the two phage sequences, 
LLADTTHHRPWT and DPIYALSWSGMA, used in the final dual-functioning peptide 





Figure 3.4: Representative confocal images from the immunohistochemistry with the 
phage containing the sequences LLADTTHHRPWT (a) and DPIYALSWSGMA (b) 
showing positive FITC signal at 488nm for the hBMSC introduced to the phage. Images 
are compressed z-stacks taken for 20µm at 2µm intervals.  Compiled images taken with 
the red laser at 568nm show the location of the cells on the slides for the hBMSCs treated 
with saponin.  Note phage binding is located only in regions where cells are present.  
Sequence DPIYALSWSGMA had the highest overall score from all of the phage 





Figure 3.5: Adsorption of five dual-functioning peptides (L-VTK, D-VTK, RGDV, 
RGEV, and E) on four substrates (BLM, HA, CA5, and TCPS).  Adsorption of phage 
display derived peptide D-VTK was significantly higher than L-VTK, RGEV, and 
RGDV on BLM and L-VTK and RGEV on HA and CA5 ((For BLM D-VTK vs: L-VTK 
p=0.019, RGDV p=0.016, RGEV p=0.019; For HA D-VTK vs: L-VTK p=0.031, RGEV 
p=0.003; For CA5 D-VTK vs: L-VTK p=0.003, RGEV p<0.001)).  Adsorption of all 
peptides was higher on the apatite-based materials displaying the specificity of the 




Figure 3.6: (a) hBMSC adhesion on BLM for all five peptides tested. L-VTK and D-VTK 
had a positive influence on cell attachment compared to BLM devoid of peptide.  RGDV, 
RGEV, and E had low levels of cell attachment compared to the BLM control.  (b) 
hBMSC adhesion on TCPS for all five peptides tested. L-VTK and RGEV were the only 
peptides that showed increased cell attachment compared to the TCPS devoid of peptide.  
All experiments were performed in duplicate, with each experiment having n=6. * - 
Statistical difference vs. appropriate control, p<0.05. 
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Figure 3.7: Cell adhesion normalized to amount of peptide adsorbed on BLM.  
Appropriate background adhesion to BLM devoid of peptide was subtracted prior to 
normalization.  L-VTK was statistically more effective at improving cell attachment than 
D-VTK and E.  L-VTK also displayed a greater mean compared with RGDV or RGEV  
(L-VTK vs. D-VTK p=0.046, For E vs: L-VTK p=0.006, D-VTK p<0.001, RGDV 
p=0.029, RGEV p=0.026).  Peptide E showed no effect on cell adhesion.  Horizontal bars 
indicate statistical differences.  
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Table 3.2 Dual-functioning Peptide Sequences Containing Both an Apatite Seeking 







UNIFORM DEPOSITION OF PROTEIN INCORPORATED MINERAL LAYER 
ON THREE-DIMENSIONAL POROUS POLYMER SCAFFOLDS  
Introduction 
The restoration and repair of orofacial and long-bone defects resulting from 
disease, trauma, or genetic inheritance is still a major clinical challenge (Feinberg et al., 
2005; Muschler and Midura, 2002; Parikh, 2002; Wiesmann et al., 2004).  Autogenous 
bone grafting is a current method used in repairing skeletal defects.  However, limitations 
including donor site morbidity, graft rejection, and inadequate bone formation or quality 
often result (Parikh, 2002; Yaszemski et al., 1996).  Current approaches in bone tissue 
engineering strive to overcome these limitations and induce bone formation using a 
combination of an extracellular matrix analogue, cells, and/or biological signals (Garcia 
and Reyes, 2005; Hubbell, 1999; Maskarinec and Tirrell, 2005; Shin et al., 2003).  
Three approaches are used in tissue engineering:  conduction, induction, and cell 
transplantation (Alsberg et al., 2001; Hirano and Mooney, 2004).  Initial research has 
focused on a conductive approach that aims to recruit host cells towards an implanted 
material and initiate bone ingrowth or regeneration.  Research using inductive approaches 
of incorporating cell-recruiting or cell-directing molecules in or on the implant has 
increased to improve the rate, amount, and quality of bone being regenerated (Chen and 
Mooney, 2003).  In parallel, control of the location and direction of bone growth via 
transplantation of bone cell lines, genetically manipulated cells, or stem cells on these 
constructs has been explored (Rose and Oreffo, 2002).   Cells are typically seeded on 
highly porous (> 90%) scaffolds fabricated from biodegradable materials.  To control cell 
responses, such as adhesion, the material can be modified via surface alterations or 
coatings. 
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Specific to bone scaffolding, strategies to increase the quantity and quality of 
regenerated bone include using organic/inorganic hybrid materials that promote bone 
healing and remodeling.  For example, the technique of biomimetically precipitating a 
bone-like mineral layer onto porous polymer scaffolding provides cells a calcium 
phosphate material surface that is chemically similar to the composition of natural bone.  
This technique of biomimetically precipitating apatite onto the surface of a biomaterial 
was first researched on silica rich Bioglass (Ogino et al., 1980) and was subsequently 
introduced on titanium hip implants to enhance implant-bone osseointegration (Abe et al., 
1990).  Biomimetic deposition of bone-like mineral occurs at biological temperatures, 
making it an attractive alternative to high temperature processing methods such as plasma 
spray and sputtering techniques (Habibovic et al., 2002; de Groot et al., 1998).  The 
biomimetic technique in bone tissue engineering has evolved into mineralizing 
biodegradable polymeric scaffolds with the intent of tailoring calcium-phosphate ratios to 
evoke particular cell behavior while also increasing scaffold mechanical integrity 
(Murphy et al., 2000).   The presence of bone-like mineral is hypothesized to recruit host 
cells as well as to have the ability to control the differentiation of transplanted cells 
towards a bone phenotype (Luong et al., 2006). 
Surface pre-treatments that create negatively charged surface groups to accelerate 
mineral nucleation benefit both 2D and 3D materials.  While growth of bone-like mineral 
on polylactic-co-glycolic acid (PLGA) is attainable when a pre-mineralization hydrolysis 
(Murphy and Mooney, 2002) or aminolysis (Croll et al., 2004)  treatment is used, the 
apatite precipitated on 3D PLGA scaffolds is often discontinuous and can take up to 16 
days to form (Murphy et al., 2000; Zhang and Ma, 2004).  The lack of mineral continuity 
in 3D exists for both materials that do and do not receive surface pre-treatments, 
supporting the need for innovations to improve current processing techniques.  The 
design goals of using second generation biomimetically mineralized materials therefore, 
aim to reduce the time of apatite formation and to uniformly mineralize the interstices of 
3D scaffolding, while controlling calcium phosphate ratios (Oliveira et al., 2003).  To 
clarify terminology used, a dense substrate amenable to mineralization, such as a polymer 
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or titanium surface is considered a 2D surface; however, when the substrate becomes 
porous and mineralization can occur through its thickness, the result is a 3D structure or 
scaffold.   
In addition to a bone-like mineral layer providing a more conductive surface, the 
incorporation of inductive agents such as proteins or growth factors into the mineral can 
expose cells to spatiotemporally controlled biomolecular cues that can further promote 
and direct osteogenesis.  Methods of incorporating proteins include covalent attachment, 
adsorption, and entrapment and are less than ideal for sustained release.  A promising 
alternative to these methods is the coprecipitation of proteins and bone-like mineral.  
Depositing a protein-mineral layer on a porous scaffold provides a system that can 
deliver protein while allowing tissue ingrowth in 3D.  Another advantage to 
coprecipitation is the ability to deposit bone-like mineral and proteins at physiological 
temperatures, minimizing potential processing parameters that could alter the biological 
activity of the incorporated biomolecules (Liu et al., 2005; Wen et al., 1997; Wen et al., 
1999).  A third advantage to coprecipitation is the ability to incorporate different 
biomolecules at different stages of mineral deposition, which provides a means of 
controlling release kinetics (Azevedo et al., 2005; Luong et al., 2006).  Coprecipitation 
also leads to more sustained biomolecule release compared to adsorption, increases 
potential loading capacity, and is able to be used in conjunction with adsorption to further 
control biomolecular release (Liu et al., 2001; Luong et al., 2006).  While coprecipitation 
is an effective means of incorporating biomolecules in bone-like mineral on dense, 
permanent implants, to be effective in tissue regeneration there is a need to rapidly and 
uniformly coat pores through the thickness of 3D scaffolding.   
To study the effects of surface mineralization and biomolecular incorporation on 
bone growth in three dimensions, a scaffold uniformly and continuously coated with 
bone-like mineral or bone-like mineral with protein is necessary.  Therefore, a filtration 
system was designed to induce flow of simulated body fluid (SBF), an ionic solution with 
similar ion concentrations as body serum, through the pores of polymer scaffolding to 
achieve mineralization throughout the thickness within 5 days.  The goals of this study 
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were to demonstrate:  1) the filtration system is capable of coating the pores of a 3D 
scaffold with a uniform, continuous bone-like mineral layer and 2) a model biomolecule, 
BSA, is capable of being incorporated throughout the 3D mineral layer.  The hypothesis 
that flow of simulated body fluid through porous scaffolding will initiate mineralization 
within the pores of 3D scaffolds and induce the formation of a uniform mineral layer in 
3D is tested.  Furthermore, the capability of precipitating a continuous mineral-protein 
layer in 3D is also investigated.  A combination of micro-computed tomography 
(MicroCT), x-ray diffraction (XRD), protein quantification, and confocal microscopy is 
utilized to illustrate uniform, continuous mineralization and protein incorporation 
throughout the thickness of 3D scaffolds.   
Materials and Methods 
Scaffold Fabrication 
The scaffolds were fabricated using a salt-leaching method.  NaCl was sieved to 
425-600 µm in diameter and packed into 10 mm diameter wells in a Delrin® (filtration 
group) or Teflon® (control groups) mold.  A 5 wt% 85:15 polylactic-co-glycolic acid (iv 
= 0.73 dL/g, Alkermes)-chloroform solution was added to each well.  The scaffolds were 
covered with aluminum foil and dried under a chemical fume hood for at least 36 hours.  
The mold was then placed in distilled water (dH2O) to leach out the salt particles for at 
least 36 hours.  The scaffolds were treated with 0.5 M NaOH for 7 minutes and rinsed 
with dH2O.  The final thickness of the scaffolds was approximately 2 mm. 
Simulated Body Fluid Preparation 
Chemicals for making SBF were purchased from Sigma-Aldrich unless otherwise 
noted.  The chemicals and concentrations used to make 1x SBF include 141 mM NaCl, 
4.0 mM KCl, 0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0 mM CaCl2•2H2O, 
and 2.0 mM KH2PO4 (Kokubo, 1995).  To prepare 2x SBF and 4x SBF, the 
concentrations were doubled and quadrupled, respectively.  All SBF solutions were 
prepared at 25°C using dH2O.  The 2x SBF was titrated to pH 6.8, and the 4x SBF was 
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titrated to pH 6.4 using 1 M NaOH.  These pH values were used to avoid homogenous 
precipitation.  Both 2x SBF and 4x SBF were buffered with Tris-HCl.  All SBF solutions 
were filtered using a 0.22 µm filter prior to use, and 0.005% sodium azide was added to 
prevent bacterial contamination.  
Mineralization of Scaffolds in the Filtration System 
The Delrin® mold with salt-leached scaffolds (n=4) was attached to the actuator 
of an Instron 8521 servo-hydraulic system and lowered into the aluminum base housing 
the SBF (Figure 4.1).  The filtration system base is filled with SBF such that the scaffolds 
within the Delrin mold are submerged with all surfaces being exposed to the SBF 
throughout the experiment.  SBF solutions were warmed to 37°C prior to adding to the 
base.  Initially, 1 L of 4x SBF (pH=6.4) was used for 12 hours, being replenished with 
fresh solution after 6 hours.  Subsequently, 1 L of 2x SBF (pH=6.8) replaced the 4x SBF 
and was replenished every 12 hours.  The SBF was changed to sustain the appropriate ion 
concentration levels in addition to maintaining the pH of 6.4 or 6.8, which is conducive to 
heterogeneous precipitation of bone like mineral onto the scaffolds.  The pH values of 
new (fresh SBF) and used (SBF being replenished) SBF were measured using a pH meter 
(Mettler Toledo MP230).  A fatigue regimen was programmed on the Instron 8521 to 
cycle the mold with the scaffolds at an amplitude of 25.4 mm at 0.011 Hz for 5 days.  A 
temperature controller (Extech Instruments, Model 48VTR) maintained a solution 
temperature of 37°C ± 1°C.  Two static control groups, submerged control (n=4) and 
floating control (n=4), were subjected to the same SBF regimen (0.5 L SBF instead of 1 
L) in a 37°C incubator for 5 days.  The submerged group scaffolds were prepared in a 
Teflon® mold.  The scaffolds in the floating static group were cast in a Teflon® mold, 
removed, and mineralized in 50 mL conical tubes containing 50 mL of SBF.  The 5 day 
mineralization experiment was repeated twice for all of the groups. 
BSA Coprecipitation  
The Delrin® mold with salt-leached scaffolds (n=8) was attached to the Instron 
8521 system and lowered into the aluminum base housing the SBF or SBF:FITC-BSA.  
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Fluoroisothiocyanate (FITC) conjugated BSA (Sigma-Aldrich, A9771) and BSA (Sigma-
Aldrich, A3294) were used to prepare SBF:FITC-BSA solutions with a 1:5 ratio of FITC-
BSA to BSA for a total protein concentration of 200 µg/mL.  The SBF for these solutions 
was filtered using a 0.22 µm filter prior to the addition of FITC-BSA or BSA.  Initially, 1 
L of 4x SBF (pH = 6.4) was used for 12 hours, being replenished with fresh solution after 
6 hours.  Subsequently, 1 L of 2x SBF:FITC-BSA (pH = 6.8) replaced the 4x SBF and 
was replenished every 12 hours. The SBF:FITC-BSA was changed to sustain the 
appropriate ion concentration levels, to replenish the FITC-BSA supply, and to maintain 
a pH of 6.8.  A fatigue regimen was programmed on the Instron 8521 to cycle the mold 
with the scaffolds at an amplitude of 25.4 mm at 0.011 Hz for a total of 3 days.  The 
temperature controller maintained a solution temperature of 37°C ± 1°C.  A submerged 
static group (n=8) was prepared in a Teflon® mold and subjected to the same SBF and 
SBF:FITC-BSA regimen in a 37°C incubator for 3 days.  The floating control group was 
excluded from this experiment, because the MicroCT analysis for this group showed the 
least amount of mineral volume % in the previously described 5 day mineralization 
experiment.  An equal volume of SBF was used for the control and experimental groups 
to maintain similar FITC-BSA concentrations.  The coprecipitation experiment was 
repeated twice for both groups. 
MicroCT Analysis of Mineralized Scaffolds 
After 5 or 3 days of mineralization, all scaffolds were removed, rinsed in dH2O, 
and dried under a chemical fume hood.  Scaffolds were scanned (n=4 for 5 day 
mineralized scaffolds, n=8 for 3 day coprecipitated mineralized scaffolds) in a MicroCT 
system (EVS MS8X-130, 16  µm voxel size) to obtain mineral volume % (MV%) and 3D 
rendered images (MicroView®, GE Systems). MicroCT scans were obtained at 75 mA 
and 75 mV for 400 frames using an aluminum filter. All reconstructed images were 
rendered in MicroView® using the Isosurface tool at a threshold of 1000 with the 
smoothing filter on, and at a surface quality factor of 0.55.  A MV % profile for each 
group (filtration, submerged control, and floating control) was calculated using a 
volumetric shrinkage program written in MATLAB.  This program calculates the 
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centroid of each scaffold from a user-defined region of interest volume in MicroView, 
and subsequently uses spline calculations to determine a 16.7% volume shrinkage from 
the original volume.  Analysis of progressively smaller concentric volumes resulted in 6 
different shells of equal volumes per scaffold.  The term ‘innermost shell’ refers to the 
innermost volume, which is cylindrical in shape.  The other five volumes calculated were 
concentric cylindrical shells.  The mineral volume % was calculated for each shell to 
compare the mineral gradient within and between the scaffold groups.   
X-ray Diffraction Analysis 
 XRD spectra were obtained using a Rigaku Miniflex X-ray Diffractometer with a 
fixed incidence of 4.2°.  A range of 10-90° was scanned using a step size of 0.1° and a 
scan rate of 1°/min. The top surface of all of the scaffolds was scanned, unless otherwise 
noted.  The raw data of a representative sample were plotted for all groups to compare the 
different conditions, which included filtration 5 days (n=2), filtration 3 days (n=1), 
filtration 1 day (n=1), submerged control (5 days, n=2), and filtration control (5 days, 
n=2).  The filtration samples retrieved after 1 day, 3 days, and 5 days were analyzed to 
evaluate time dependent changes in mineral.  A blank PLGA scaffold was also scanned to 
detect background from the substrate material.  To investigate if the mineral formed in 
the center of the filtration scaffolds was similar to the mineral formed on the surface, 5 
day filtration scaffolds were transversely cut and analyzed (Filtration Center 5 Days, 
n=2).  Hydroxyapatite (Sigma-Aldrich #289396) and 6wt% carbonated apatite (generous 
gift from Dr. Mike Morris, University of Michigan) were scanned as standards.  
FTIR Analysis 
Characteristic peaks for apatite were detected using a Fourier Transform Infrared 
Spectroscopy (Spectrum BX FT-IR, Perkin Elmer).  A 300:1 ratio of KBr to deposited 
mineral was used prepare a pellet and analyze the filtration, submerged control, and 




The amount of BSA coprecipitated onto the scaffolds (n=8) was detected using a 
UV spectrophotometer (SmartSpec 3000, BioRad).  Each scaffold was demineralized in 
10 mM HCl.  An aliquot of the demineralization solution was measured at a wavelength 
of 494 nm to detect the FITC conjugated to the BSA.  Concentrations of coprecipitated 
FITC-BSA were determined from a standard curve prepared with a 1:5 ratio of FITC-
BSA to BSA.  The calibration curve was constructed for the FITC-BSA:BSA solution 
using serial dilutions in 1x PBS.  Protein densities were calculated using values for the 
amount of mineral precipitated from MicroCT analyses and the amount of BSA 
coprecipitated from the quantitative UV spectrophotometry.  
Confocal Microscopy 
A 1-2 mm thick center cross-section from protein incorporated scaffolds was cut 
to expose the 2 mm depth of the scaffolds (n=4).  Each section, rectangular in shape (10 
mm x 2 mm x1-2 mm), was sandwiched between a glass slide and glued cover slip and 
viewed using confocal microscopy (Nikon TE 3000 Inverted Microscope) at an excitation 
wavelength of 488 nm.  A BioRad Radiance 2000 LaserSharp program was used to 
image 750 µm into the 1-2 mm section at 3 µm intervals under 10x magnification.  The 
series of images was compiled in the LaserSharp program to yield images showing FITC-
BSA incorporation throughout the 750 µm.  Multiple images were obtained across each 
sample and were mosaic-tiled together.   The center cross-sections from scaffolds 
mineralized via filtration (5 day mineralization using the previously described 4x SBF/2x 
SBF regimen) without fluorescent-labeled protein were also investigated to characterize 
any mineral autofluorescence.  
Statistics 
The effect of filtration on MV% was determined using a One-Way Analysis of 
Variance (ANOVA) on Ranks with Student-Newman-Keuls post-hoc evaluation. 
Significant differences in MV% between the concentric volumes within each group were 
also determined using a One-Way Analysis of Variance (ANOVA) on Ranks.  The 
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effects of filtration on MV% and on FITC-BSA incorporation for the BSA-scaffolds were 
determined using a Student’s t-test. Significance was defined as p<0.05, and all statistics 
were calculated using SigmaStat v3.1. 
Results 
Uniform, Continuous Mineral Precipitated Throughout the Depth of Filtered Scaffolds 
Filtration of SBF through the scaffold pores significantly increased the mineral 
deposition compared to both the submerged and floating static control groups (Figures 
4.2 and 4.3).  The qualitative 3D MicroCT renderings for the filtration and submerged 
control groups show increased mineral within the filtration group (Figure 4.2).  The 
cross-section images (Figure 4.2c-f) also confirmed that mineral was present throughout 
the thickness of the filtration scaffolds.  The floating control group 3D renderings did not 
show any mineralization (images not shown).  The MV% in the filtration scaffolds was 
significantly greater than both control groups (floating control p=0.029, submerged 
control p=0.029).  There was also an even distribution of mineral throughout the filtration 
scaffolds compared with both control groups, which had >60% of the precipitated 
mineral in the two outermost shell volumes (Figure 4.4).   If the average amount of 
mineral precipitated (~8%, Figure 4.3) on the filtration scaffolds is combined with the 
initial amount of PLGA present (5%), the scaffold porosity would decrease, on average, 
from 95% to approximately 87% for the filtration scaffolds.    
The mineral deposited on the scaffolds showed characteristic FITR peaks for both 
hydroxyapatite (v3c P-O 1032 cm-1, v1 P-O 962 cm-1, v4a O-P-O 602 cm-1, and v4c O-P-O 
561 cm-1 [filtration group only]) and carbonated apatite (v1 CO3(2-) 1465 cm-1 [filtration 
and floating control groups]) (Figure 4.5) (Koutsopoulos, 2002).  XRD spectra for all of 
the groups also show apatite characteristic 2θ peaks between 25.9°-26.8°, between 31.8°-
32.7°, at 40.1°, and between 45°-55° (Figure 4.6) (Koutsopoulos, 2002).  The XRD 
spectra further reveal that the peaks from the filtration scaffolds are consistent over the 5 
days of mineralization, providing evidence that the mineral being precipitated on days 1 
and 3 is similar to the mineral being precipitated on day 5.  Last, XRD analysis confirms 
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that the type of mineral deposited was similar in all three experimental groups (filtration, 
submerged control, and floating control).  
Uniform and Increased BSA Incorporation in Filtered Scaffolds 
A ten-fold increase in protein incorporation (Figure 4.7) was established in the 
scaffolds mineralized using the filtration device.  Confocal microscopy supported the 
increased protein incorporation within the filtration group, in addition to showing 
uniform precipitation throughout the thickness of the scaffolds (Figure 4.8). The confocal 
microscopy methods followed in these (Figure 4.8c) and other experiments revealed no 
interfering autofluorescence from the PLGA or the mineral (Luong et al., 2006).   Similar 
to the 5 day filtration mineralized scaffolds, a greater amount of mineral was deposited 
on the 3 day coprecipitated filtration scaffolds compared to the static controls, p<0.001 
(Figure 4.9).   
Discussion 
Using the filtration system developed, a uniform 3D substrate surface that mimics 
the inorganic composition of bone was created, providing a microenvironment that could 
potentially enhance osteogenesis (Kohn et al., 2005).  Designing a biomaterial that can 
enhance the ability of cells to attach and proliferate is an imperative aspect of controlling 
cellular microenvironment.  Seeding cells on 3D scaffolding as a first step in controlling 
cell function however, is not trivial (Toh et al., 2005).   Non-uniform apatite coverage on 
scaffolding is preventative of uniform cell seeding.  By establishing a technique that can 
consistently provide uniform and continuous mineral coverage of 3D porous scaffolding, 
it is hypothesized that cell seeding uniformity will be enhanced and uniform osteogenesis 
will be more likely to occur. 
The precipitation of a continuous mineral film onto pore surfaces of the polymer 
substrate was the goal of the initial filtration experiment.  Appropriate ion concentrations 
are necessary for calcium phosphate growth (Feng et al., 2000), particularly within the 
internal pores of a 3D scaffold.   In order to maintain film formation, the thermodynamics 
of the SBF must be held below the homogenous precipitation limit and above the solute 
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saturation limit (Bunker et al., 1994).  If these conditions are not met, then no or minimal 
mineral will form (Bunker et al., 1994; Murphy and Mooney, 2002).  To provide the pore 
surfaces within the interstices of the scaffolds appropriate ion concentrations for film 
formation to occur, the delivery method of SBF can be enhanced.  Flow perfusion 
bioreactors have already shown that increased mass transfer in 3D is responsible for 
increases in cell numbers, resulting in uniform tissue growth (Bancroft et al., 2003).  
Additionally, the flow conditions and resulting shear stresses that occur within these 
bioreactors have been modeled (Porter et al., 2005).  By facilitating flow of the SBF 
through the scaffold pores, an appropriate ion concentration was expected to occur within 
the interstices of the scaffolds allowing mineral to form throughout the thickness.   
To further accelerate mineral nucleation on all pore surfaces, the PLGA polymer 
surface was treated with NaOH, facilitating alkaline hydrolysis that increases the number 
of free carboxylic acid groups on the surface.  This treatment accelerates heterogeneous 
precipitation of a bone-like mineral by creating an environment where free carboxylic 
acid groups that can interact with ions in solution are formed at a greater rate than just by 
hydrolysis in SBF (Murphy and Mooney, 2002).  The presence of negatively charged 
surface groups provides a substrate more capable of apatite nucleation compared to 
positively charged surfaces (Tanahashi and Matsuda, 1997).  
The enhancements to the SBF delivery and more rapid functionalization of the 
polymer surface together indicate that an appropriate ion concentration was established 
within the filtration scaffolds.  While both control scaffold groups were treated with 
NaOH, neither group showed continuous mineralization through the scaffold thickness, 
showing that the improvement to SBF delivery via flow is responsible for the continuous 
mineralization seen within the filtration scaffolds.  Maintaining this appropriate ionic 
environment depends on temperature, pH, and the concentration of the solutes.  Efforts to 
control the temperature and pH were enforced by the use of a temperature controller held 
at 37°C ± 1°C and frequent replacement of the SBF solution.  The pH values of both the 
new and used SBF were monitored every time the SBF was changed (every 6 hours for 
4x SBF and every 12 hours for 2x SBF), and the filtration group had an average increase 
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in pH of 0.47 ± 0.09, whereas the submerged group had an average increase of 0.37 ± 
0.07.  The pH changes reported are the maximum values that the pH had increased over a 
12 hour period and are likely to occur for a small percentage of each incubation period, 
because the SBF is replenished in a timely fashion.  These pH changes keep the pH value 
of the solution between 6.4 and 6.8 when the scaffolds are submerged in 4x SBF and 
between 6.8 and 7.2 when the scaffolds are submerged in 2x SBF. The pH changes that 
occurred are thought to be greater than pH changes resulting solely from ion depletion, 
because the SBF in all groups is not completely sealed from the atmosphere nor titrated 
to maintain a constant pH.      
Despite fluctuations in pH, the mineral precipitated in the filtration, submerged 
control, and floating control groups all show characteristic XRD peaks of carbonated 
apatite.  The mineral formed at 1, 3, and 5 days using the filtration system is similar 
(Figure 4.6).  The 1 day filtration spectrum had the lowest intensity above the 
background, suggesting that the mineral could be less crystalline than the mineral formed 
at later times.  This indicates that a more amorphous apatite phase or a nano-crystalline 
phase could be forming during the first day of precipitation.  This XRD spectrum after 1 
day of mineralization is consistent with spectra of apatite precipitated on PLLA and PGA 
films after 24 hours in a 5x SBF solution (Chen et al., 2005).  Spatially, the mineral 
precipitated on the outer scaffold surface (filtration 5 days) showed similar peaks as the 
mineral precipitated within the center of the scaffold (filtration center 5 days), supporting 
the deposition of uniform mineral throughout the filtration scaffolds.  Because most 
forms of calcium phosphate that differ by a few percent in carbonate substitution have 
overlapping peaks, it is difficult to discern the specific type of apatite or calcium 
phosphate being formed in these experiments from the XRD spectra.  However, 
carbonated apatite characteristic peaks were detected for the filtration and floating control 
groups in FTIR analysis, providing evidence that a carbonated apatite is being 
precipitated onto the scaffolds.  The decreased resolution of the precipitated bone-like 
apatite compared to the hydroxyapatite and carbonated apatite standards could result 
from either the precipitated mineral being crystalline but having nanometer-range crystal 
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size or the precipitated mineral containing a large fraction of an amorphous phase (Posner 
et al., 1984).   A slight peak shift to higher 2θ values was seen for the submerged control 
and filtration (3 days) samples compared to the rest of the samples, which could be 
indicative of chloride substitutions within the apatite being formed (Koutsopoulos, 2002).   
A model protein, BSA, was successfully incorporated into the mineral layer 
within 3 days.  A ten-fold increase of protein incorporation was found in the 
coprecipitated scaffolds via filtration compared to the submerged control scaffolds 
(Figure 4.7).  More protein incorporation in the filtration coprecipitation group is 
attributed to increased mineral formation on these scaffolds (Figure 4.8).  The amount of 
protein coprecipitated within the filtration and submerged control groups (1308 ± 464 µg 
and 139 ± 45 µg, respectively) are comparable to previous coprecipitation reports that 
incorporated biomolecules within mineral or polymeric materials (Kim et al., 2003; 
Luong et al., 2006; Shea et al., 1999).  Additionally, the scaffolds coprecipitated via 
filtration displayed uniform protein incorporation throughout the scaffold thickness, 
whereas the scaffolds coprecipitated via submersion showed protein incorporation only 
on the outer surfaces (Figure 4.9).  This uniform incorporation would allow uniform 
biomolecular release throughout the scaffold in an in vitro or in vivo setting.  
The protein densities for the filtration and submerged control groups were 345 ± 
164  µg/mm3 and 1260 ± 410 µg/mm3, respectively.  The increased density within the 
submerged control is likely attributed to a static mineralization that allowed the BSA to 
adsorb to the surface of the scaffold prior to mineralization, whereas in the filtration 
group fluid movement limited BSA adsorption.  However, cells transplanted onto 
coprecipitated scaffolds could favor a lower protein loading density.   Coprecipitated 
inorganic coatings have shown to be effective on a dense 3D materials (Liu et al., 2004; 
Liu et al., 2005; Stigter et al., 2002), and spatial control of the organic constituents within 
the coating of a film has been achieved (Luong et al., 2006); however, to our knowledge, 
this is the first investigation of coprecipitation of mineral with protein on a 3D porous 
template.  The aim of using the filtration method is to spatially localize biomolecules that 
promote bone formation into a more effective bone engineered template.  
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When coating implant materials, such as titanium hip replacements, the 2D 
surface is coated with a thick mineral layer to ensure the coating is present on the implant 
after the surgery. However, the design strategy of coating the pores of a 3D scaffold for 
tissue engineering differs from coating a 2D surface, because a main objective of coating 
a 3D scaffold is to retain porosity.  Therefore, current coating techniques would not be 
effective in uniformly coating all pore surfaces within a 3D scaffold with a thin mineral 
layer, demonstrating the need for a method to uniformly coat pore surfaces of 3D 
scaffolds without compromising porosity.  
Techniques to precipitate a uniform, continuous calcium phosphate layer on 
porous polymer scaffolds via pre-mineralization aminolysis or hydrolysis have not been 
able to establish a continuous mineral layer in a time effective manner.  Even with longer 
precipitation times, the mineral layer is not continuous throughout the thickness.  The 
result is a thicker layer of mineral around the periphery of the scaffold, which can lead to 
pore occlusion and compromise cell function.  An increase in the volume fraction of 
regenerated bone occurs on statically mineralized PLGA scaffolds having a 250-425µm 
pore size range, compared to PLGA controls (Kohn et al., 2005).  In the presented work, 
the scaffold pore size ranged from 425-600 µm, so, as an example, a 20 µm thick layer of 
mineral would decrease the pore size range to 405-580 µm, which is larger than the pore 
size reported by Kohn et al. but within an identified range for bone ingrowth (Hollister et 
al., 2005).  Ultimately, the presence of continuous bone-like mineral throughout the 
polymer scaffolds is expected to lead to more continuous in vivo osteogenesis.   
Although the initial design of the system enables a batch of sixteen 10 mm 
diameter scaffolds, mineralization of twenty-five 5 mm diameter scaffolds has also 
proved feasible (data not shown).  Moreover, this system is not limited to PLGA 
scaffolds.  Any material capable of being constrained in the Delrin® mold can be utilized 
with scaffold diameter and thickness as variable parameters.   
  In summary, incorporating a bone-like apatite mineral layer on polymer scaffolds 
in an environment conducive to biomolecular incorporation has the potential to increase 
the ability of cell recognition, attachment, and regeneration in vivo.  A filtration device 
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designed to force SBF through the pores of scaffolds enabled a uniform, continuous 
bone-like mineral layer to form throughout, and uniform mineral coverage could be 
attained in only 4-5 days.  Additionally, a model protein, BSA, was coprecipitated 
uniformly in the bone-like mineral layer throughout the thickness of the scaffolds. 
Scaffolds mineralized within the filtration device displayed an increase in mineral 
volume % and in the amount of incorporated BSA via coprecipitation compared to static 
mineralization. This filtration system can potentially be used to incorporate cell-signaling 
biomolecules, such as growth factors or DNA, to promote in vivo osteogenesis, in 
addition to just serving as a technology to develop conductive materials.    
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Figure 4.1: Schematic showing the filtration device.  The device consists of a Delrin® 
mold (A), aluminum base (B), thermocouple (C), temperature controller (D), and heating 
element (E). The Delrin® mold is connected to the actuator of an Instron 8521 servo-
hydraulic system (F) and cyclically loaded via an aluminum rod (G). The SBF level and 
maximum and minimum positions that the Delrin® mold is displaced to are labeled on 
the figure.  Holes in the Delrin® mold that did not have a PLGA scaffold were plugged 
with rubber stoppers.  1 L of SBF solution is housed in the aluminum base during 
mineralization. The Delrin® mold can simultaneously cast sixteen 10 mm diameter 





Figure 4.2: Representative MicroCT images of the filtration group (a-c) and the 
submerged control group (d-f). These images represent top (a,d), side (b,e), and center 
cross-sections (c,f).  A greater amount of mineral formed on the filtration scaffolds in 
comparison to the submerged control group.  Renderings of the floating control group are 
not shown because mineral present in the images was minimal (<0.2 MV%). All images 
were created in MicroView® using the Isosurface tool (voxel size = 16 µm, threshold = 




Figure 4.3: Mineral Volume % (MV%) for the filtration, floating control, and submerged 
control groups demonstrated the filtration group mineralized the greatest amount.  (* - p 
= 0.029 vs. both controls).  MV% was calculated from MicroCT data using MicroView® 





Figure 4.4: Volumetric mineral analysis of the MicroCT images (threshold = 1000) 
showing the filtration scaffolds have a uniform mineral profile throughout all 6 regions of 
the scaffolds analyzed.  The % of total mineral volume for 6 concentric shell volumes 
show the control mineralized scaffolds have at minimum 60% of the mineral present in 
the 2 outer shells (shells 1 and 2). The floating control group shell volumes were 
statistically different from one another (n=4, p=0.002), whereas the submerged control 
and filtration groups did not show significance (n=3, p=0.051 and n=4, p=0.104, 





Figure 4.5: FTIR spectra for filtration, floating control, and submerged control groups 
showing the mineral deposited on the scaffolds was characteristic of hydroxyapatite with 
carbonate peaks (v3c P-O 1032 cm-1, v1 P-O 962 cm-1, v4a O-P-O 602 cm-1, and v4c O-P-O 
561 cm-1 [filtration group only]) and carbonated apatite (v1 CO32- 1465 cm-1 [filtration 
and floating control groups]).  Stronger peaks for the filtration group indicate the 




Figure 4.6: XRD spectra for all three groups (filtration, floating control, submerged 
control) show characteristic apatite peaks between 25.9°-26.8°, between 31.8°-32.7°, at 
40.1°, and between 45°-55° when compared to the hydroxyapatite standard.  A similar 
type of mineral was precipitated over the 5 days of filtration (1, 3, and 5 days).  To assess 
if the mineral formed within the center of the filtration scaffolds was similar to the 
mineral formed on the surface of the filtration scaffolds, 5 day scaffolds were sectioned 
transversely and analyzed (Filtration Center 5 Days).  The mineral formed on the interior 
surface of 5 day filtration scaffolds showed a similar spectrum to the mineral formed on 
the outer surface of the same scaffolds at 5 days, verifying that a similar mineral formed 





Figure 4.7: Quantitative coprecipitated BSA values (µg) showing greater protein 
incorporation in the filtered scaffolds.  The amount of BSA incorporated was quantified 
utilizing UV Spectrophotometry at 494nm wavelength to detect the FITC-BSA.  (* - 





Figure 4.8: Representative confocal microscopy images of transverse sections of filtration 
(a) and submerged control (b) groups coprecipitated with BSA for 3 days.  The mosaic 
images were compiled from multiple images of the center cross-section for each scaffold 
in each group (n=4 per group). The incorporation of BSA is shown by the fluorescence of 
FITC conjugated to the BSA.  The filtration scaffolds showed uniform BSA 
coprecipitation throughout.  A typical mineral shell, evidenced by more FITC seen on the 
left and right edges, is seen for the submerged control group. The presence of a mineral 
shell also supports less BSA incorporation. Autofluorescence of the mineral was not 
detected, shown by a representative image of a center cross-section of a scaffold 
mineralized via filtration for 5 days using the 4x SBF/2x SBF regimen precipitated 




Figure 4.9: Mineral Volume % (MV%) for the filtration and submerged control 
coprecipitation groups demonstrated the filtration group mineralized the greatest amount.  
(* - p < 0.001).  MV% was calculated from MicroCT data using MicroView® at a 






SUMMARY AND FUTURE WORK 
 
 
The work throughout this dissertation aims to improve the design rationale and 
methodologies used to engineer bone.  The goal that all bone engineers strive to 
accomplish is complete repair of large defects with new bone tissue having the quality of 
native bone tissue.  As conditions caused by diseases, accidents, and genetic defects still 
create bone defects too large for the body to heal by itself, we continue to search for 
better materials and a better understanding of how we can provide influential biological 
cues to guide bone growth.  Current repair techniques for large bone defects include 
permanent metal implants that provide mechanical integrity, but often lack complete 
integration at the bone-implant interface, which can cause loosening and require further 
repair.  An ideal implant would be comprised of temporary, biodegradable materials that 
direct the body to heal itself with or without spatiotemporal cues on or within the implant.  
Because bone is a complex organ, we look to multiple disciplines to learn how we can 
integrate biology, chemistry, and materials science not just at the whole bone level, but 
also at the nanoscopic level.  The work presented in this thesis has introduced a new 
rationale for designing biological molecules in the form of dual-functioning peptides, in 
addition to improving the apatite coating techniques used on porous implants.   
Using a commercially developed phage display combinatorial library on both 
inorganic apatite and a source of clonally derived human bone marrow stromal cells, 
short peptide sequences were separately identified as preferential binders towards the 
apatite and cells (Chapters Two and Three).  Combining the two short peptide sequences 
yielded a dual-functioning peptide that provides improved cell attachment to apatite-
based materials.  The design rationale for the inorganic-organic hybrid system studied in 
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this thesis for bone repair can now be explored in other hybrid systems throughout the 
body. Isolating preferential binding sequences in the form of peptides may prove 
invaluable when trying to integrate two dissimilar tissues (e.g. bone and cartilage).  
Furthermore, such peptides can be combined with established pattern processing 
techniques to direct tissue growth and integration. In general, any organic-inorganic 
hybrid system requiring the union of two constituents that do not inherently bond could 
benefit from the presented design strategy. 
The Identification of Peptide Sequences for Bone Tissue Engineering 
There has been limited use of phage display with the materials and cells used in 
bone regeneration.  Until this work, phage display had been used in vitro to identify 
potential osteoblast binding sites during bone remodeling (Sheu et al., 2002) and there 
was a brief mention in a review that it was used to identify peptides with affinity towards 
hydroxyapatite (Sarikaya et al., 2003; Tamerler et al., 2003).  Therefore, using this 
microbiological technique to discover peptides unique to apatite-based materials and 
hBMSCs sources was an ambitious, unexplored goal.  A tri-fold analysis involving phage 
display, computational modeling, and ELISA techniques proved successful in identifying 
peptide sequences with preferential apatite-binding capabilities (Figure 2.4) after multiple 
rounds of phage panning on two apatite-based materials, bone-like mineral and sintered 
hydroxyapatite.  The unexpected result that peptides identified from the phage 
experiments did not contain long strings of acidic amino acid sequences may have 
transpired because such peptides were not present in the parent library.  This would be a 
limitation of the 12-mer phage display library used.   It should also be noted that one 
consensus peptide sequence did not surface in these experiments, suggesting that other 
peptides identified could be as good at binding to apatite as the peptides STLPIPHEFSRE 
and VTKHLNQISQSY.  However, the rigorous validation techniques combined (shown 
in Figure 2.1) to isolate these two peptides would support that they have the best ability 
to preferentially adsorb on apatite-based materials for the experimental conditions tested.  
Combinatorial libraries also had not been applied to bone regeneration research 
on cells, except for one in vitro study on osteoblasts.  Phage display is capable of 
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identifying informative peptide sequences on various tissues (e.g. muscle (Samoylova 
and Smith, 1999), breast vasculature (Essler and Ruoslahti, 2002), bone marrow 
(Nowakowski et al., 2004)).  The same 12-mer combinatorial library used on the apatite 
materials was introduced to a population of clonally derived human bone marrow stromal 
cells.  This population of cells has the capability of differentiating down an osteoblast 
lineage resulting in the ability to form bone tissue.  Bioinformatic and 
immunohistochemistry analyses (Figures 3.2 and 3.3) identified two sequences as having 
the highest potential to bind to the clonally derived human bone marrow stromal cells 
(LLADTTHHRPWT and DPIYALSWSGMA).   
Dual-Functioning Peptide Performance 
The peptide sequences that preferentially bound to the apatite-based materials and 
the human bone marrow stromal cell population were combined to build dual-functioning 
peptides.  Adsorption of the VTKHLNQISQSY peptide (Figure 2.4) on multiple apatite-
based materials was superior to STLPIPHEFSRE, so the VTKHLNQISQSY was used in 
the final dual-functioning peptide design.  The VTKHLNQISQSY sequence was kept at 
the carboxy-terminus of the peptide design, as this is the configuration that the peptide 
would see when expressed on the protein coat of the bacteriophage.  This meant the 
identified cell binding sequences LLADTTHHRPWT and DPIYALSWSGMA were 
present towards the amino-terminus of the dual-functioning peptide.  Glycine (G) spacers 
were used at the amino-terminus end and also between the cell and apatite recognition 
sequences to preserve any peptide conformation and decrease any steric effects from 
neighboring charges.  The adhesion and cell attachment influence of the final dual-
functioning peptides were compared with the E7PRGDT positive control peptide derived 
from bone-sialoprotein (Chapter Three) that has a positive influence on cell adhesion to 
hydroxyapatite sintered disks (Itoh et al., 2002; Sawyer et al., 2005b).   
The dual-functioning peptide D-VTK had superior binding to bone-like mineral 
compared to all other peptides tested except E7PRGDT (Figure 3.5), indicating that the 
cell sequence DPIYALSWSGMA was contributing to the adsorption of the peptide to the 
apatite-based materials.  However, while this peptide exhibited greater adsorption to 
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bone-like mineral than other peptides, when hBMSC attachment was normalized to the 
amount of peptide present on the BLM, this peptide proved to be not as effective as L-
VTK (Figure 3.7).  The positive control peptide E7PRGDT had a higher mean adsorption 
to BLM compared with L-VTK; however, E7PRGDT was not capable of increasing cell 
attachment to BLM.  Previous designs of cell influencing peptides have included 
polyacidic tails on cell adhesive sequences (e.g. RGD) to increase peptide binding to 
apatite-based materials (Itoh et al., 2002; Sawyer et al., 2005b).  The inability for E7-
PRGDT to increase cell attachment is inconsistent with previously published results (Itoh 
et al., 2002; Sawyer et al., 2005b).  Neither study quantified the amount of peptide on the 
surface of their HA samples, and both studies used serial washing as a method of cell 
detachment, making it difficult to compare the results to those reported in this study.  
Developed cell adhesion methods using centrifugation reduce any questions of 
reproducibility and sensitivity than previously developed washing methods that are 
dependent on the person pipeting (Garcia and Gallant, 2003; Reyes and Garcia, 2003a). 
Also, slight changes in substrate morphology can influence peptide adhesion at similar 
initial adsorption concentrations (Chapter Two).  While adhesive proteins may contain 
acidic and RGD amino acid sequences, isolating these portions of proteins as peptides 
may not be beneficial on all apatite-based substrates and/or cell sources.   
The Effect of Surface Composition and Morphology on Peptide Adsorption 
 The adsorption of the short peptides identified as preferential binders to apatite-
based materials was tested on four apatite substrates.  Investigation into whether 
compositional or morphological changes affect peptide adsorption has merit as changes 
in percent carbonate of bone with age may effect adsorption of specific proteins/peptides 
because of this compositional change (Boskey, 1999).  Understanding the changing bone 
composition with age and its effect on the extracellular matrix could help in identifying 
the mechanisms involved in osteoporosis. 
 Normalization of peptide adsorbed to MicroSA, quantified via BET, was 
performed to investigate the effects carbonate incorporation and morphology have on the 
amount of peptide adsorbed.  Slight changes in carbonate percentage did not influence 
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peptide adsorption for the apatite-based materials studied in these experiments.  The 
range of carbonate present in the materials did vary; however, at the same morphological 
scale, the carbonate differences were minimal (~2wt%).  A trend of decreased adsorption 
to CA10 in comparison to CA5 and HA was shown across all peptides. These results do 
not rule out that a larger change in carbonate incorporation could produce an effect on 
peptide adsorption.  CA5 adsorbed significantly higher amounts of peptide S compared 
with CA10, indicating that a morphological difference, not a compositional difference, 
was evident for this case only.  The morphology difference between CA5 and CA10 
could affect peptide adsorption resulting from a change in charge distribution on the 
apatite surface that promotes peptide adsorption. Better control of the surface 
morphology accompanied by larger differences in carbonate content would better 
investigate if higher amounts of carbonate incorporation have an effect on peptide 
adsorption.  
 The large surface area for BLM suggests that all of the available sites on the BLM 
are not saturated with peptide.  However, the feature size on the BLM is very small with 
plates growing to dimensions of 500nm length x 50nm thickness.  The distinct 
morphology of BLM could be inhibiting peptide access to all of the measured surface 
area, which implies that the BET method could be overestimating the available surface 
area to which peptides may have access.  Or, the BLM morphology could be presenting 
unfavorable surface charge arrangements, meaning the peptides are able to access all of 
the measured surface area, but do not because of unfavorable presentation of charge. 
Phosphorylation as a Method to Tailor Peptide Adhesion 
 Since one approach in identifying apatite-binding peptide sequences is to perform 
post-translational modifications (e.g. phosphorylation) (Goldberg et al., 2001; Pampena 
et al., 2004; Shaw et al., 2000a) on peptide sequences derived from proteins, it was of 
interest to see if phosphorylating the VTK peptide identified in the presented work would 
improve peptide adsorption to apatite-based materials.  Phosphorylation introduces a 
phosphate group onto a serine, threonine, or tyrosine amino acid and serves as a 
regulatory mechanism on proteins in the body.  The addition of a phosphate group on a 
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peptide can influence its charge and ability to interact with charged surfaces.  The 
VTKHLNQIS(p)QS(p)Y (VTK-phos) peptide was fabricated on a Rainin Symphony 
synthesizer and determined as >86% pure via HPLC (UM Protein Core).  Amino acid 
analysis was performed to verify VTK-phos peptide concentration for standard curves 
created with UV absorbance at 205nm, 220nm, and 274nm wavelengths (BioRad 
Smartspec 3000).    
The VTK-phos peptide was reconstituted in ddH2O and diluted to ~500µg/mL in 
50mM Trizma buffer (Sigma, pH=7.5).  In 24-well tissue culture dishes, BLM films, HA 
disks, CA5 disks, CA10 disks, and blank TCPS wells were soaked in ddH2O overnight at 
4°C (n=5).  Prior to introducing 1mL of the peptide or buffer solutions for negative 
controls, plates were allowed to warm to room temperature and then the overnight 
solution was removed.  The plates were agitated on a Titer Plate Shaker at ~80rpm for 3 
hours at room temperature.  The films and disks were rinsed with ddH2O and then soaked 
in a 10mM HCl solution for 18 hours at room temperature on the same shaker.  Aliquots 
of the HCl solution were read on a UV spectrophotometer.  The entire experiment was 
performed in duplicate. 
Phosphorylating the two end serines on the VTK peptide led to a 10-fold increase 
in peptide adsorption on BLM, p=0.028 (Figure 5.1).  Significant increases in VTK-phos 
adsorption compared to VTK were also seen for the carbonated disks, CA5 and CA10 
(CA5 p=0.009, CA10 p=0.009).  The non-carbonated HA disks did not experience a 
significant change in peptide adsorption between the phosphorylated and non-
phosphorylated VTK peptides.  These results have interesting implications on the ability 
to control adsorption on carbonated apatite, in particular, BLM.  The data suggest that 
phosphorylating available amino acids on peptide sequences can provide a means of 
increasing peptide concentration to a carbonated apatite surface.   Subjecting the VTK-
phos to the same cell attachment assay reported in Chapter Three, the VTK-phos peptide 
alone was not able to increase cell attachment on BLM (Figure 5.2).  The opportunity for 
future research on VTK-phos is discussed further in Future Studies section.   
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Inducing Fluid Flow Improves Mineralization in Three-Dimensional Scaffolds 
The bioreactor, designed in Chapter Four, forced SBF through the pores of highly 
porous PLGA scaffolds and was able to induce continuous, uniform mineral formation. 
While the BLM can increase osteogenesis in vivo, the additional bone growth is not 
uniform or spatially controlled, suggesting the need for uniform apatite coverage to direct 
tissue growth through the thickness of the scaffold.  The protocol presented completely 
mineralized a 2mm thick porous polymer scaffold in 5 days, displaying potential the 
bioreactor could present in coating biomaterial surfaces.  Furthermore, it was 
demonstrated that a model protein could be incorporated into the BLM coating, allowing 
more utility in spatiotemporal bone scaffold design.  The ability to uniformly and 
continuously coat porous scaffolds with BLM will advance BLM coatings in three-
dimensions.  The data presented will hopefully convince those using techniques of 
biomimetic film deposition on bone engineered constructs to seek a method of providing 
uniform, continuous film coverage by inducing fluid flow in the interstices of the 
construct rather than passive static soaking methods that are typically employed.  
Ultimately, porous scaffolds that enable spatiotemporal release of growth factors and/or 
DNA can be coated with dual-functioning peptides to increase initial cell attachment in 
vitro.  This strategy may provide better-directed bone growth in large defects.   
Future Studies 
 The work presented in this thesis provides a new perspective on how peptides can 
be designed for bone tissue engineered constructs.  By capitalizing on the apatite-based 
adhesive properties of synthetic peptides identified via phage display, cell adhesive 
sequences can be joined to improve initial cell attachment to a material.  This initial cell 
attachment is the imperative first step in cell survival, proliferation, and differentiation.  
The introduction of using phage display on apatite-based materials elucidated sequences 
that may not have been found using the current approach in the field of deciphering 
protein sequences.  Furthermore, using the combinatorial library approach on a source of 
human bone marrow stromal cells is the first attempt to isolate sequences that may 
preferentially bind to the clonally derived hBMSCs tested.  The approach of using phage 
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display to isolate subsets of cells could be used to fabricate the next level of peptide-
laden substrates for bone repair.  Never in bone material development has phage display 
been implemented on both the substrate material and the cell source to identify peptide 
sequences that can influence and improve cell behavior and function.  Thus, this work is 
first to introduce the idea of using phage display to create dual-functioning peptides. 
 While apatite-binding and preferential hBMSC-binding sequences were identified 
in this work, many new questions can be studied to understand how the identified 
sequences can be used to their full potential.  It is evident from the work in Chapter Two, 
that small differences in carbonate percentage between apatite-based materials do not 
influence peptide adsorption behavior.  However, if larger ranges of carbonate 
differences were established up to 15% carbonate (e.g. 5%, 10%, 15%), peptide 
adsorption could potentially change.  A change in peptide adsorption over larger 
carbonate percentage differences could indicate protein/peptide adsorption is altered with 
compositional changes in bone that occur with disease and age.  The effect of carbonate 
incorporation into apatite on protein adsorption is not clearly shown anywhere in the 
literature.   If it is found that large changes in carbonate percentage do not affect peptide 
adsorption, this could lead researchers to investigate other mechanisms with disease and 
age that could alter bone remodeling, such as post-translational modifications or changes 
in the micro-environments near the bone surface.  The methodologies for performing 
peptide adsorption experiments are well outlined throughout this thesis and could be used 
as a starting point for such experiments.  
 Furthermore, it was shown that phosphorylating the serine residues present on the 
VTK peptide dramatically increase its adsorption to BLM.  As phosphorylation is 
important in protein function, the influence of phosphorylation on mineralization and 
peptide adhesion to apatite-based materials are both exciting areas of research.  The 
location of the phosphorylated serine residues within the VTK peptide, the number of 
phosphorylated serine residues, and the ability for phosphorylated VTK peptides to 
increase cell attachment has yet to be determined.  Scrambling the VTK sequence with 
and without phosphorylated residues would identify any specific portions of VTK are 
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responsible for its adsorption behavior.  When the VTK peptide was run in the MATCH 
program of RELIC against bone protein sequences, it did contain the motif NQIS (Asn-
Gln-Ile-Ser), a sequence conserved in small leucine-rich proteins (SLRP) such as 
fibromodulin, lumican, and decorin.  Another motif of the VTK peptide, VTXXL was 
found in a collagen I protein sequence.  Since the VTK peptide was identified as a 
preferential binder to apatite-based materials, and the SLRPs family of proteins are 
thought to regulate collagen fibril assembly, which would occur prior to apatite 
formation, the VTK peptide could be a link between collagen and extracellular bone 
proteins that allows aggregation of correct ion concentrations for apatite nucleation.  
Research on the protein decorin has also suggested decorin contains N-linked 
oligosaccharide attachment sites near the asparagine residue of the NQIS motif (Weber et 
al., 1996).   
 While it was not in the scope of this thesis, further work on how the apatite-
binding portion of the dual-functioning peptides influences the conformation of the cell-
binding portion would provide further support for the increased attachment results for L-
VTK.  Performing cell attachment experiments on the apatite-binding and cell-binding 
portions alone would provide more information as to how each sequence influences the 
other in cell attachment.  The increased attachment values for RGDV and RGEV in 
comparison to D-VTK could result because VTK has an inherent ability to increase cell 
attachment (Figure 3.7).  VTK-phos does not enhance cell attachment (Figure 5.2); 
however, the non-phosphorylated version could behave differently.  To increase our 
understanding of conformational changes of the dual-functioning peptides, they could 
also be computationally modeled on larger hydroxyapatite surfaces, in addition to 
multiple face planes (e.g. (001), (010), and (100)).  Incorporating hydration into the 
model would also prove beneficial, as it would better simulate the experimental scenario.   
 Further studies investigating the cellular influence that the phage identified cell-
binding sequences have on hBMSCs or other cell populations could also be done on 
TCPS.  Because TCPS can be modified to covalently attach peptides in known 
concentrations, TCPS could be used as a control material to establish consistent peptide 
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concentrations for different peptide sequences.  The cell-identified sequences could be 
covalently linked at both termini to provide insight as to which end, if only one, is 
responsible for increased cell attachment.  Likewise, the efficacy of increasing initial cell 
attachment using the peptide L-VTK can also be studied in an in vivo subcutaneous bone 
model in mice or an in vivo craniofacial rodent defect model.  
 Cell work related to advanced stages of cell adhesion, and not just attachment, 
would also provide insight to the efficacy of the identified peptides.  In the presented 
work, attachment was only allowed during a 1 hour incubation; however, if the 
incubation time was increased upwards of 3 hours, hBMSC cell adhesion would be able 
to be quantified.  The centrifugation assay utilized in Chapter Three is a harsh assay on 
the cells, although more consistent than serial washing.  Thus, even if focal adhesion 
assays are performed after 1 hour of attachment, the influence on cell adhesion by the 
peptides may be masked, as the cells may not behave normally after being subjected to 
high gravity forces.  Perhaps a more appropriate experiment would combine the 
suggested TCPS work above and incorporate longer cell attachment incubation times to 
tease out peptide effect on focal adhesion formation.  
 As the ultimate goal is to develop better bone-guided repair scaffolds, combining 
the findings of all of the research aims in this thesis would be a step in the right direction.  
The scaffolds fabricated using the bioreactor designed in Chapter Four, can now be 
loaded with the dual-functioning peptide L-VTK to influence in vitro hBMSC cell 
attachment during incubation prior to implantation in an in vivo model that can determine 
its potential to increase osteogenesis.   
Broader Applications of Dual-Functioning Peptides 
 As the main goal in this work was to improve materials used in bone repair, the 
substrate and cell source were appropriately chosen for this application.  However, the 
idea of a dual-functioning peptide can be expanded to other areas of research trying to 
join two dissimilar materials.  For example, the methods used in this thesis can be 
tailored to bone-tendon or bone-ligament junctions.  Other applications where apatite-
based peptides can be utilized in the dual-functioning peptide design would be bone-
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cartilage and enamel-soft tissue systems.  The dual-functioning idea can also be 
implemented across other bodily system research that aims to join two dissimilar tissues.  
The cells of each tissue can be panned using the phage display, which could isolate 
sequences unique to each population of cells, and the two peptide sequences could be 
joined together to help facilitate a tissue junction.   
 Outside the realm of biomaterials and tissue engineering, the idea of dual-
functioning peptides can be utilized in any discipline trying to join an organic matrix with 
an inorganic substrate.  Examples include bacteria inhibiting sequences being attached to 
metals and organic films being joined with ceramics or semi-conductors in the aerospace 
and electronic fields.  Surely, the dual-functioning peptide can be tailored for specific 




Figure 5.1: Adsorption of VTK vs. VTK-phos on apatite-based substrates.  
Phosphorylating the end serines on the BLM increased the peptide adsorption to 10-fold 
greater than non-phosphorylated peptide VTK, p=0.028. A similar trend was found on 
CA5 and CA10 substrates (CA5 p=0.009, CA10 p=0.009).  All data are presented as 
mean values ± one standard deviation.   Statistics in SigmaStat ran an Independent 
Samples T-Test to determine differences between VTK and VTK-phos on each material.  
(*) Indicate statistical significance was found between VTK and VTK-phos. 
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Figure 5.2:  Cell attachment data reported in Figure 3.7 with the addition of VTK-phos.  
VTK-phos alone was not able to increase cell attachment when present on BLM.  
Attaching a cell adhesive sequence to the VTK-phos would test whether the better 





Computational Modeling of Peptides on Apatite 
 Modeling organic molecules has proven useful in a variety of organic-inorganic 
systems including the investigation of protein-substrate and peptide-substrate interactions 
in calcite and calcium oxalate (Qiu et al., 2004).  Despite a basis of modeling work on the 
apatite lattice alone (Astala and Stott, 2005; Hauptmann et al., 2003; Mkhonto and de 
Leeuw, 2002), limited studies have modeled organic molecules on an apatite lattice 
(Fujisawa and Kuboki, 1998). Using Newtonian physics in a time dependent manner to 
calculate forces on a system, molecular mechanics simulations allow the calculation of 
peptide adsorption energies.  A greater negative peptide adsorption energy translates into 
a peptide possessing more potential to favorably adsorb to the lattice.  When a step is 
introduced to the hydroxyapatite lattice, adsorption energies increase, likely because of 
the altered charge and higher degree of under-coordination of atoms and molecules on the 
surface of the step.  The effect of negatively charged amino acid sequences on adsorption 
has been suggested as one mechanism of protein/peptide adsorption to hydroxyapatite 
(Fujisawa et al., 1997).   These data provide molecular modeling evidence that given 
appropriate charge for a neutral pH environment, acidic peptides exhibit favorable 
binding over basic peptides.  Furthermore, the model system used in these experiments 
provides a high-throughput validation technique where multiple interactions can be 
investigated prior to further in vitro or in vivo testing.  
Using a HYDROXYAPATITE force field (Biswas, 2007) (HAF) developed from 
the UNIVERSAL 1.02 force-field (UFF) (Rappe et al., 1992), peptide adsorption 
energies were calculated from simulations using molecular modeling techniques between 
HA and 19 peptides that emerged from multiple phage display experiments.  The 
potential parameters used in the HYDROXYAPATITE force field are listed in Table A1, 
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and non-bonded van der Waals terms generated by fitting the potentials listed in Table 
A1 to the experimental structure are listed in Table A2.  The HYDROXYAPATITE force 
field is a hybrid force field that has basic properties of the UNIVERSAL1.02 force field 
with additional terms like off-diagonal van der Waals, bond-stretch, and angle-bend that 
are added for interaction within the apatite.  The experimental terms (Table A2) are in 
agreement with similar systems studied before (Wierzbicki and Cheung, 2000; de Leeuw, 
2004), and provide the basis that this HYDROXYAPATITE force field is appropriate for 
this study.  Cluster calculations are more appropriate for this study than periodic slabs 
due to the use of charged adsorbates. Coulomb and van der Waals cutoff values were 
greater than the cluster dimensions, which was large enough (e.g., 200 Å) to include all 
atom-atom interactions within the cluster.   
Hydroxyapatite (001) surfaces and a surface step parallel to [001] were created in 
Cerius2 modeling software. A small dipole moment perpendicular to the [001] step was 
unavoidable.  Charge distribution within each peptide, calculated using a QEq charge 
equilibration (Rappe and Goddard, 1991), was performed by distributing the appropriate 
charge of the peptide in a neutral environment, pH 7.2, across the molecule.  After 
assigning charge, the individual atomic charges were kept constant in subsequent 
calculations to avoid energy fluctuation introduced during energy optimization of the 
structure of the isolated molecule and of its adsorbate.  The charges of atoms in the 
hydroxyapatite are those listed in Table A1.  To find the absolute energy minimum 
through optimization, molecular dynamics (MD) simulations under constant NVE 
(constant number of atoms, volume, and energy) at 300K were performed after every 
energy minimization. Every 100 simulation steps, velocities are rescaled if the averaged 
temperature goes outside a predefined window around the target temperature.  The 
predefined window of target temperature was between 295 K and 310 K.  In each MD 
simulation, the dynamic step was 0.001ps and total simulation time 700 steps (0.7ps).  
Energy minimization and the subsequent MD were run 7X for each peptide under each 
initial start orientation.  Each peptide was run as a neutral or appropriately charged 
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molecule on both a flat (001) apatite plane and a [010] step introduced on the (001) plane 
(Figure A1).  Four initial start orientations were simulated for each peptide on both the 
flat and step apatite cluster.  This resulted in a total of 16 permutations run for each 
peptide investigated.  The atoms in the hydroxyapatite lattice were not allowed to move 
during any simulations run.  The adsorption energy of each peptide (Eads) was calculated 
using the following equation. 
Eads = E(peptide+HA) – [Epeptide in vacuum + EHA] 
The average of the two lowest adsorption energies out of the four initial start orientations 
run for each peptide, both neutral and charged, was calculated (Table A3).  The 
computationally derived peptide adsorption energies were then ranked for the four set-
ups:  neutral peptide – (001) HA plane, charged peptide – (001) HA plane, neutral 
peptide – [010] step on (001) HA plane, and charged peptide – [010] step on (001) HA 
plane. 
 It was expected that the peptides with negatively charged R groups for the 
charged peptides modeled would have higher adsorption trends than those with without 
basic amino acids in their compositions (Table A.3).  This trend has been identified both 
experimentally and computationally in the literature (Fujisawa et al., 1996; Fujisawa et 
al., 1997; Sawyer et al., 2005b). This was apparent for the [010] hexagonal step case, 
where the charged peptides aligned by isoelectric point.  This alignment indicated that 
peptides with low isoelectric points, which would be negative in a neutral pH solution, 
had higher adsorption energies than peptides with higher isoelectric points. The charged 
peptides run on the (001) HA plane also saw some alignment in peptide adsorption 
energy with isoelectric points. The isoelectric points for all peptides were estimated from 
contributions of C, D, E, H, K, R, Y, the amino- and carboxy- termini as 9.9, 5.3, and 9.7, 
respectively (Table A.4).  The neutral peptides did not indicate any preferential 
adsorption ranking by isoelectric point.  The top five ranking peptides for each of the four 
scenarios modeled were used, along with ELISA data and frequency results in Chapter 
 126 
Two, to determine the peptide sequences with the most potential to adsorb favorably on 
apatite-based materials.   
 Limitations to the model include the lack of incorporation of water molecules.  
Addition of hydration to the model would be computationally expensive and would prove 
inefficient.  Therefore, the modeling performed was done to compare relative adsorption 
energies for different peptides in the same computational set-up.  The ability to analyze 
19 different peptide sequences in a computational model for two HA crystal set-ups is 
valuable information that provides insight as to the organic-inorganic interactions that 
may be occurring at the atomic level.  Such interactions are not always detectable in 
bench-top experiments, and they are often at the limits of peptide analysis techniques.
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Figure A.1:  Hydroxyapatite lattice cluster set-ups.  A flat cluster on the (001) HA plane 
and a hexagonal step introduced on the [010] on the (001) HA plane were used to model 
the 19 peptide sequences derived from phage display experiments on apatite-based 
materials.  The adsorption energies of all 19 peptides were calculated in a vacuum for 
both neutral and charged peptide values.   
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Table A.1: HYDROXYAPATITE Force Field Potential Parameters Used in Molecular 
Modeling of the 19 Phage Derived Peptides on Hydroxyapatite Surface and Surface Step 
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Table A.2: Comparison of Experimentally Determined and Computational (Using Table 
A.1 Force Field Values) Cell Parameters and Fractional Units 
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Table A.3:  Peptide Charge Assignments Based on Peptide Composition 
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Table A.4: Molecular Modeling Results for 19 Phage Display Derived Apatite-Binding 






PHAGE DISPLAY AND PEPTIDE PROTOCOLS 
Phage Display Modified for Panning on hBMSCs 
Phage Display on hBMSCs Protocol 
Media and Solutions: 
LB Medium - Per liter: 10 g Bacto-Tryptone, 5g yeast extract, 5g NaCl.  Autoclave, store 
at room temperature. 
LB/IPTG/Xgal plates - 1 liter LB medium + 15 g/L agar.  Autoclave, cool to < 70C, add 
1 mL IPTG/Xgal and pour into sterile plates.  Store plates at 4C in the dark.  
Agarose top - Per liter: 10g Bacto-Tryptone, 5g yeast extract, 5g NaCl, 1 g MgCl26H2O, 
7 g agarose. Autoclave, dispense into 50mL aliquots.  Store solid at room temperature 
and microwave as needed. 
Tetracycline Stock - 20mg/mL tetracycline in Ethanol.  Store at -20C in the dark.  Vortex 
before using 
LB-Tet Plates - 1 liter LB medium + 15 g/L agar.  Autoclave, cool to <70C, add 1 mL 
tetracycline stock and pour into sterile plates.  Store plates at 4C in the dark.  Do not use 
if brown or black. 
Blocking buffer - 0.1M NaHCO3 (pH=8.6), 5mg/mL BSA, 0.02% NaN3.  Filter sterilize, 
store at 4C. 
TBS - 50mM Tris-HCl (pH=7.5), 150mM NaCl.  Autoclave, store at room temperature. 
TBST (Wash buffer) - First Round: TBS + 0.1% (v/v) Tween-20, Second Round: TBS _ 
0.5% (v/v) Tween-20 
TBS with NaN3 - TBS + 0.02% NaN3 
PEG/NaCl - 20% (w/v) polyethylene glycol-8000, 2.5M NaCl.  Autoclave, store at room 
temperature 
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Iodide Buffer - 10mM Tris-HCl (pH=8.0), 1mM EDTA, 4M NaI.  Store at room 
temperature in the dark 
Streptavidin Stock Solution - Dissolve 1.5mg Lyophilized streptavidin in 1mL 10mM 
sodium phosphate (pH=7.2), 100mM NaCl, 0.02% NaN3.  Store at 4C or -20C  
IPTG/Xgal - Mix 1.25 g IPTG (isopropyl b-D-thiogalactoside) and 1g Xgal (5-Bromo-4-
chloro-3-inodlyl-b-D-galactosie) in 25mL Dimethyl formamide.  Solution can be stored 
at -20C in the dark. 





250 Erlenmeyer flask 
Tissue Culture plates (75cm2) 
Paper towels 
Titer plate shaker, LabLine  
24 well plates (3 per run) 
6-well plates 
Aerosol-resistant, sterile pipet tips (1000uL, 200uL, 10uL)  
Sterile culture tubes (125 per run) 
Mineralize films 5 Days with 1xmod SBF   
 
Cell Materials: 
α-MEM (Minimum Essential Media) Gibco #12561 
P/S (0.25% Penicillin-Streptomycin) Gibco #15140  
FBS (Fetal Bovine Serum) Gibco # 
BSA (Bovine Serum Albumin) Sigma # 
PBS (Phosphate Buffer Solution, pH 7.4) Gibco #10010 
Alpha-MEM with 20% FBS + 1% P/S 
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Alpha-MEM with 20% FBS + 1% P/S + 10-8M Dexamethasone + 10-4M Ascorbic Acid 
Alpha-MEM with 0.1% BSA 
Sterile 6-well plates 
T-25 flasks 
Sterile Millipore containers w/vacuum filter 
 
Bringing up cells: 
1. Bring up frozen hBMSC in osteogenic media in 2 T-25 tissue culture flasks. 
2. After 1.5 days, switch media to normal alpha-MEM media 
3. Passage cells 1:3 (so 2 T-25 → 4 T-25 (in normal media) and 2 6-well dishes 
(10,000 cells seeded per well) 
a. For all T-25 continue to use normal alpha-MEM media 
b. For one 6-well dish use normal alpha-MEM media 
c. For one 6-well dish use osteogenic media 
4. Allow cells to grow and/or begin differentiation for at least 6 days. 
5. When cells in T-25 have reached confluence, freeze 3 T-25 flasks down in 
freezing media. 
6. After cells are ~80-90% confluent from step #4, prep for Day One. 
 
Groups:  
1) Prescreen against HA → Introduce supernate to undifferentiated cells 
2) Prescreen against HA → Prescreen #2 against differentiated cells → Introduce 
supernate to undifferentiated cells 
3) Streptavidin control incubated at 37C during phage binding (but without any 
introduction of media) 
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Day One  
1. Incubate HA disks & control overnight at 4C in a humidified container (a sealable 
plastic box lined with damp paper towels).  Store plates until needed.  Incubated 
in 1.5mL ddH2O for films.  Use carbon tab to “glue” samples to bottom of well. 
a. Streptavidin control solution:  4.2mL 0.1M NaHCO3 + 300uL of 
streptavidin stock (1.5mg/mL). 
2. Streak out 2 plates ER2738 form the included glycerol culture onto an LB-Tet 
plate. Invert and incubate at 37C overnight and store wrapped with parafilm at 4C 
in the dark for a maximum of 1 month. 
 
Day Two 
1. Inoculate 10mL LB medium with ER2738.  This is the plating culture for 
tittering.  Incubate at 37C with vigorous shaking.  Takes ~3hrs in past to get to 
OD~0.5.   
a. If amplifying eluted phage on the same day, inoculate 20mL LB medium 
in a 250mL Erlenmeyer flask PER SAMPLE.  Do not use a 50mL tube.  
Can leave on bench until ready to use.  Can shake for ~15min prior to 
adding phage. 
2. Get ice. 
3. Blocking step HA & control 
a. For HA & control:  Pour off the coating solution from each plate and 
firmly slap it face down onto a clean paper towel to remove residual 
solution.  Fill each plate or well completely with Blocking buffer*.  
Incubate at least 1 hour at 4C. 
i. * - Control blocking solution has 0.1ug/mL streptavidin [8uL of 
100ug/mL from control initial solution + 8mL of blocking buffer] 
4. Discard the blocking solution for  HA & control.  Wash each plate rapidly 6X 
with TBST (0.1%).  Coat bottom and sides of plate or well by swirling, pour off 
Time  
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the solution, and slap the plate face down on a clean paper towel each time.  Work 
quickly to avoid drying out plates.   
5. Introduction of phage for Prescreen #1: 
a. Dilute 2x1011 phage (10uL of original library) with 1mL TBST.  Pipet 
onto HA & control and rock gently (speed 2) for 40 minutes at RT.  (30uL 
phage + 3mL of TBST in 15 mL tube) 
b. Recover supernate and label.  
6. Blocking step for cells (start after phage is introduced to HA & control) 
a. For cells: Wash differentiated cells grown in osteogenic media 2x with 
PBS.  Incubate these cells with 1mL of alpha-MEM containing 0.1% BSA 
for 30min at 37C. (2mL Blocking Buffer + 48mL alpha-MEM media = 
blocking buffer for cells) 
For sample that only gets Prescreen #1, continue to step # 8.  For Streptavidin control, 
continue to step #9. 
7. Introduction of phage for Prescreen #2: 
a. Add recovered supernate from HA in step #5 to media containing alpha-
MEM with 0.1% BSA on differentiated cells. 
b. Incubate with gentle agitation for 1 hour at 37C. 
c. Recover supernate, rinse differentiated cells 1x with 1mL PBS and add 
this to supernate 
d. Centrifuge supernate for 10min at 2000g. 
e. Transfer supernate to a new tube and label 
8. Prep Undifferentiated Cells for Phage (2 wells): 
a. Wash undifferentiated cells in 6-well plates 2x with PBS 
b. Incubate undifferentiated cells with 1mL of Alpha-MEM with 0.1% 
BSA[WITHOUT FBS!!] for 30min-1hour at 37C in 5%CO2. 
c. Add recovered supernate from HA or Prescreen #2.  
d. Incubate for 1 hour 
9. Discarding Phage: 
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For control:  
a. Discard nonbinding phage by pouring off and slapping plate face-down 
onto a clean paper towel.   
b. Wash plates 10X with TBST (0.1%) rapidly Coat bottom and sides of 
plate or well by swirling, pour off the solution, and slap the plate face 
down on a clean paper towel each time to prevent cross-contamination.  
Work quickly to avoid drying out plates.  
c. Elute control with 0.1mM biotin in TBS for 30min.  Do not have to 
neutralize the control sample. [Biotin solution to elute control:  30uL 
Biotin stock in 3mL of TBS] 
For cells: 
d. Discard supernatant on undifferentiated cells and wash 5x with cold PBS. 
e. Elute bound phage with 1mL of general buffer (Glycine/HCl pH=2.2, 
1mg/mL BSA).  Rock gently for no more than 10 minutes at RT,  Pipet 
eluate into a microcentrifuge tube.   
f. Neutralize with 150uL 1 M Tris-HCl (pH-9.1).  Keep on ice until tittered. 
g. (Optional) Wash cells 2 more x with PBS.  Lyse cells in 1mL of 30mM 
Tris, pH 8, 1mMEDTA for 1 hour on ice to recover cell-associated phage 
fraction.  Set aside phage fraction recovered from cells. 
10. Amplification of Phage: 
a. Titer a small amount of the eluate (~1uL) from Groups 1, 2 & 3.  [for 
groups 2 & 3 only amplify the cell surface phage].  Plaques from the first 
or second round eluate tittering can be sequenced if desired.  
b. Check the inoculated LB media to see if it is at mid-log phase (OD600~0.5) 
c. While cells are growing, melt Agarose Top in microwave and dispense 
3mL into sterile culture tubes, one per expected dilution.  Equilibrate tubes 
at 55C in water bath until ready for use.  Microwave on Power 2 for 2 min. 
Pre-warm 1 LB/IPTG/Xgal plate per expected dilution at 37C in incubator 
until ready to use. 
Time  
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d. Prepare 10-fold dilutions of phage in LB.  Use a fresh pipet tip for each 
dilution.  
i. Unamplified panning eluates:  101-104 for control, 102 – 105 for 
mineral film, HA disk, and TCPS. 
 
 LB Eluate  
1:101 18uL 2uL  
1:102 198uL 2uL A 
1:103 18uL 2uL A  
1:104 99uL 1uL A B 
1:105 18uL 2uL B  
1:106 99uL 1uL B  
 
e. Once culture has reached mid-log phase, dispense 200uL culture into 
microfuge tubes, 1 for each phage dilution. 
f. Add 10uL of each dilution to each tube, vortex quickly, and incubate at 
RT for 5min. Microwave agarose on Power 2 for 2 minutes during the 5 
min. incubation period. 
g. Lay out a couple of bench pads to keep the counter top warms.  Else, the 
agar will clump.  Work with no more than 4 plates at a time. 
h. One at a time, transfer the infected cells to a culture tube containing 45C 
Agarose Top, vortex quickly, and IMMEDIATELY pour onto a pre-
warmed LB/IPTG/Xgal plate.  Spread Agarose top by tilting plate.  If 
plates come out clumpy, the agarose was not heated thoroughly.   
i. Allow plates to cool 5 minutes, invert, and incubate overnight at 37C. 
j. Inspect plates and count plaques on plates having ~102 plaques.  Multiply 
each number by the dilution factor for that plate to get the phage titer in 
plaque forming units (pfu) per 10uL. 
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11. The rest of the eluate should be amplified:  Add the eluate to the 20mL ER2738 
culture (should be early log at this point) and incubate at 37C with vigorous 
shaking for 4.5 hours. 
12.  Turn on Ultra Centrifuge before leaving – after incubating eluate to be amplified 
so that the centrifuge is cold after 4.5 hours. 
13. Transfer the culture to a centrifuge tube and spin 10 minutes at 10000rpm (Sorvall 
SS-34, Beckman JA-17, or equivalent) at 4C.  Transfer the supernatant to a fresh 
tube and respin. 
14. Pipet the upper 80% of the supernatant (~16mL) to a fresh tube and add 1/6 
volume of PEG/NaCl.  Allow phage to precipitate at 4C for at least 60 minutes, 
preferably overnight.  Added 2.6mL of PEG/NaCl.  Make sure you mix the PEG 
solution before using it.   
 
Day Three 
1. Spin PEG precipitation 15 minutes at 10,000rpm at 4C.  Decant supernatant, re-
spin briefly, and remove residual supernatant with a pipette.  Will barely be able 
to see pellet. 
2. Suspend the pellet in 1mL TBS.  Transfer the suspension to a microcentrifuge 
tube and spin for 5 minutes at 10,000rpm to 4C to pellet residual cells. 
3. Transfer the supernatant to a fresh microcentrifuge tube and re-precipitate with 
1/6 volume of PEG/NaCl (~17uL).  Incubate on ice for 60 minutes.  
Microcentrifuge for 10 minutes at 4C.  Discard supernatant, re-spin briefly, and 
remove residual supernatant with a micropipet.   
4. Suspend the pellet in 200uL TBS, 0.02% NaN3.  Microcentrifuge for 1 minute to 
pellet any remaining insoluble matter.  Transfer the supernatant to a fresh tube.  
THIS IS THE AMPLIFIED ELUATE.   
5. Titer the amplified eluate on LB/IPTG/Xgal plates. Titer a small amount of the 
eluate (~1uL).  Inoculate 10mL LB w/ ER2738 
a. Check the inoculated LB media to see if it is at mid-log phase (OD600~0.5) 
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b. While cells are growing, melt Agarose Top in microwave and dispense 
3mL into sterile culture tubes, one per expected dilution.  Equilibrate tubes 
at 45C in water bath until ready for use.   
c. Pre-warm 1 LB/IPTG/Xgal plate per expected dilution at 37C in incubator 
until ready to use. 
d. Prepare 10-fold dilutions of phage in LB.  Use a fresh pipet tip for each 
dilution.  
i. Amplified phage culture supernatant:  108-1011 (Mineral – 109-
1012, Control 109 – 1011).  Be sure to vortex well. 
 LB Eluate  
1:102 99uL 1uL A 
1:104 99uL 1uL A B 
1:106 99uL 1uL B C 
1:107 18uL 2uL C  
1:108 99uL 1uL C D 
1:109 18uL 2uL D  
1:1010 99uL 1uL D E 
1:1011 18uL 2uL E  
1:1012 99uL 1uL E  
 
e. Once culture has reached mid-log phase, dispense 200uL culture into 
microfuge tubes, 1 for each phage dilution. 
f. Add 10uL of each dilution to each tube, vortex quickly, and incubate at 
RT for 1-5min. 
g. Lay out a couple of bench pads to keep the counter top warms.  Else, the 
agar will clump.  Work with no more than 4 plates at a time. 
h. One at a time, transfer the infected cells to a culture tube containing 45C 
Agarose Top, vortex quickly, and IMMEDIATELY pour onto a pre-
warmed LB/IPTG/Xgal plate.  Spread Agarose top by tilting plate. 
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i. Allow plates to cool 5 minutes, invert, and incubate overnight at 37C. 
j. Inspect plates and count plaques on plates having ~102 plaques.  Multiply 
each number by the dilution factor for that plate to get the phage titer in 
plaque forming units (pfu) per 10uL. 
6. Store plates at 4C 
7. Prep another mineralized sample and control for round two. 
 
Day Four 
1. Count blue plaques and determine the phage titer. Use this value to calculate an 
input volume corresponding to 2 x 1011 pfu.  If the titer is too low, succeeding 
rounds of panning can be carried out with as little as 109 pfu of input phage. [Last 
run used all but 10uL because the amplification was low] 
Amplified phage in this step has been consistently low. Usually use most of 
the amplified phage eluate (all but 10uL for freezing). 
15. Inoculate 10mL LB medium with ER2738.  This is the plating culture for 
tittering.  Incubate at 37C with vigorous shaking.  Takes ~3hrs in past to get to 
OD~0.5.   
a. If amplifying eluted phage on the same day, inoculate 20mL LB medium 
in a 250mL Erlenmeyer flask PER SAMPLE.  Do not use a 50mL tube.  
Can leave on bench until ready to use.  Can shake for ~15min prior to 
adding phage. 
16. Get ice. 
17. Blocking step HA & control 
a. For HA & control:  Pour off the coating solution from each plate and 
firmly slap it face down onto a clean paper towel to remove residual 
solution.  Fill each plate or well completely with Blocking buffer*.  
Incubate at least 1 hour at 4C. 
i. * - Control blocking solution has 0.1ug/mL streptavidin [8uL of 
100ug/mL from control initial solution + 8mL of blocking buffer] 
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18. Discard the blocking solution for  HA & control.  Wash each plate rapidly 6X 
with TBST (0.1%).  Coat bottom and sides of plate or well by swirling, pour off 
the solution, and slap the plate face down on a clean paper towel each time.  Work 
quickly to avoid drying out plates.   
19. Introduction of phage for Prescreen #1: 
a. Dilute 2x1011 phage (10uL of original library) with 1mL TBST.  Pipet 
onto HA & control and rock gently (speed 2) for 40 minutes at RT.  (30uL 
phage + 3mL of TBST in 15 mL tube) 
b. Recover supernate and label.  
20. Blocking step for cells (start after phage is introduced to HA & control) 
a. For cells: Wash differentiated cells grown in osteogenic media 2x with 
PBS.  Incubate these cells with 1mL of alpha-MEM containing 0.1% BSA 
for 30min at 37C. 
For sample that only gets Prescreen #1, continue to step # 8.  For Streptavidin control, 
continue to step . 
21. Introduction of phage for Prescreen #2: 
a. Add recovered supernate from HA in step #5 to media containing alpha-
MEM with 0.1% BSA on differentiated cells. 
b. Incubate with gentle agitation for 1 hour at 37C. 
c. Recover supernate, rinse differentiated cells 1x with 1mL PBS and add 
this to supernate 
d. Centrifuge supernate for 10min at 2000g. 
22. Prep Undifferentiated Cells for Phage: 
a. Wash undifferentiated cells in 6-well plates 2x with PBS 
b. Incubate undifferentiated cells with 1mL of Alpha-MEM with 0.1% 
BSA[WITHOUT FBS!!] for 30min-1hour at 37C in 5%CO2. 
23. Discarding Phage: 
For control:  
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a. Discard nonbinding phage by pouring off and slapping plate face-down 
onto a clean paper towel.   
b. Wash plates 10X with TBST (0.1%) rapidly Coat bottom and sides of 
plate or well by swirling, pour off the solution, and slap the plate face 
down on a clean paper towel each time to prevent cross-contamination.  
Work quickly to avoid drying out plates.  
c. Elute control with 0.1mM biotin in TBS for 30min.  Do not have to 
neutralize the control sample. [Biotin solution to elute control:  30uL 
Biotin stock in 3mL of TBS] 
For cells: 
d. Discard supernatant on undifferentiated cells and wash 5x with cold PBS. 
e. Elute bound phage with 1mL of general buffer (Glycine/HCl pH=2.2, 
1mg/mL BSA).  Rock gently for no more than 10 minutes at RT,  Pipet 
eluate into a microcentrifuge tube.   
f. Neutralize with 150uL 1 M Tris-HCl (pH-9.1).  Keep on ice until tittered. 
g. Wash cells 2 more x with PBS.  Lyse cells in 1mL of 30mM Tris, pH 8, 
1mMEDTA for 1 hour on ice to recover cell-associated phage fraction.  
Set aside phage fraction recovered from cells. 
24. Amplification of Phage: 
a. Titer a small amount of the eluate (~1uL) from Groups 1, 2 & 3.  [for 
groups 2 & 3 only amplify the cell surface phage].  Plaques from the first 
or second round eluate tittering can be sequenced if desired.  
b. Check the inoculated LB media to see if it is at mid-log phase (OD600~0.5) 
c. While cells are growing, melt Agarose Top in microwave and dispense 
3mL into sterile culture tubes, one per expected dilution.  Equilibrate tubes 
at 55C in water bath until ready for use.  Microwave on Power 2 for 2 min. 
Pre-warm 1 LB/IPTG/Xgal plate per expected dilution at 37C in incubator 
until ready to use. 
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d. Prepare 10-fold dilutions of phage in LB.  Use a fresh pipet tip for each 
dilution.  
i. Unamplified panning eluates:  101-104 for control, 102 – 105 for 
mineral film, HA disk, and TCPS. 
 LB Eluate  
1:101 18uL 2uL  
1:102 198uL 2uL A 
1:103 18uL 2uL A  
1:104 99uL 1uL A B 
1:105 18uL 2uL B  
1:106 99uL 1uL B  
 
e. Once culture has reached mid-log phase, dispense 200uL culture into 
microfuge tubes, 1 for each phage dilution. 
f. Add 10uL of each dilution to each tube, vortex quickly, and incubate at 
RT for 5min. Microwave agarose on Power 2 for 2 minutes during the 5 
min. incubation period. 
g. Lay out a couple of bench pads to keep the counter top warms.  Else, the 
agar will clump.  Work with no more than 4 plates at a time. 
h. One at a time, transfer the infected cells to a culture tube containing 45C 
Agarose Top, vortex quickly, and IMMEDIATELY pour onto a pre-
warmed LB/IPTG/Xgal plate.  Spread Agarose top by tilting plate.  If 
plates come out clumpy, the agarose was not heated thoroughly.   
i. Allow plates to cool 5 minutes, invert, and incubate overnight at 37C. 
j. Inspect plates and count plaques on plates having ~102 plaques.  Multiply 
each number by the dilution factor for that plate to get the phage titer in 
plaque forming units (pfu) per 10uL. 
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25. The rest of the eluate should be amplified:  Add the eluate to the 20mL ER2738 
culture (should be early log at this point) and incubate at 37C with vigorous 
shaking for 4.5 hours. 
26.  Turn on Ultra Centrifuge before leaving – after incubating eluate to be amplified 
so that the centrifuge is cold after 4.5 hours. 
27. Transfer the culture to a centrifuge tube and spin 10 minutes at 10000rpm (Sorvall 
SS-34, Beckman JA-17, or equivalent) at 4C.  Transfer the supernatant to a fresh 
tube and respin. 
28. Pipet the upper 80% of the supernatant (~16mL) to a fresh tube and add 1/6 
volume of PEG/NaCl.  Allow phage to precipitate at 4C for at least 60 minutes, 
preferably overnight.  Added 2.6mL of PEG/NaCl.  Make sure you mix the PEG 
solution before using it.   
 
Day Five 
8. Spin PEG precipitation 15 minutes at 10,000rpm at 4C.  Decant supernatant, re-
spin briefly, and remove residual supernatant with a pipette.  Will barely be able 
to see pellet. 
9. Suspend the pellet in 1mL TBS.  Transfer the suspension to a microcentrifuge 
tube and spin for 5 minutes at 10,000rpm to 4C to pellet residual cells. 
10. Transfer the supernatant to a fresh microcentrifuge tube and re-precipitate with 
1/6 volume of PEG/NaCl (~17uL).  Incubate on ice for 60 minutes.  
Microcentrifuge for 10 minutes at 4C.  Discard supernatant, re-spin briefly, and 
remove residual supernatant with a micropipet.   
11. Suspend the pellet in 200uL TBS, 0.02% NaN3.  Microcentrifuge for 1 minute to 
pellet any remaining insoluble matter.  Transfer the supernatant to a fresh tube.  
THIS IS THE AMPLIFIED ELUATE.   
12. Titer the amplified eluate on LB/IPTG/Xgal plates. Titer a small amount of the 
eluate (~1uL).  Inoculate 10mL LB w/ ER2738 
a. Check the inoculated LB media to see if it is at mid-log phase (OD600~0.5) 
Time  
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b. While cells are growing, melt Agarose Top in microwave and dispense 
3mL into sterile culture tubes, one per expected dilution.  Equilibrate tubes 
at 45C in water bath until ready for use.   
c. Pre-warm 1 LB/IPTG/Xgal plate per expected dilution at 37C in incubator 
until ready to use. 
d. Prepare 10-fold dilutions of phage in LB.  Use a fresh pipet tip for each 
dilution.  
i. Amplified phage culture supernatant:  108-1011 (Mineral – 109-
1012, Control 109 – 1011).  Be sure to vortex well. 
 LB Eluate  
1:102 99uL 1uL A 
1:104 99uL 1uL A B 
1:106 99uL 1uL B C 
1:107 18uL 2uL C  
1:108 99uL 1uL C D 
1:109 18uL 2uL D  
1:1010 99uL 1uL D E 
1:1011 18uL 2uL E  
1:1012 99uL 1uL E  
 
e. Once culture has reached mid-log phase, dispense 200uL culture into 
microfuge tubes, 1 for each phage dilution. 
f. Add 10uL of each dilution to each tube, vortex quickly, and incubate at 
RT for 1-5min. 
g. Lay out a couple of bench pads to keep the counter top warms.  Else, the 
agar will clump.  Work with no more than 4 plates at a time. 
h. One at a time, transfer the infected cells to a culture tube containing 45C 
Agarose Top, vortex quickly, and IMMEDIATELY pour onto a pre-
warmed LB/IPTG/Xgal plate.  Spread Agarose top by tilting plate. 
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i. Allow plates to cool 5 minutes, invert, and incubate overnight at 37C. 
j. Inspect plates and count plaques on plates having ~102 plaques.  Multiply 
each number by the dilution factor for that plate to get the phage titer in 
plaque forming units (pfu) per 10uL. 
13. Store plates at 4C 
Prep samples and control for round three. 
 
Day Six 
1. Carry out a third round of panning using 2 x 1011 pfu of the second round 
amplified eluate as input phage, again using 0.5% Tween in the wash steps.  
2. Count blue plaques and determine the phage titer. Use this value to calculate an 
input volume corresponding to 2 x 1011 pfu.  If the titer is too low, succeeding 
rounds of panning can be carried out with as little as 109 pfu of input phage. 
3. Inoculate 10mL LB medium with a single clone of ER2738.  This is the plating 
culture for tittering.  Incubate at 37C with vigorous shaking. 
a. If amplifying eluted phage on the same day, inoculate 20mL LB medium 
in a 250mL Erlenmeyer flask.  Do not use a 50mL tube.  Incubate at 37C 
with vigorous shaking. 
4. Pour off the coating solution from each plate and firmly slap it face down onto a 
clean paper towel to remove residual solution.  Fill each plate or well completely 
with Blocking buffer.  Incubate at least 1 hour at 4C. 
5. Discard the blocking solution as in step 2.  Wash each plate rapidly 6X with 
TBST (0.5%).  Coat bottom and sides of plate or well by swirling, pour off the 
solution, and slap the plate face down on a clean paper towel each time.  Work 
quickly to avoid drying out plates. 
6. Pipet 2x 1011 pfu of the second round amplified eluate onto coated plate and rock 
gently for 40 minutes at RT. 
7. Discard nonbinding phage by pouring off and slapping plate face-down onto a 
clean paper towel.   
Time  
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8. Wash plates 10X with TBST (0.5%) rapidly Coat bottom and sides of plate or 
well by swirling, pour off the solution, and slap the plate face down on a clean 
paper towel each time to prevent cross-contamination.  Work quickly to avoid 
drying out plates.  
9. Elute bound phage with 1mL of general buffer (Glycine/HCl pH=2.2, 1mg/mL 
BSA).  Rock gently for no more than 10 minutes at RT,  Pipet eluate into a 
microcentrifuge tube.  Neutralize with 150uL 1 M Tris-HCl (pH-9.1).   
10. Titer a small amount of the eluate (~1uL).  Plaques from the first or second round 
eluate tittering can be sequenced if desired.  
a. Check the inoculated LB media to see if it is at mid-log phase (OD600~0.5) 
b. While cells are growing, melt Agarose Top in microwave and dispense 
3mL into sterile culture tubes, one per expected dilution.  Equilibrate tubes 
at 45C in water bath until ready for use.   
c. Pre-warm 1 LB/IPTG/Xgal plate per expected dilution at 37C in incubator 
until ready to use. 
d. Prepare 10-fold dilutions of phage in LB.  Use a fresh pipet tip for each 
dilution.  
i. Unamplified panning eluates:  101-104 
e. Once culture has reached mid-log phase, dispense 200uL culture into 
microfuge tubes, 1 for each phage dilution. 
f. Add 10uL of each dilution to each tube, vortex quickly, and incubate at 
RT for 1-5min. 
g. Lay out a couple of bench pads to keep the counter top warms.  Else, the 
agar will clump.  Work with no more than 4 plates at a time. 
h. One at a time, transfer the infected cells to a culture tube containing 45C 
Agarose Top, vortex quickly, and IMMEDIATELY pour onto a pre-
warmed LB/IPTG/Xgal plate.  Spread Agarose top by tilting plate. 
i. Allow plates to cool 5 minutes, invert, and incubate overnight at 37C. 
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j. Inspect plates and count plaques on plates having ~102 plaques.  Multiply 
each number by the dilution factor for that plate to get the phage titer in 
plaque forming units (pfu) per 10uL. 
11. Time the procedure so that the plates are incubated no longer than 18 hours.  Store 
the remaining eluate at 4C. 
12. Set up an overnight culture of ER2738 in LB-Tet from a colony, not by diluting 
the plating culture.  Shake at 37C 
 
Day Seven – Plaque amplification  
1. Dilute the ER2738 overnight culture 1:100 in LB.  Dispense 1mL dilute culture 
into culture tubes, one for each clone to be characterized.  Stab 75 clones from the 
third round for mineral film, HA disk, and TCPS.  Stab 20 clones from the 
streptavidin control sample. 
2. Using a sterile pipet tip, stab a blue plaque and transfer to a tube containing 
diluted culture.  IMPORTANT: pick plaques from plates having no more than 
~100 plaques.  This will insure that each plaque contains a single DNA 
sequence. 
[Can only fit ~100 samples on shaker at one time, so have to do 2 batches] 
3. Incubate tubes at 37C with shaking for 4.5-5 hours (NO LONGER!) 
4. Transfer cultures to microcentrifuge tubes, centrifuge 30 seconds.   
a. If immediately going to prepare samples for rapid purification of 
sequencing templates for DNA sequencing, follow the inset letters.  If 
not, continue to step 5. Takes about 1 hour for 24 samples [1.5 hours if 
you do 48 samples simultaneously].   
b. Transfer 500uL of the phage-containing supernatant to a fresh microfuge 
tube. 
c. Add 200uL PEG/NaCl.  Invert to mix, and let stand at RT for 10 minutes 
d. Centrifuge 10 minutes, discard supernatant. 
e. Re-spin briefly.  Carefully pipet away any remaining supernatant. 
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f. Suspend pellet thoroughly in 100uL Iodide Buffer and add 250uL ethanol.  
Incubate 10 minutes at RT.  Short incubation at RT will preferentially 
precipitate single-stranded DNA, leaving most phage protein in solution. 
g. Spin 10 minutes, discard supernatant.  Wash pellet in 70% ethanol, dry 
briefly under a vacuum. 
h. Suspend pellet in 20uL RNAse-DNase free H2O. 
i. 5uL of the resuspended template should be sufficient for manual or 
automated cycle sequencing with dye-labeled dideoxynucleotides.  More 
or less template may be required depending on the sequencing method 
used. 
5. Transfer the supernatant to a fresh tube and re-spin.  Using a pipet, transfer the 
upper 80% of the supernatant to a fresh tube.  THIS IS THE AMPLIFIED 
PHAGE STOCK AND CAN BE STORED AT 4C FOR SEVERAL WEEKS 
WITH LITTLE LOSS OF TITER.  For long term storage, dilute 1:1 with sterile 
glycerol and store at -20C. 
 
Notes:  Conversion factor for UV Spec:  A260 @ 1.000 = 33 ug/mL for ssDNA. 
Factor on UV spec to read OD is 9.3 x 108. 
 
Preparing DNA for DNA Core From Phage Display Library Kit 7-mer peptide (New 
England Biolabs) DNA Sequencing at DNA Core 2560 MSRBII 
1. Transfer 500uL of the phage-containing supernatant to a fresh microfuge tube. 
2. Add 200uL PEG/NaCl.  Invert to mix, and let stand at RT for 10 minutes 
3. Centrifuge 10 minutes, discard supernatant. 
4. Re-spin briefly.  Carefully pipet away any remaining supernatant. 
5. Suspend pellet thoroughly in 100uL Iodide Buffer and add 250uL ethanol.  
Incubate 10 minutes at RT.  Short incubation at RT will preferentially precipitate 
single-stranded DNA, leaving most phage protein in solution. 
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6. Spin 10 minutes, discard supernatant.  Wash pellet in 70% ethanol, dry briefly 
under a vacuum. 
7. Suspend pellet in 30uL TE buffer [10mM Tris-HCl (pH=8.0), 1mM EDTA]. 
8. 5uL of the resuspended template should be sufficient for manual or automated 
cycle sequencing with dye-labeled dideoxynucleotides.  More or less template 
may be required depending on the sequencing method used. 
 
General Notes:  First try submitting prepared ssDNA for control and mineral (10 uL of 
each sample at 100ng/uL)  [control: 2 samples, mineral: 5 samples].  DNA Core requests 
10 uL of primer per sample, however will only submit 20uL of primer (1pmol/uL) 
A good time to stop if the experiment cannot be finished seven days in a row is at the 
PEG/NaCl precipitation.  The phage is very stable at this point. 
Peptide Adsorption Standard Curves Used in Peptide Quantification 
  UV Spectroscopy was determined the most feasible method of peptide detection 
for the adsorption studies.  A standard curve for each peptide was determined at A205nm 
or A220nm.   The peptides containing tryptophan (W), tyrosine (Y), or phenylalanine (F) 
were also read at A280nm, A274nm, and A257, respectively.  The standard curves were 
forced through zero, and the best non-linear fit was determined for each curve. The initial 
peptide concentration introduced to the substrates was also read for each adsorption 
experiment conducted.  An aliquot of the initial peptide concentration was sent for amino 
acid analysis, and the results were used to adjust the standard curve accordingly.  Peptide 
standard curves are presented for short peptides from Chapter Two [A (Figure B.1), E 
(Figure B.2), S (Figure B.3), and V (Figure B.4)], long peptides from Chapter Three [D-
VTK (Figure B.5), L-VTK (Figure B.6), RGDV (Figure B.7), RGEV (Figure B.8), E 
(Figure B.9)], and the phosphorylated peptide from Appendix C [VTK-phos (Figure 
B.10). 
Other options of peptide quantification include amino acid analysis (Dee et al., 
1998; Fujisawa et al., 1997), radiolabeling of the amino acid tyrosine (Hern and Hubbell, 
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1998), fluorescent tagging (Sawyer et al., 2005b), x-ray photoelectron spectroscopy 
(Rezania et al., 1997), or protein quantification kits (e.g. bicinchoninic acid). 
Developed Protocols for Peptide Adsorption and Cell Attachment 
Peptide Adsorption Protocol 
Materials Needed: 
Millipore H2O (ddH2O) 
Trizma buffer, sterile filtered (50mM, pH=7.5, Sigma pre-crystal packet #T7818) 
24-well sterile tissue culture dishes  
1000µL and 200µL sterile pipette tips  
Polypropylene 1.5mL tubes, autoclaved  
Microcuvette for the UV Spectrophotometer (Biorad, Model Smartspec 3000) 
Mineralized films (5 Day soak in 1Xmodified SBF) 
HA, CA5, and CA10 Disks, sonicated clean and autoclaved (as prepared in methods of 
Chapters Two and Three) 
10mM HCl, sterile filtered 
 
Standard Curve Methods: 
1. Reconstitute the peptide in ddH2O at a concentration of 10mg/mL. 
2. Dilute the peptide in Trizma buffer to a concentration of 1 mg/mL to get a 
working amount of 1.5mL for the standard curve.  
3. Perform serial dilutions according to Table B.1. 
4. On the UV Spectrometer, run an absorbance curve over the wavelength range 
(200-300nm) to determine the optimum wavelenth(s) to read each peptide.  
5. After determining the optimum wavelength(s) to quantify the peptide with, read 
the standard curve samples, each sample in duplicate. 
6. Plot the standard curve and use to determine the concentration of adsorbed 
peptide in the experiment. 
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Peptide Adsorption Methods: 
1. Soak mineralized films in Trizma buffer overnight at 4°C in a humidifier box 
(plastic Tupperware container with wet lining paper towels). 
2. Determine working concentration of peptide in solution.  Use reconstituted 
peptide from Standard Curve Methods step 1 and dilute the peptide in Trizma 
buffer to an initial starting concentration of 750 µg/mL. 
3. Soak samples in 1mL peptide solution for 3 hours with gentle agitation (LabLine 
Titer Plate Shaker at setting 2).  Control samples receive 1mL of Trizma buffer 
devoid of peptide. 
4. After 3 hours, transfer peptide solution into labeled polypropylene tubes.  
5. Rinse the substrates 1X with Trizma buffer. 
6. Demineralize films in 1mL of 10mM HCl solution for 18 hours with agitation 
(again on Lab-Line Titer Plate Shaker, setting 2-3).  Samples should be 
demineralized in the same 24-well plate that the experiment was run. 
7. Read a 100µL aliquot for each sample at the determined absorbances.  (A205nm, 
A220nm). This is an indirect measurement of peptide adsorption.  Blank UV 
Spectrometer with ddH2O. 
8. After 18 hours agitation in 10mM HCl, transfer demineralized peptide solution 
(1mL) into polypropylene tubes. 
9. Read a 100µL aliquot for each sample at the determined absorbances.  (A205nm, 
A220nm). This is the direct measurement of peptide adsorption. Blank UV 
Spectrometer with 10mM HCl.  Use standard curves to determine amount of 
peptide adsorbed. 
 
Cell Attachment Assay Protocol 
Materials Needed: 
hBMSCs  
Millipore H2O (ddH2O) 
Trizma buffer, sterile filtered (50mM, pH=7.5, Sigma pre-crystal packet) 
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24-well sterile tissue culture dishes  
15mL sterile tubes 
1000µL, 200µL, 50µL, and 10µL sterile pipette tips  
Polypropylene 1.5mL tubes, autoclaved  
Microcuvette for the UV Spectrophotometer (Biorad, Model Smartspec 3000) 
Mineralized films (5 Day soak in 1Xmodified SBF) 
HA, CA5, and CA10 Disks, sonicated clean and autoclaved (as prepared in methods of 
Chapters Two and Three) 
α−MEM with glutamine and 20%FBS, 1% P/S 
α−MEM with glutamine without any supplements 
0.25% Trypsin/EDTA solution 
Dulbecco’s Phosphate Buffer Solution (PBS) 
Denatured BSA (dBSA)  (1g BSA in 50mL PBS, heat to 80°C and hold for 6 minutes) 
WST-1 Premixed Reagent (Clonetech, #630118) 
Hemacytometer 
70% Ethanol solution 
 
Peptide Adsorption:  
1. Follow the Peptide Adsorption Protocol until step #5 (rinse substrates 1X with 
Trizma) 
2. Add 1mL of dBSA per well and let sit without agitation for 1 hour at room 
temperature. 
3. Remove dBSA solution, and rinse each well 1X with PBS.  
4. During the dBSA incubation, prepare hBMSCs for seeding. 
a. Trypsinize appropriate number of flasks with 0.25% Trypsin/EDTA.  
Incubate cells at 37°C with 5% CO2 for 2 minutes (2mL Trypsin solution 
for a T75 flask).  Add 2mL of α−MEM with glutamine and 20%FBS, 1% 
P/S.   
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b. Spin the cell solution for 5 minutes at 1000rpm. Resuspend the cells in n 
mL of α−MEM with glutamine. 
c. Count cells on hemacytometer.  Determine the cell concentration by 
adding the cell numbers in all four quadrants on the hemacytometer, 
dividing by 4, and multiplying by n x104. Cell concentration = 
([A+B+C+D]/4) x n mL used to resuspend x 104 
5. Prepare two cell solutions:  cell seeding solution and cell standard curve solution.  
a. Cell seeding solution should contain enough cells to seed 5x104 cells in 
500µL of  α−MEM with glutamine per well.  
b. Cell standard curve solution should suspend 5x105 cells in 1mL of 
α−MEM with glutamine in a 1.5mL polypropylene tube. 
6. Seed cells on substrates (500 uL per sample; 50,000 cells/film) and let incubate at 
37°C with 5% CO2 for 1 hour. 
7. Prepare a cell standard curve in α−MEM with glutamine according to Table B.2. 
8. Seed cell standard curve in a 24-well tissue culture plate, n=2 for each cell 
concentration. 
9. After allow cells to adhere for 1 hour at 37°C in 5% CO2, remove liquid from 
wells in all samples except standard curve. 
10. Centrifuge 24-well dishes upside down in a Eppendorf 5810R or equivalent for 5 
minutes at 300rpm.  
11. Rinse wells 1X with PBS. 
12. Add 500µL α−MEM with glutamine per well. 
13. Add 50µL of WST-1 premixed reagent (CloneTech #630118) to both centrifuged 
plates and plate with cell standard curve. 
14. Allow WST-1 to incubate with cells for 2-3 hours. 





When performing the cell attachment assay, it is best to also prepare wells in a separate 
24-well dish to monitor α−MEM, α−MEM with WST-1, and n=4 initial seeding 
concentrations that all the substrates received.  Additionally, be sure to prepare enough 
wells for both BLM and TCPS controls (n=6) that receive the dBSA blocking treatment, 
but do not have any peptide adsorbed.  This background cell attachment varies from day 




Figure B.1:  Standard curve for peptide APWHLSSQYSRT [A] (MW = 1431.7 g/mol) 
determined via UV spectroscopy at A205. 
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Figure B.2: Standard curve for peptide EEEEEEEPRGDT [E] (MW = 1447.6 g/mol) 
determined via UV spectroscopy at A220. 
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Figure B.3: Standard curve for peptide STLPIPHEFSHRE [S] (MW = 1411.7 g/mol) 
determined via UV spectroscopy at A205. 
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Figure B.4: Standard curve for peptide VTKHLNQISQSY [V] (MW = 1416.7 g/mol) 
determined via UV spectroscopy at A205. 
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Figure B.5: Standard curve for peptide GGDPIYALSWSGMAGGGSVTKHLNQISQSY 
(MW = 3081.2 g/mol) determined via UV spectroscopy at A205. 
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Figure B.6: Standard curve for peptide GGLLADTTHHRPWTGGGSVTKHLNQISQSY 
(MW = 3218.0 g/mol) determined via UV spectroscopy at A205. 
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Figure B.7: Standard curve for peptide GGRGDGGGSVTKHLNQISQSY (MW = 2117.6 
g/mol) determined via UV spectroscopy at A205. 
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Figure B.8: Standard curve for peptide GGRGEGGGSVTKHLNQISQSY (MW = 2131.6 
g/mol) determined via UV spectroscopy at A205. 
 165 
 
Figure B.9: Standard curve for peptide EEEEEEEPRGDT (MW = 1447.6 g/mol)  
determined via UV spectroscopy at A205. 
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Figure B.10: Standard curve for peptide VTKHLNQIS(p)QS(p)Y (MW = 1576. g/mol)  
determined via UV spectroscopy at A205. 
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Table B.1:  Standard Curve Dilution Scheme for Peptide Adsorption 
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BIOREACTOR PROTOCOL AND MATLAB PROGRAM  




Aluminum shaft (with 3/16” 20 threading)* 
3/16” 20 Alan Bolt* 
8 x 8” glass baking pan* 
4 small Petri dishes* 
Aluminum base plate 
4 large C-clamps 
Circular 5 ½” Delrin mold 









* - To be autoclaved daily (can autoclave on ‘solids’ setting at 250°F for 25min, cool 
down time of 20min) 
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Procedure:   
1. Fabricate 3mm thick scaffolds in circular Delrin mold following scaffold 
fabrication protocol.  For each scaffold use 375 µg NaCl and 288 µL 
PLGA/chloroform solution. (300mg NaCl, 236uL PLGA/chloroform solution for 
2.5mm scaffolds) 
2. Autoclave aluminum base, Alen bolt, and aluminum foil (enough foil to cover 
opening on cylinder and plug screw holes in mold). 
3. Filter and warm to 37C in hot water 1L 1x modified SBF (w/ NaN3 0.05 g/L). 
4. Sample 8 mL of filtered SBF in 15 mL Falcon tube to test pH. 
5. Turn on water supply to Instron and power up the machine. 
6. Calibrate any sensors that require calibration (most likely the load sensor).  
Sensors that need calibration will have a blinking green light.   
7. Using gloves clean circular mold, o-ring, and aluminum plunger with 70% 
ethanol. 
8. Plug screw holes in mold with autoclaved rubber stoppers.  Secure thermocouple 
with dental rubberbands on the Delrin mold.   
9. Jog the crosshead up to a position to attach the plunger with aluminum rod.  Bolt 
mold into position on plunger with the flush side of the scaffolds facing down (the 
plunger, aluminum rod, can be removed/tightened by using the clamp control unit 
(behind the tower) and foot petal (to the right of the tower). 
10. Turn on hydraulics and actuator. 
11. Put aluminum cylinder in position under the mold (w/o o-ring attached).  Use 
knobs on front of machine to lower mold into and out of cylinder to align. 
12. Make sure piston in positioned close enough to middle position to allow the 
machine to cycle. 
13. Attach o-ring.  Add 1L SBF.  Using gloves wet insides of cylinder and o-ring with 
SBF on a Kimwipe. 
14. Use knobs on front of machine to lower mold into cylinder.  Be extra careful 
when moving o-ring into opening of the cylinder.  Push down on sides of mold to 
ensure it goes in level. 
15. Lower mold into position using knobs.  It is in position when the bottom of the 
blue tape on the plunger is aligned with the rim of the cylinder (this step produces 
a large load on the mold, >1000 N, so be careful and wear safety glasses). 
16. Use c-clamps to clamp aluminum cylinder to aluminum base plate. 
17. Cover the top of the aluminum cylinder with autoclaved aluminum foil. 
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18. Set positional waveform on control panel: cyclic, triangular, 25.4 mm (this is the 
amplitude: the distance from the midline to the peak of the wave), 0.0011 Hz (this 
frequency corresponds to 1 cycle/15 minutes) 
19. Turn on amplitude control by pressing the amplitude control button on the consol 
followed by the button corresponding to ‘on’. 
20. Plug in temperature controller. 
21.  Press start.  Run Instron for 6 hours.  Loads will be large for the first few cycles 
(~ 800 N) but should reduce to 300-500 N after a few cycles.  Check on cycling 
periodically to troubleshoot any problems that may occur. 
22. Clean Tupperware used for overnight soaks well with ethanol. 
23. Make SBF (w/ NaN3) if needed (every other day) following SBF protocol. 
24. Filter and warm to 37C in hot water 1 L 1x modified SBF (w/ NaN3). 
25. Sample 8mL SBF in a 15mL Falcon tube after 6 hour run. 
26. Place mold in cleaned Tupperware.  Add 1L warmed SBF. 
27. Leave in incubator set at 37C overnight. 
28. Sample 8mL SBF in a 15mL Falcon tube from baking pan the next morning. 
29. Repeat steps 2-27 each day for 5 days. 
30. Rinse scaffolds in deionized water to remove excess salt. 
31. Remove the scaffolds from the mold using a brass tube cutter and a spatula.  
Remove them gingerly, to keep the scaffolds intact. 
32. Dry scaffolds under hood for 1-2 days. 
 
General Notes:  O-rings need to be replaced in the middle of a 5-6 Day run.  Be sure to 
wipe them thoroughly with ethanol.   




Aluminum shaft (with 3/16” 20 threading) 
Rubber stoppers* 
3/16” 20 Alan Bolt 
Aluminum base plate 
4 large C-clamps 
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Circular 5 ½” Delrin mold 
5x and 2x SBF with NaN3 filtered with 0.22um sterile filter (The NaN3 helps prevent 
bacterial contamination) 
450-600um diam. NaCl 




Plastic pitcher, 25mL syringe  
FITC-BSA, BSA  
10mM HCl 
6-well culture plate dishes for demineralization 
PLGA (85:15 from Alkermes), Chloroform (Sigma), and NaCl (Sigma) for casting 
scaffolds 
Delrin mold with 8 salt-leached scaffolds & o-ring (McMaster-Carr, Buna 251) 
Teflon mold with 8 salt-leached scaffolds 
Scintillation vials for pH reading samples 
pH meter (Mettler-Toledo) 
Tupperware for Teflon mold 
* - To be autoclaved (can autoclave on ‘solids’ setting at 250F for 25min, cool down time 
of 20min) 
 
Procedure for Bioreactor: 
1.  Fabricate 2.5-3mm thick scaffolds in circular Delrin mold and Teflon mold 
following scaffold fabrication protocol.  For each scaffold use 600 µg NaCl 
and 472µL PLGA/chloroform solution.  
2. Autoclave aluminum base, rubber stoppers, and aluminum foil (enough foil to 
cover opening on cylinder and plug screw holes in mold). 
3. Filter and warm to 37C in hot water 1L 5xSBF (w/ NaN3 0.05 g/L). 
4. Sample 3 mL of filtered SBF in scintillation vial to test pH. 
5. Turn on water supply to Instron and power up the machine. 
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6. Calibrate any sensors that require calibration (most likely the load sensor).  
Sensors that need calibration will have a blinking green light.   
7. Using gloves clean circular mold, o-ring, and aluminum plunger with 70% 
ethanol. 
8. Plug screw holes in mold with autoclaved rubber stoppers.  Secure 
thermocouple with dental rubberbands on the Delrin mold.   
9. Jog the crosshead up to a position to attach the plunger with aluminum rod.  
Bolt mold into position on plunger with the flush side of the scaffolds facing 
down (the plunger, aluminum rod, can be removed/tightened by using the 
clamp control unit (behind the tower) and foot petal (to the right of the tower). 
10. Turn on hydraulics and actuator. 
11. Put aluminum cylinder in position under the mold (w/o o-ring attached).  Use 
knobs on front of machine to lower mold into and out of cylinder to align. 
12. Make sure piston in positioned close enough to middle position to allow the 
machine to cycle. 
13. Attach o-ring.  Add 1L 5x-SBF.  Using gloves wet insides of cylinder and o-
ring with SBF on a Kimwipe. 
14. Use knobs on front of machine to lower mold into cylinder.  Be extra careful 
when moving o-ring into opening of the cylinder.  Push down on sides of 
mold to ensure it goes in level. 
15. Lower mold into position using knobs.  It is in position when the bottom of 
the blue tape on the plunger is aligned with the rim of the cylinder (this step 
produces a large load on the mold, >1000 N, so be careful and wear safety 
glasses). 
16. Use c-clamps to clamp aluminum cylinder to aluminum base plate. 
17. Cover the top of the aluminum cylinder with autoclaved aluminum foil. 
18. Set positional waveform on control panel: cyclic, triangular, 25.4 mm (this is 
the amplitude: the distance from the midline to the peak of the wave), 0.0011 
Hz (this frequency corresponds to 1 cycle/15 minutes) 
19. Turn on amplitude control by pressing the amplitude control button on the 
consol followed by the button corresponding to ‘on’. 
20. Plug in temperature controller. 
21. Press start.  Loads will be large for the first few cycles (~ 800 N) but should 
reduce to 300-500 N after a few cycles.  Check on cycling periodically to 
troubleshoot any problems that may occur. 
22. After 6 hours, replace 5x-SBF with another 1L of 5X-SBF.  Take pH aliquots. 
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23. Start static mineralization of Teflon mold scaffolds in Tupperware, following 
same SBF regiment.  
24. Sample 3 mL of filtered SBF in scintillation vial to test pH. 
25. After 6 more hours, replace with pre-warmed 2x-SBF.  Take pH aliquots. 
26. After 12 hours, replace with pre-warmed FITC-BSA 2x-SBF.  Take pH 
aliquots. 
27. Repeat #26 for next 36 hours.  
28. Stop the run after 72 hours. 
29. Rinse scaffolds in deionized water to remove excess salt. 
30. Remove the scaffolds from the mold using a brass tube cutter and a spatula.  
Remove them gingerly, to keep the scaffolds intact. 
31. Dry scaffolds under hood for 1-2 days. 
 
Demineralization and BSA Quantification: 
1. Demineralize 4 scaffolds from experimental and control groups in 2mL of 10mM 
HCl in 6-well culture plate dishes.  Cut up scaffolds using razor or microtome 
blade. 
2. Agitate on LabLine Titer plate shaker at setting 3-3.5 (200rpm) for 24 hours.  
Cover plates with aluminum foil to protect from light. 
3. Read BSA concentration on UV Spec. 
 
MicroCT of Scaffolds: 
1. 4 scaffolds from each group should be scanned on the MicroCT to determine % 
mineral volume.  Scan using Polymer_Parker_15um protocol at 75mV, 75mA 
with 400planes. 
SBF Needed for 3-Day Run: 
 Instron Mold Teflon Control Mold Totals 
Day One 2L 5x SBF (pH=6.2 @ RT) 
1L 2x SBF (pH=6.8 @ RT) 
1L 5x SBF (pH=6.2 @ RT) 
0.5L 2x SBF (pH=6.8 @ 
RT) 
3L 5x SBF 
1.5L 2x SBF 
Day Two 2L 2x SBF with BSA 1L 2x SBF with BSA 3L 2x SBF with BSA 
Day 
Three 
2L 2x SBF with BSA 1L 2x SBF with BSA 3L 2x SBF with BSA 
   3L 5xSBF 
1.5L 2xSBF 
6L 2xSBF with BSA 
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Procedure for making FITC-BSA:BSA SBF Solution: 
1. Weigh out BSA and FITC-BSA  
a. Use a 1:5 ratio of FITC-BSA to BSA 
b. 100mg FITC-BSA : 500mg BSA per day 
c. per liter:  33mg FITC-BSA; 167mg BSA 
[200ug/mL x 3000mL = 600mg per day x 2 days = 1.2g for entire experiment] 
2. Add BSA:FITC-BSA into filtered 2x SBF and allow to mix for at least 30 min. 
(protect solution from light; cover with Al foil.  Might want to do this in 4L 
Nalgene bottle so you can filter and mix in same container) 
3. Store in refrigerator until use; protected from light. 
 
3mL Aliquots for pH and Initial protein concentrations in scintillation vials: 



















BSA concentrations must be read immediately on the UV Spec. Using the 1mL quartz 
cuvette.  Wavelengths 280 and 494nm should be read.  Save the remainder of the aliquot 
in the refrigerator protected from light. 
Micro-Computed Tomography MATLAB Program for Mineral Distribution 
Throughout a 3-Dimensional Scaffold 
[ImFileName,ImPathName] = uigetfile('*.vff','MultiSelect','off'); %let the user select the path 
ImToLoad=strcat(ImPathName,ImFileName); %form a string that has the path and filename combined 
disp(['Reading the file: ' ImToLoad]) 
disp(' ') 
 [ImHeader] = readvff_header(ImToLoad); %Read the header from the .vff file 
origin_ind = strmatch('origin=',ImHeader); %find the entry within the ImHeader cell array containing the origin 
origin_str = char(ImHeader(origin_ind));%extract the cell containing the origin data and make it a string 
start_ind = strfind(origin_str,'=') +1;%get the index number after the = sign 
fin_ind = strfind(origin_str,';') -1 ;%get the index number before the ; sign 
origin_str = origin_str(start_ind:fin_ind); %extract just the portion containing the numbers 
origin_split = strsplit(origin_str,' '); %split it up into a 1x3 cell array  
origin_coord1 = str2num(char(origin_split(1))); %get the x coordinate of the origin 
origin_coord2 = str2num(char(origin_split(2))); %get the y coordinate of the origin 
origin_coord3 = str2num(char(origin_split(3))); %get the z coordinate of the origin 
ImOrigin = [origin_coord1 origin_coord2 origin_coord3]; %append all three of the origin coords together 
clear start_ind fin_ind 
elsize_ind = strmatch('elementsize=',ImHeader); 
elsize_str = char(ImHeader(elsize_ind)); %extract the cell containing the data and make it a string 
elstart_ind = strfind(elsize_str,'=') +1; %get the index number after the = sign 
elfin_ind = strfind(elsize_str,';') -1;  %get the index number before the ; sign 
elsize_str =elsize_str(elstart_ind:elfin_ind); %extract just the portion containing the numbers 
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voxsize=str2num(elsize_str); 
if isempty(elsize_ind)  
    elsize_ind = strmatch('spacing=',ImHeader); 
elsize_str = char(ImHeader(elsize_ind)); 
elstart_ind = strfind(elsize_str,'=') +1; 





size_str = char(ImHeader(size_ind));%extract the cell containing the origin data and make it a string 
start_ind = strfind(size_str,'=') +1;%get the index number after the = sign 
fin_ind = strfind(size_str,';') -1 ;%get the index number before the ; sign 
size_str = size_str(start_ind:fin_ind); %extract just the portion containing the numbers 
size_split = strsplit(size_str,' '); %split it up into a 1x3 cell array  
size_coord1 = str2num(char(size_split(1))); %get the x coordinate of the origin 
size_coord2 = str2num(char(size_split(2))); %get the y coordinate of the origin 
size_coord3 = str2num(char(size_split(3))); %get the z coordinate of the origin 
ImSize = [size_coord1 size_coord2 size_coord3]; %append all three of the origin coords together 
clear start_ind fin_ind 
percent_chg = input('Enter the percentage that ROI should shrink by, as a positive decimal (ex. 0.10): ') 
%make sure the number is positive 
if percent_chg <=0 
    error(strcat('The number that was input was less than or equal to zero.',... 
        'The number must be a positive decimal, so the program will now stop.')) 
end 
 
remainder = rem(1,percent_chg); %Calculate a remainder 
if remainder == 0 %i.e., when the percentage evenly divides into 1 
    percent_vector = [(1-percent_chg) : -percent_chg : percent_chg]; 
else %when the percentage does not evenly divide into 1 
    disp('WARNING: The percentage decrease that was input is not evenly divisible into 1!') 
    disp('WARNING: The last increment will not equal the percent change input') 
    disp(' ') 
    percent_vector = [(1-percent_chg) : -percent_chg : percent_chg, percent_chg]; 
end 
disp('The percentages that the ROI will be shrunk are:') 
disp(percent_vector) 
disp(' ') 
 [FileName,PathName] = uigetfile('*.xml','MultiSelect','off'); %let the user select the path 
FileToLoad=strcat(PathName,FileName); %form a string that has the path and filename combined 
disp(['Reading the file: ' FileToLoad]) 
disp(' ') 
[storage,transform_data,roi_transform_data] = AdvROI_Load(FileToLoad); 
x_spline_pts = squeeze(storage(:,1,:)); 
xcent = mean(nonzeros(x_spline_pts)); 
y_spline_pts = squeeze(storage(:,2,:)); 
ycent = mean(nonzeros(y_spline_pts)); 
z_spline_pts = storage(:,3,:); 
zmin = min(max(storage(:,3,:))); 
zmax = max(max(storage(:,3,:))); 
zcent = mean([zmin zmax]); 
centroid_array = [xcent ycent zcent]; 
centroid_array = centroid_array./voxsize-ImOrigin; 
ImOrigin_matrix = ones(size(storage,1),1)*ImOrigin; %1D to 2D 
for ctr=1:1:size(storage,3) 





coord_matrix = (storage./voxsize) - ImOrigin_matrix; 
coord_matrix(zero_indices)=0; 
 [centroid_matrix] = centroid_3d(coord_matrix,centroid_array); 
radius_matrix_orig = coord_matrix - centroid_matrix; 
for BIGctr = 1:length(percent_vector) 
    percent_scale = percent_vector(BIGctr); 
    disp(['The algorithm is now running for the percentage at: ',num2str(percent_scale)]) 
    [radius_matrix] = CoordShrink_cyl(radius_matrix_orig,percent_scale); 
    radius_matrix = round(radius_matrix); 
    trial_array = zeros(size(radius_matrix,1),size(radius_matrix,3)); 
    trial_array(:,:) = radius_matrix(:,3,:); 
    trial_array = trial_array(1,:); 
    find_repeats = [1,diff(trial_array)]; 
    repeats = find(diff(trial_array)==0); 
    if isempty(repeats)==0 
        radius_matrix_corr = zeros(size(radius_matrix,1),size(radius_matrix,2),(length(trial_array)-length(repeats))); 
        for ctr=1:1:size(radius_matrix,3) 
            if find_repeats(ctr)==1 
                index=min(find(radius_matrix_corr(1,1,:)==0)); %find the first non-zero entry in 'radius_matrix_corr' 
                radius_matrix_corr(:,:,index) = radius_matrix(:,:,ctr); 
            end 
        end 
    else 
        radius_matrix_corr = radius_matrix; 
    end 
    centroid_matrix_corr = centroid_matrix(:,:,1:size(radius_matrix_corr,3)); 
    coord_matrix_new = radius_matrix_corr + centroid_matrix_corr; 
    zero_indices=find(coord_matrix_new(:,:,:)==0); 
    ImOrigin_matrix_corr = ImOrigin_matrix(:,:,1:size(radius_matrix_corr,3)); 
    key_frames = round(coord_matrix_new(1,3,1:size(coord_matrix_new,3))); 
    coord_matrix_final = (coord_matrix_new + ImOrigin_matrix_corr) .* voxsize; 
    coord_matrix_final(zero_indices)=0; 
    coord_matrix_final = fix2(coord_matrix_final,4); 
    FileRootName=FileToLoad(1:strfind(FileToLoad,'.xml')); 
    FileEndName=strcat(num2str(percent_scale*100),'percent.xml'); 
    FileToSave = strcat(FileRootName,FileEndName); 
    disp(['Saving the file: ',FileToSave]) 




function [header] = readvff_header(fname) 
fid = fopen(fname,'r','b'); 
fInfo = dir(fname); 
endHeader = 0; 
lineNbr = 1; 
tline = fgetl(fid); % skip the ncaa line without a ; 
header{lineNbr} = tline; 
lineNbr = lineNbr + 1; 
while(endHeader == 0) 
  tline = fgetl(fid); 
  if(tline(end) == ';') 
    header{lineNbr} = tline; 
    lineNbr = lineNbr + 1; 
  else 
    endHeader = 1; 






    function [contour_data,transform_data,roi_transform_data] = AdvROI_Load(FileToLoad) 
inputdata = xml_load(FileToLoad); 
        num_slices = size(inputdata,2); %find the number of slices with contours 
for ctr=1:size(inputdata,2) 
            rowsizes(ctr) = (size(inputdata(1,ctr).contour,2)); %create a vector to hold the x-coordinates for every slice 
        end 
        max_rowsize=max(rowsizes); 
        contour_data = zeros(max_rowsize,3,num_slices); %note, the second digit in this so 
        for slicectr = 1:1:num_slices %run this for every slice 
            point_lim = max(size(inputdata(1,slicectr).contour)); %calculate the number of points at for each contour 
            pt_data_cell = struct2cell(inputdata(1,slicectr).contour); %get the data containing the coordinates. every row is 
stored as a string. format is as a cell 
            for ptctr = 1:1:point_lim 
                pt_data = cell2mat(pt_data_cell(:,:,ptctr)); 
                point=pt_data_cell(1,1,ptctr); %get the data into a 1x1 cell 
                point=strsplit(char(point),'('); %remove the ( 
                point=strsplit(char(point),')'); %remove the ) 
                point=strsplit(char(point),','); %remove the commas, separating 'point' into a 1x3 cell 
                coord1=str2num(char(point(1,1))); 
                coord2=str2num(char(point(1,2))); 
                coord3=str2num(char(point(1,3))); 
                        contour_data(ptctr,1,slicectr) = coord1; 
                contour_data(ptctr,2,slicectr) = coord2; 
                contour_data(ptctr,3,slicectr) = coord3; 
            end 
        end 
        transform_data = inputdata(1,1).transform; 
        roi_transform_data = inputdata(1,1).roi_transform; 
    end 
end 
%---------------------------------------- 
function [centroid_matrix] = centroid_3d(data_matrix,centroid_array) 
zero_indices=find(data_matrix(:,:,:)==0); 
centroid_matrix = ones(size(data_matrix,1),1)*centroid_array; 
for ctr=1:1:size(data_matrix,3) 





function [radius_matrix_new] = CoordShrink_cyl(radius_matrix_orig,percent) 
radius_matrix_new = zeros(size(radius_matrix_orig)); %Create a new radius matrix to store all of the radii 
for ctr1=1:size(radius_matrix_orig,3) %use to go slice by slice 
    for ctr2=1:size(radius_matrix_orig,1) %use to go row by row 
        temp_coords_cart = radius_matrix_orig(ctr2,:,ctr1) 
        tempx = temp_coords_cart(1); 
        tempy = temp_coords_cart(2); 
        tempz = temp_coords_cart(3); 
        [theta,rad_old,z_old] = cart2pol(tempx, tempy, tempz); 
        rad_new = percent*rad_old; 
        z_new = percent*z_old; 
        [tempx2,tempy2,tempz2] = pol2cart(theta,rad_new,z_new); 
        radius_matrix_new(ctr2,1,ctr1) = fix2(tempx2,4); 
        radius_matrix_new(ctr2,2,ctr1) = fix2(tempy2,4); 
        radius_matrix_new(ctr2,3,ctr1) = fix2(tempz2,4); 
    end 
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    refcoord3 = fix2(radius_matrix_new(1,3,ctr1),4); 
    ptcheck = find(((radius_matrix_new(:,3,ctr1))~=refcoord3) & ((radius_matrix_new(:,3,ctr1))~=0)); 
    if isvector(ptcheck) %this should run where there are some points that don't match 
        radius_matrix_new(ptcheck,3,ctr1)=refcoord3; 





fid = fopen(FileToSave, 'w'); 
fprintf(fid,'%s\n','<?xml version="1.0" encoding="UTF-8" ?>'); 
fprintf(fid,'%s\n','<!DOCTYPE MicroViewContours>'); 








fprintf(fid,'%s\n',['<contour slice="' num2str(key_frames(ctr3)) '" keyframe="1">']); 
    for ctr1 = 1:1:size(contour_data(:,:,ctr3),1) 
        if (contour_data(ctr1,1,ctr3))~=0 %added so that the rows with zeros are not written into the output file 
            outputrow = ['( ' num2str(contour_data(ctr1,1,ctr3) ,'%.4f') ... 
                ', ' num2str(contour_data(ctr1,2,ctr3),'%.4f') ... 
                ', ' num2str(contour_data(ctr1,3,ctr3),'%.4f') ')']; 
            outputrow2=xml_formatany(outputrow,'p'); 
            fprintf(fid,'%s\n',outputrow2); 
        end 
    end 






function b = fix2(a, n) 
if nargin < 2 || ~any(n) || isempty(a) 
    b = fix(a); return 
end 
% general case(round to n decimals ) 
if ~isscalar(a) && ~isscalar(n) && ~isequal(size(a),size(n)) 
    error('Non-scalar inputs must be the same size') 
end 
t2n = 10.^floor(n); 
b = fix(a.*t2n)./t2n; 
end 
 
Protocol for Using the MATLAB ROIShrink Program 
Using the ROIShrink Program 
In MicroView 
1. Open a .vff in MicroView 
2. Using the ‘Advanced ROI’ tool, define contours of the sample at 10 slice 
increments.  Save the contours (will save as an .xml files).  
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3. Interpolate the contours 
4. Generate 3D ROI 
5. In the Bone Analysis tab (original menu on MicroView), autothreshold at 1000 
and check the BMD box.   
6. Run the BMD analysis and record the analysis. 
7.  
In Matlab 
1. Type in the command prompt:  ROIShrink 
2. A window will pop up to select a .vff file.  Choose a .vff file to analyze. 
3. Enter at the prompt 0.01 increment 
4. Another window will pop up to select a .xml file (saved from the defined ROI 
using the Advanced ROI tool).  Choose the .xml file that corresponds to the .vff 
file you opened in the second step.   
5. Matlab will save incremental files into the folder that you opened the .xml file in 
step 4.   
 
In MicroView 
1. Go back to Microview and open up the original .vff file for the sample. 
2. Under the ‘Advanced ROI’ tool, click on ‘Load Contours’.   
3. To analyze the sample in 15% increments, load the following files. 
 







4. Perform the BMD analysis on each of the 15% increments on the files.  This 
means each file has to be separately opened in Microview under the ‘Load 
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